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ABSTRACT
Food-borne disease continues to be a major cause of human morbidity and mortality.
During the past few decades, Campy/obaeter jejuni has ascended to become the greatest
cause of bacterial enteric disease worldwide. Anecdotal evidence suggests the majority
of human campylobacteriosis in industrialised countries is caused by the consumption of
undercooked chicken. Campy/obaeter continues to frustrate current control strategies
throughout the food chain and in 2001 was responsible for over 56, 000 cases of food
poisoning in the U.K. alone. The work presented in this thesis examined the potential of
host-specific bacteriophage as a novel measure to control the population of
Campy/obaeter in poultry production.
Several surveys in this thesis revealed that campylobacters and their bacteriophage
permeate the entire poultry meat supply chain, from chickens in the broiler house to
packaged retail products. Characterisation of the bacteriophage recovered from such
sources showed that retail poultry isolates exhibited greater similarities in host range than
those originating from broiler houses, implying poultry processing selected for a sub-
population of phage. Additionally, broiler chickens harbouring bacteriophage in their
gastrointestinal tract generally contained fewer campylobacters. All of the phage isolates
studied belonged to the Myoviridae virus family as they possessed dsDNA genomes
encapsulated in an icosahedral head with a rigid, contractile tail. Fragments of the phage
genomes exhibited significant sequence homology with a number of genes involved in
DNA replication from phage T4. Studies of the attachment and replication of the phage
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isolates in vitro suggested that adsorption to the host cell was efficient but the burst size
was low «10 virions per cell). Campy/obaeter jejuni was found to produce membrane
vesicles but these did not significantly affect bacteriophage replication in vitro.
A series of trials using 'phage therapy' in broiler chickens revealed that Campy/obaeter
colonisation can be reduced by ~loglo 8.0 cfu s" caecal contents by dosing with specific
bacteriophage. However, both the timing and extent of the reduction in Campy/obaeter
colonisation showed considerable variation. Additionally, the ability of bacteriophage to
infect their host in vitro was not a reliable indicator of their efficacy in vivo. The direct
application of bacteriophage to the surface of chicken skin artificially contaminated with
Campylobaeter led to a significant reduction in the number of recoverable host cells.
Host resistance to bacteriophage infection was not detected in either the in vivo trials or
when recovering Campylobacter cells from chicken skin treated with phage.
The work presented in this thesis demonstrates that bacteriophage have considerable
potential in the control of Campylobacter in poultry production. They already appear to
constitute a limiting factor in Campylobaeter colonisation of the chicken gastrointestinal
tract and can be detected with their host on retail products. However, further research is
required to fully realise their potential and optimising the timing, level and type of
bacteriophage used in dosing will be important for their efficacy in vivo.
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CHAPTER 1
INTRODUCTION
1.0 OBJECTIVES
Bacteriophage have successfully been used to control populations of food-borne
pathogens such as Salmonella and E. coli colonising the gastrointestinal tracts of
domestic fowl and cattle (Smith and Huggins, 1983; Berchieri et al., 1991). However,
comparatively little is known about bacteriophage of Campylobacter. The work
presented in this thesis sought to expand current knowledge about the presence of
bacteriophage and their Campylobacter host populations in poultry production at various
points of the human food chain. This information was then used to evaluate
bacteriophage as potential agents for controlling Campylobacter in broiler chickens.
1.1 CHARACTERISTICS OF THE CAMPYLOBACTER GENUS
Campylobacters were first thought to have been observed by Theodor Escherich in 1886
who described non-culturable spiral shaped rods in the stools of children who died from
diarrhoeal disease (Butzler, 2000). It was almost a century later when Skirrow was able
to successfully isolate and culture these organisms (Skirrow, 1977). In the near three
decades since isolation methods became available, Campylobacter has become
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recognised as the leading cause of human bacterial enteritis in the developed world
(Tauxe, 2000).
The Campylobaeter genus is the largest constituent of the Campylobacteriaeceae family
in the order Campylobacteriales. They are the most studied examples of the epsilon
subdivision of the proteobacteria phylum. Other important members of the
Campylobacteriaceae family are the Arcobacter and Sulfurospirillum genera. Until
recently, Helicobacter was also a member of this family but, due to taxonomic
dissimilarities, has been reclassified into a new family. There are currently 18 species
and subspecies of Campylobaeter (Stern et at, 1992; Vandamme, 2000) of which the
most studied and clinically important species are C. jejuni subspecies jejuni, C. coli and
C. lari. These species have collectively been named the 'thermophilic' campylobacters
owing to their reported optimal growth temperature at 42 - 43°C and inability to grow
below 25°C (Phillips, 1995).
Campylobacters are Gram negative and biochemically characterised as oxidase positive
and nitrate reducing. They produce negative results for Methyl Red and Voges -
Proskaur tests and are unable to hydrolyse gelatin (phillips, 1995). Since campylobacters
are not saccharolytic, classical carbohydrate utilisation tests for Gram negative bacteria
have little use in their speciation (Smibert, 1984). However, biochemical tests have been
developed to assist in preliminary identification (Stern et at, 1992) and are core
constituents of certain commercial testing kits (e.g. APICampy, biolvlerieux, Lyon,
France). Probably the most widely used biochemical assay for Campylobacter is the
hippurate test (Collins et al., 1995). At present, only Ci jejuni has been shown to possess
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the hipO gene, whose
(C6HS.CO.NH.CH2.COn to
product
benzoate
(hippuricase) hydrolyses
(C2HS02) and glycine
hippurate
(C2HsN02).
Campylobacters may also be broadly divided according to their ability to produce
catalase, which is a characteristic associated with strains which cause human disease
(Stern et al., 1992). Campylobacters are microaerophiles and capnophilic, growing
optimally in a gaseous environment consisting of a reduced atmospheric oxygen tension
with a greater concentration of carbon dioxide (Smibert, 1984). Typically, these
organisms are cultured in an atmosphere consisting of 5% O2, 10% C02 and 85% N2
which is usually achieved either through evacuation and replacement of the air in a gas
jar or the use of commercial chemical-based "gas pack" systems (Stern et al., 1992).
In terms of morphology, campylobacters are classified as pleomorphs as their size and
shape varies at different stages of their life cycle, ranging from spiral shaped rods to
coccoid forms (Ng et al., 1985; Griffiths, 1993; Thomas et ai; 1999). During
exponential growth phase these bacteria usually display a "gull wing" shape with a
diameter of 0.2 - 0.5 J.1mand a length of up to 5 J.1m(Singleton and Sainsbury, 1999).
campylobacters possess single or bipolar unsheathed flagella and are highly motile,
typically exhibiting a darting motility with occasional "corkscrew" movements (Smibert,
1984; Singleton and Sainsbury, 1999).
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1.2.0 HUMAN CAMPYLOBACTERIOSIS
The Communicable Disease Surveillance Centre (CDSC), at the time of writing part of
the Public Health Laboratory Service for England and Wales (PHLS), has monitored the
number of human campylobacteriosis cases since 1986. During this time, the annual
number of human Campylobacter enteritis cases has risen from 24, 809 to 56, 420 in
2001 (http://www.phls.org.ukltopics_azJcampylo/menu.htm) costing the UK. an estimated
£150 m per annum (Gillespie et al., 2002). Similar increases have been observed in other
Western countries over a comparable time scale (Tauxe, 2000). This increase may be
explained partly by the development of more sophisticated and sensitive isolation
techniques in conjunction with an increase in the awareness of public health professionals
(Phillips, 1995; Tauxe, 2000). However, there remains a general concern that the
increase in reported (or 'visible') Campylobacter infections may underestimate the actual
occurrence of this disease in the general population. This underestimate is believed to be
up to ten times in the UK (Pebody et aL, 1997) and thirty-eight times in the United States
of America (Tauxe, 2000). However, this could be an indication that most patients
suffering from campylobacteriosis recover adequately by themselves and do not usually
require professional medical attention. When such treatment is necessary, macrolide
antibiotics (particularly erythromycin) are the drugs of choice although 68% of C. coli
food isolates are reported to be resistant to this antibiotic (Kramer et aL, 2000). The
mechanism of erythromycin in treating Campylobacter infections is equivocal. This drug
is known to bind to motilin receptors in the gut, promoting gastrointestinal peristalsis
which may playa major part in removing Campylobacter from the patient (Archer and
Polk, 2001). Erythromycin can also directly bind to the 50S subunit of bacterial
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ribosomes and inhibit protein synthesis in a range of bacteria (Archer and Polk, 2001).
Resistance to macrolides is mediated by a plasmid-encoded methylase which modifies
ribosomal RNA, preventing the drug binding to its target (Archer and Polk, 2001). All
of the above factors against the backdrop of a successful campaign to reduce the number
of human enteric Salmonella infections (Cogan and Humphrey, 2003) has made
Campylobacter a priority in the development of government food safety policy.
1.2.1 Symptoms of human Campylobacter enteritis
The number of Campylobacter cells required to infect humans is thought to be low
(Phillips, 1995). Reports suggest that as few as 500 - 800 cfu may be sufficient to cause
enteric disease in a healthy human adult (Black et at, 1988). Following infection the
incubation period ranges from 48 - 72 h before the onset of symptoms. Clinical
symptoms are usually presented as a fever (40°C) followed by nausea and severe
abdominal cramps (Blaser, 2001). Diarrhoea often follows rapidly and is characterised
by being either watery and profuse or mucoid, sometimes containing blood (Skirrow and
Blaser, 2000). These symptoms are usually accompanied by acute inflammatory enteritis
extending from the small intestine to the colon and rectum. Fatalities resulting from
Campylobacter infections are rare and consequently current knowledge of the
histological changes occurring during such infections has been accrued from
proctosigmoidoscopy studies (Wassenaar and Blaser, 1999). Such studies clearly
demonstrate inflammatory bowel disease is an integral part of many Campylobacter
infections. This observation is underpinned by data showing that leukocytes and
erythrocytes can both be recovered from the stools of patients, even when the diarrhoea is
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not bloody (Wassenaar and Blaser, 1999). Campylobacter invasion of human cells has
been demonstrated both in vitro and in vivo (Wooldridge and Ketley, 1997; Wassenaar
and Blaser, 1999). Although deep tissue penetration is a possible progression from
invasion, the sensitivity of Campylobacter to complement-mediated lysis in
immunocompetent individuals is thought to limit proliferation in the blood and prevents
further systemic dissemination (Wassenaar and Blaser, 1999). However, blood samples
are not routinely cultured in cases of campylobacteriosis and thus bacteraemia is unlikely
to be detected unless it develops into systemic disease, usually in immunocompromised
individuals (Black et al., 1988; Skirrow et al., 1993; Wassenaar and Blaser, 1999).
It may take up to two weeks for patients to fully recover from the initial symptoms of
campylobacteriosis but mild relapses can occur, which are more persistent in
immunocompromised patients (Blaser, 2001). After the regression of clinical symptoms,
patients may continue to excrete campylobacters in their faeces for several weeks. One
study revealed the mean post infection shedding period was 37.6 days (Kapperud et aL,
1992). Although this may present a short term problem for patients who work in the
catering, hospitality or healthcare services (Murphy et aL, 1995), long term
asymptomatic carriage as seen with other food-borne diseases such as typhoid fever
(Salyers and Whitt, 1994) has not been reported for Campylobacter.
1.2.2 Pathogenesis and Immunity
Campylobacteriosis is usually self-limiting and typical treatment consists of rest and fluid
replacement (Blaser, 2001). Patients show a marked increase in serological anti-
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Campylobacter antibodies (Wassenaar and Blaser, 1999) which may offer protection
from the same or related strains for a period of at least one year (Cawthraw et al., 2002).
The protective duration of such seroconversion may depend on each individual's
response but serum titres of IgG, IgM and IgA usually decline rapidly after clinical
symptoms of the disease have subsided. A degree of immunity is developed in people
with a continually high level of exposure to this organism (Cawthraw et al., 2000) and
serious recurring infections in AIDS sufferers suggest cell-mediated immunity is an
important factor in long-term protection (Wassenaar and Blaser, 1999; B1aser,2001).
The mechanism of Campylobacter pathogenesis in humans has yet to be fully
understood. Campylobacters exhibit positive chemotaxis to L-fucose and L-serine, both
constituents of mucin (Marchant et al., 2002). Moreover, this bacterium can subsist on
mucin as its sole carbon source (Scboeni and Doyle, 1992). Mucous-filled intestinal
crypts are the primary colonisation site in chickens (Beery et aL, 1988) but, due a paucity
of analogous animals disease models, this area of Campylobacter pathogenesis is poorly
understood in man (young et at; 2000). Although campylobacters can produce a range
of toxins (Ketley, 1997; Wassenaar, 1997; Wassenaar and Blaser, 1999) their role in
the disease process is unclear. The extensive range of symptoms experienced by
campylobacteriosis sufferers is thought by some to be a consequence of Campylobacter
producing different toxins in the gut (Wassenaar, 1997).
1.2.3Chronic complications of Campy/obaeter infection
In recent years, Campylobacter has been increasingly associated with a range of serious
long term complications (Nachamkin, 2002). The most serious of these is Guillain Barre
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syndrome (GBS) which is a potentially life-threatening autoimmune disease. GBS, or
acute ascending polyradioculoneuropathy, is a disease affecting the peripheral nerves
which, if left untreated, can lead to respiratory paralysis and death (Nacbamkin et al.,
2000). GBS is the most common acute neurological disease in the developed world
(Hugbes et al., 1999). Serological evidence suggests that Campylobacter infections
occur in up to 40% of GBS patients, even though culture-positive Campylobacter can
only be isolated from the stools of 15% of these (Nacbamkin, 2002). Previous studies
have suggested that GBS is triggered by complement-mediated damage of neuron myelin
sheaths, leading to dymyelination and flaccid paralysis (Nacbamkin, 2002). Certain
Campylobacter serotypes (in particular HS: 19) are known to possess lipo-oligosaccharide
core regions which mimic the sialic acid structures found in the gangliosides of
peripheral nerve tissue (Nacbamkin, 2002). Pathogenic antibodies against GM 1
gangliosides are thought to lead to GBS whereas antibodies against other gangliosides
may trigger related conditions such as Miller Fisher Syndrome (Nacbamkin, 2002).
However, not all people exposed to HS:19 go on to develop GBS suggesting host
response is important in the development of this condition (Bowes et al., 2002).
1.2.4 Epidemiology
Given the large number of Campylobacter enteritis cases reported to the CDSC every
year and the relatively low infective dose, it is perhaps surprising that campylobacteriosis
is mainly a sporadic disease (Phillips, 1995; Pebody et aL, 1997; Friedman et al.,
2000). Although several well-studied outbreaks have been reported (Istre et al.; 1984;
Murpby et aL, 1995; Anon, 1998; Evans et al., 1998) they are still relatively rare, and in
8
ha fer 1
many cases it is difficult to pinpoint the origin of infection. This problem is compounded
by the lack of consensus on the most effective epidemiological typing tools (Wassenaar
and Newell, 2000) coupled with the high degree of genetic heterogeneity in the genus
(Wassenaar et al., 2000; Dorrell et at., 2001). Data from most first-world countries
indicates approximately 95% of human campylobacteriosis is caused by C. jejuni and C.
coli with other species such as C. lari responsible for a minor proportion (Lastovica and
Skirrow, 2000; Shane, 2000). The reason for the predominance of C. jejuni in human
infection remains undetermined as it appears that many different species of
Campylobacter have the potential to cause disease (Lastovica and Skirrow, 2000). As
co-infection with multiple Campylobacter species and strains appears to be rare in
humans (Richardson et al., 2001) ultimately this may be a reflection of exposure, host
responses or the ability of specific Campylobacter strains to persist in infection
reservoirs.
A growing consensus among researchers points to contaminated poultry, in particular
chicken, as a significant risk factor in acquiring human Campylobacter enteritis (Jacobs-
Reitsma, 2000). This assertion is founded primarily on anecdotal evidence as no study
has yet conclusively proven a 'cause and effect' relationship (Stern et aL, 2003).
Nevertheless, of the outbreaks of Campylobacter which have been studied in detail, many
strongly implicate undercooked chicken (Istre et aL, 1984; Harris et aL, 1986; Evans et
al; 1998; Shane, 2000). Taking this into consideration, a recent risk assessment study
predicted that a 10glO 2.0 cfu reduction in the Campylobacter load on individual retail
broiler carcasses could lead to a fall in the number of human campylobacteriosis cases by
up to 30 fold (Rosenquist et al., 2003).
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1.3 PREVALENCE OF CAMPYLOBACTER IN RETAIL POULTRY
PRODUCTS
In the year 2000 the UK chicken market produced 0.7 million tonnes of poultry meat with
an estimated value of £1.6 bn, accounting for almost 30% of the £5.4 bn meat market
(Anon, 1999). The whole and portioned chicken market accounted for the majority of
this produce (0.52 m tonnes) with the remainder supplying ingredients for value-added
poultry products. The high prevalence of Campylobacter in retail poultry products has
been widely reported in European countries (Jacobs-Reitsma, 2000; Kramer et al.,
2000; Dominguez et al., 2002; Jorgensen et aL, 2002) and the United States of
America (Friedman et al., 2000; Shane,2000; Zhao et aL, 2001). Campylobacters are
sensitive to freeze-thaw damage (Chan et aL, 2001) and consequently, frozen poultry
products are .generally contaminated to a lesser extent than fresh products (Stern et aL,
1984; Jacobs-Reitsma, 2000; Stern et al., 2003). The rising number of human
campylobacteriosis cases together with a growing body of research linking this disease
with the consumption of contaminated poultry meat has prompted public-funded research
into practical control strategies throughout the food chain (Anon, 2001 b).
Two surveys of retail poultry meat in the UK concluded that approximately 80% of
products were contaminated with Campylobaeter at levels of up to 109 cfu per product
(Kramer et al., 2000; Jorgensen et aL, 2002). In the year 2000 the FSA commissioned
a large survey to examine UK poultry meat for Campylobaeter and Salmonella
contamination (Anon, 2001c). They found that 50% of fresh chicken produce was
contaminated with Campylobaeter compared with 5.7% for Salmonella. Half of all the
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C. jejuni isolates from this survey were resistant to at least one antibiotic. A concurrent
FSA survey assessed consumer attitudes towards food and their knowledge of food
safety. They found that, although there was great concern over food safety and hygiene,
a considerable number of respondents were not handling and preparing their food safely
(Anon, 200la). Cogan et al; (2002) found that Campylobacter contamination in
kitchens could be significantly reduced when study participants used a specified cleaning
procedure with detergent. However, another study revealed that during undirected food
preparation, there was extensive cross contamination of kitchen surfaces with
Campylobacter and Salmonella, which were not significantly decreased by cleaning
(Cogan et al., 1999). Despite being sensitive to desiccation, Campylobacter cells have
been found to survive for at least three hours on contaminated domestic surfaces (Cogan
et aL, 1999). Taking the above information into account it is perhaps unsurprising that
cross-contamination in food preparation areas has been identified as a major risk factor in
acquiring Campylobacter infections (Rosenquist et al., 2003).
Practices employed in UK poultry abattoirs have, thus far, failed to significantly impact
on carcass contamination on the supermarket shelf. The chemical decontaminant
hypochlorite has previously been used in the scald water and chill tanks of abattoirs at
concentrations of 50 - 250 ppm in an effort to reduce the numbers of pathogenic and
spoilage bacteria (Alien et al., 2000). Free chlorine in solution is a potent antimicrobial
agent, however, under commercial operating conditions its efficacy is poor in reducing
carcass contamination (Alien et aL, 2000; Whyte et al., 2001; Yang et al., 2001). This
is purportedly due to inactivation by organic matter in the tanks and the protective effect
of chicken skin for bacteria associated with the cuticle (Berndtson et al., 1996),
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Although still routinely applied in many countries, the use of hypochlorite in EU member
states should have ceased in 2001 in accordance with article #9712138.
Unfortunately, far from reducing carcass contamination, current abattoir codes of practice
may unwittingly serve to disseminate Campylobacter cells. As a consequence of their
increased environmental exposure, organic and free-range flocks are more frequently
colonised with Campylobacter (Heuer et at; 2001). However, the code of practice from
the body governing organic food production, the Soil Association
(www.soilassociation.org). dictates that to maintain their status, organic birds must be
slaughtered prior to conventionally reared flocks. Previous studies have demonstrated
that flocks testing negative for Campylobacter at slaughter can be contaminated by
strains found in the caeca of birds slaughtered earlier in the production line (Miwa et al.,
2002).
A major study of the enclosed Icelandic poultry industry by Stern et al: (2003)
highlighted that a significant fall in human campylobacteriosis was recorded by the
Iceland Health Department following a reduction in the number of Campylobacter
positive broiler chicken carcasses. The Icelandic government's proactive response to the
increasing number of human Campylobacter infections in their country led to many
intervention strategies operating concurrently. Consequently, it was impossible to
determine Which of these strategies contributed most to reducing human disease.
A study examining the multi-locus sequence types (MLSTs) of campylobacters isolated
from human, animal and environmental sources concluded that there was a broad range
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of sequence types (STs) colonising chickens whereas most human isolates clustered
around S1'2l (Dingle et al., 2001). Why only certain sequence types should cause
disease when humans are probably exposed to many more remains undetermined. It is
possible that not all strains of C. jejuni are pathogenic to humans or that some strains
survive carcass processing better than others. There may also be other important
reservoirs of the Campylobacter strains that can cause human disease. In any case, if not
universally regarded as the most aetiologically important source of human
Campylobacter infection, poultry products must be considered an important risk factor.
1.4 CAMPYLOBACTER IN BROILER FLOCKS
Campylobacters are excellent colonisers of the gut of many avian species (Waldenstrom
et al., 2002). Although some evidence suggests that campylobacters may, in certain
circumstances, invade extra-intestinal sites of the chicken (Young et al., 1999), the
general consensus in the research community is that this bacterium is not an avian
pathogen and its primary role is commensal (Newell and Wagenaar, 2000; Shane,
2000; Waldenstrom et al., 2002). This commensal relationship is thought to be the
result of a long evolutionary history between a parasite and its host (Waldenstrom et aL,
2002). Campylobacters are not a natural constituent of human gut flora and their
pathogenic modus operandi in man is suggested to be merely coincidental.
Campylobacter is an extremely infectious agent of chickens with maximal colonisation
achieved with as few as 35 cfu of some strains (Cawthraw et aL, 1996). Given this fact
it is unsurprising that the increased biosecurity measures implemented so effectively to
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combat Salmonella (Cogan and Humphrey, 2003) did not prevent Campylobacter
colonisation. Moreover, passage through the chicken gut is known to enhance the
colonisation of some Campylobacter strains by almost 3,000 fold (Cawthraw et al.,
1996). This has led to the general resignation of the poultry industry to the prospect that
nothing may prevent their flocks becoming infected. This is supported by the fact that
even breeder flocks, which are maintained under high levels of biosecurity, can become
positive (Stern et al., 2003) as can newly-constructed purpose-built facilities (Gregory et
al., 1997). Despite the difficulty farmers face in dealing with Campylobacter
colonisation of their flocks, leading figures in food safety have continually called for
poultry producers to do more to prevent infection (Lacey, 1994).
Although the UK poultry industry is worth an estimated £1.6 bn per annum (Anon,
1999), legislation and the continual pressure from retailers to produce cheaper birds have
reduced profit margins on the average chicken carcass. In addition, the poultry industry
has never received farming subsidies from the EU and bearing these facts in mind, any
attempt to control campylobacters at the farm level must be practical but inexpensive
(Anon, 2003). Enhanced biosecurity may reduce the probability of Campylobacter
infection in a flock but may be considered too draconian for the poultry industry to bear
(Newell and Wagenaar, 2000). Moreover, the costs of such measures are likely to be
absorbed solely by the poultry industry as retailers would be reluctant to increase prices.
In addition to financial pressures, the poultry industry is increasingly constrained by
stringent codes of practice and government legislation. Most major retailers insist that
the poultry they sell is reared in accordance with the Assured Chicken Production (ACP)
scheme (www.asssuredchicken.org).This scheme is supported by the UK government
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with the intention of ensuring poultry destined for human consumption in the UK is
produced to a consistently high standard with humane treatment of farmed animals.
A large body of research indicates that broiler chicks are not born with gut flora
containing viable Campylobacter cells (Gregory et al., 1997) and that the risk of
infection increases with age (Newell and Wagenaar, 2000). Campylobacters are able to
penetrate intact egg shells (Jacobs-Reitsma, 2000) and colonise the reproductive tract of
chickens (Cox et aL, 2002b; Hiett et al., 2002). Although vertical transmission has been
reported (Cox et aL, 2002a), it is generally considered to be a rare event and remains a
controversial issue among researchers (Newell and Wagenaar, 2000). Arguing against a
major role for vertical transmission was a study showing that few offspring of a highly
colonised breeder flock had Campylobacter positive caeca (Stern et al., 2003). There
also appears to be a period in the early life of the chick when campylobacters cannot be
isolated from the caecum (Newell and Wagenaar, 2000; Shane, 2000). However,
proponents of vertical transmission highlight research revealing Campylobacter DNA can
be detected from such caeca using more sensitive non-culture based techniques (Chuma
et aL, 1997).
Previous studies have consistently shown that chicks reared both in commercial broiler
houses and under controlled conditions are not colonised by Campylobacter for a period
of 2 - 3 weeks (Newell and Wagenaar, 2000; Shane, 2000). This period has been
called the "lag phase" and is currently the subject of much debate in the Campylobacter
research community. As Campylobacter is ubiquitous in the environment and an
excellent coloniser of chickens it seems unlikely that the lag phase can be explained by a
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lack of exposure (Newell and Wagenaar, 2000). There is some evidence suggesting
maternal anti-Campylobacter antibodies are responsible for this phenomenon (Sahin et
al., 2001). However, if experimentally inoculated with a high enough dose, day old
chicks may still become colonised by Campylobacter (Young et al., 1999). The genetic
diversity (Dorrell et al., 2001) and variable surface structures of Campylobacter
(parkhill et al., 2000) would suggest that antibodies probably could not account for the
universality of the lag phase in chickens. Moreover, breeder flocks possessing anti-
Campylobacter antibodies are still intestinally colonized with this bacterium (Widders et
al., 1996) suggesting such antibodies are either not cross-protective or only prevent
invasion, not colonization. Other potential explanations of the lag phase include an
inhospitable gut environment created by competitive microflora (Humphrey et al.,
1989), changes in feed composition or the possibility that, as for Salmonella, some birds
have an innate resistance to infection (Newell and Wagenaar, 2000).
Although the role of vertical transmission remains equivocal there is little disagreement
among researchers about the importance of horizontal infection. Once one bird in a
broiler house is infected, it is common for the entire flock to become positive within days
(Shreeve et al., 2000). Campylobacter can quickly colonise the chicken caecum to levels
greater than 1010 cfu g-} (Ahmed et aL, 2002) and has a multitude of transmission routes
at its disposal including aerosols (Berndtson et aL, 1996), water (Gregory et aL, 1997)
or vector-mediated infection (Jacobs-Reitsma et al., 1995). As chickens are
coprophagic, the main transmission route between birds is likely to be faecal - oral
(Newell and Wagenaar, 2000). Conventionally reared flocks in the UK tend to be
colonised by a restricted number of Campylobacter subtypes (Ayling et al., 1996)
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although multiple strain infections have been reported more frequently in other countries
(Jacobs-Reitsma et al., 1995). The probability of infection appears to increase with bird
age (Evans and Sayers, 2000) and exposure to the environment since organic birds
appear to be colonised with the greatest variety of Campylobacter strains (Heuer et al.,
2001).
The source of initial flock infection is still a highly contentious issue and the wide range
of environmental reservoirs in which Campylobacter can persist frustrates efforts to focus
on specific critical control points. Different parts of the world rear poultry in different
ways and the relative importance of specific environmental reservoirs in Campy/obaeter
contamination will change according to their particular circumstances. Consequently,
there is considerable disparity in the positivity of poultry flocks from different countries
(Shane, 2000) although the sensitivity and frequency of Campylobacter surveillance may
also have an influence. In addition, some countries experience a seasonality in human
and poultry Campylobacter infections (Newell and Wagenaar, 2000). This is still an
equivocal issue in the UK with some research failing to find any such pattern
(Humphrey et al., 1993).
Many environmental reservoirs have been implicated as sources of Campy/obaeter
infection of broiler flocks (Gregory et aL, 1997). Certain taxa of migrating birds are
known to carry Campy/obaeter species (Waldenstrom et al., 2002), although their role
as a source in broiler infection remains debatable (petersen et at; 2001). Insects, in
particular flying insects, have also been implicated as a possible source (Jacobs-Reitsma
et al., 1995; Gregory et al., 1997). Most farms have effective vermin control
17
Cha fer
programmes and consequently rodents are not considered a major source (Evans and
Sayers, 2000). The presence of other domestic animals on the farm is associated with an
increased risk of broiler flock infection with Campy/obaeter (Jacobs-Reitsma et aL,
1995; Gregory et aL, 1997). As campylobacters are highly sensitive to desiccation
(Shane, 2000), feed is not considered a major source of Campy/obaeter. Similarly, spent
litter is not thought to sustain campylobacters long enough to cause infection (payne et
al., 1999; Shane, 2000). Campy/obaeter has been shown to survive well in aqueous
environments at low temperature over an extended period of time (Buswell et aL, 1998).
Despite this, water is not generally highlighted as a major infection source for broiler
flocks. Although supplying potable or sanitised water to broiler houses is a suggested
critical control point for preventing flock infection in the UK. (Anon, 1999), research in
the U.S.A. suggests chlorination of water seems to have little impact on flock positivity
(Stern et aL, 2002). Under experimental conditions, campylobacters are able to survive
in biofilms (Trachoo et aL, 2002) which have been shown to imbue bacteria with greater
resistance to chemical decontaminants (Dunne, 2002).
A persistent risk of flock infection on a farm is the relatively frequent access of farm
workers in the broiler house (Newell and Wagenaar, 2000). Asymptomatic carriage of
campylobacters in humans is rare and thus the main infection hazard will be horizontal
transfer from environmental reservoirs into the broiler house. Berndtson et aL (1996)
reported that human-mediated transfer was a possible source of Campy/obaeter infection
of flocks. Broiler house cleaning procedures appear to adequately remove
Campy/obaeter between flocks (Evans and Sayers, 2000). Nevertheless, successive
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flock rotations can become infected by the same strain (petersen and Wedderkopp,
2001) which suggests a common environmental reservoir.
One practice consistently highlighted as an infection risk for flocks is thinning (Anon,
1999; Anon, 2003). This procedure involves the periodic removal of birds from the
broiler house at certain ages to satisfy the market demand for birds of different sizes and
to comply with UK laws on animal stocking density. Thinning may take place up to
three weeks prior to final depopulation and, given the high infectivity of Campylobacter
in poultry, provides ample opportunity for colonisation of the entire flock before
slaughter. Moreover, abattoir transport crates used in this procedure are usually not
thoroughly washed and decontaminated and can act as a source of contamination to the
birds either directly or via abattoir staff (Berndtson et aL, 1996; Newell et aL, lOOI).
1.5.0 METHODS OF CONTROLLING CAMPYLOBACTER ON THE FARM
1.5.1 Biosecurity
Controlling Campylobacter contamination of poultry products in the human food chain
has principally targeted three areas: the farm, the abattoir and the consumer. Irradiation
(or 'cold pasteurisation') of the fmal food product is often seen by scientists as a
definitive solution to food-borne infections (Corry et al., 1995a). However, recent
research suggests that Campylobacter may be able to initiate an inflammatory response
irrespective of the viability of the ingested organism (Mellits et al., 2002) and public
opposition to irradiated food is considerable (Corry et al., 1995a). Consequently, it
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would be sagacious to reduce the presence ofCampylobacter at the beginning of the food
chain, Le. on the farm. Increasing the level ofbiosecurity on farms to exclude pathogenic
organisms from food animals is a primary aim of the UK government (Anon, 2003).
However, stringent biosecurity is difficult and expensive to maintain and only serves to
limit, not eliminate infection (Newell and Wagenaar, 2000). Although some success
has been achieved using this approach with Campylobacter (Gibbens et ai; 2001),
improving farm biosecurity on a general basis only appears to delay the onset of
colonisation. Targeted biosecurity measures may prove to be more effective but a
paucity of data on definitive environmental sources of Campylobacter has led to general
disagreement about which areas should be selected. Ultimately, only longitudinal studies
examining the dynamics of Campylobacter in the farm environment using molecular
epidemiology will resolve this problem (Newell and Wagenaar, 2000).
1.5.2 Competitive exclusion
Microbial competitive exclusion (CE) is a process by which micro flora in a given
ecological niche prevent the establishment of other bacterial populations. This is
achieved by either competing more successfully for limited resources or by producing
inhibitory metabolites. CE was originally described by Nurmi and Rantala (1973) who
were investigating the resistance of chicks to Salmonella infection. They observed a link
between the environmental conditions in which the chicks were reared and their
susceptibility to infection (Rantala and Nurmi, 1973). Chicks reared in more sanitised
environments often do not develop an intestinal microflora capable of competing with
salmonellas (Mead, 2000). Nurmi and Rantala (1973) also found that mature
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microflora from Salmonella-negative birds could be cultured and re-administered to
chicks to protect them from Salmonella infection. Since then, several defined
commercial CE preparations have been developed (Mead, 2000) these include: Briolact
(Orion corp.); CF-3 (Milk Specialities Co.) and Mucosal Starter Culture (Continental
Grain Co.). Undefined preparations (i.e. the bacterial constituents in the product are
unknown) include Avigard (Bayer AG); and Avifree (Alltech Ltd.). CE has been
relatively successful in preventing caecal colonisation of Salmonella but less so for
Campylobaeter. Commercial CE products such as Avian Pac™ (Loveland Industries
Inc) have shown modest protection against Campylobaeter (Morishita et al., 1997).
However, such protection is uncommon as many commercial products effective against
Salmonella are not consistently effective against Campylobaeter (Chen and Stern,
2001). This is reported as a consequence of the unique niche occupied by Campylobaeter
in the caecum, where it swims freely in the mucous-filled crypts (Beery et al., 1988) as
opposed to Salmonella which attaches to receptor sites on the mucosal epithelium (Mead,
2000). Inoculating chicks with bacteria capable of utilising mucin as a carbon source,
thus directly competing with Campylobaeter, has achieved some success (Scboeni and
Doyle, 1992). However, other workers have failed to reproduce this when selecting
bacterial species using similar criteria (Mead et aL, 1996). Stern (1994) and Mead et aL
(1996) report the ability of undefined anaerobic chicken intestine mucous preparations to
prevent Campylobaeter colonisation.
Interestingly, recent research in this area has focussed on heterologous CE i.e. using
campylobacters to prevent the colonisation of other campylobacters (Newell and
Wagenaar, 2000; Chen and Stern, 2001). If non-pathogenic strains of Campylobaeter
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can be identified, this technique may prove useful. However, given the genomic
plasticity of Campylobaeter (Wassenaar et al.; 2000) and that natural transformation has
been demonstrated in vitro (Wang and Taylor, 1990) and in vivo (Boer et al., 2002), a
considerable amount of research is required to identify suitably stable strains before this
technique is feasible.
1.5.3Vaccination
The dramatic decrease of human salmonellosis in the UK during the past few years is
primarily attributed to the control of Salmonella in chickens through vaccination (Cogan
and Humphrey, 2003). However, the development of a vaccine to combat
Campylobaeter in poultry is more problematic for a number of reasons. Firstly,
Campylobaeter contamination of broiler carcasses is considered the major threat to
human health compared with eggs for Salmonella. Laying hens are generally kept for a
considerably longer period than broiler chickens and therefore have a fully-developed
immune system capable of mounting a response to a live oral vaccine. The lifespan of
the average broiler chicken is only six weeks which gives little time for their immature
immune systems to develop a protective response (Newell and Wagenaar, 2000). A
possible solution to this is passive immunisation (Newell and Wagenaar, 2000).
However, mature breeding hens often possess circulating anti-Campylobaeter antibodies
(Sahin et al., 2001) which do not prevent them from being caecally colonized by
Campylobae/er (Newell and Wagenaar, 2000). This raises doubts about the efficacy of
such antibodies in preventing colonisation in chicks through maternal inheritance.
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However, antibodies administered orally to chicks appear to be effective m both
therapeutic and prophylactic trials (Tsubokura et al., 1997).
Live vaccines are generally regarded to induce a more comprehensive immune response
than killed or subunit vaccines (Kuby, 1997) and have been effective against Salmonella
in chickens (Cogan and Humphrey, 2003). However, since a detectable seroconversion
accompanies Campylobacter presence in most chickens, there is uncertainty as to how
this response can be enhanced to prevent colonisation. Killed vaccines may provide
some protection when administered parenterally but this may be too time consuming and
costly for broilers (Newell and Wagenaar, 2000).
A recent trend in vaccine development is the utilization of recombinant vector vaccines.
These vaccines are produced by introducing genes encoding major antigens of virulent
pathogens into an attenuated bacterium or virus. A number of attenuated Salmonella
mutants are able to interact with the lymphoid tissues in Peyer's patches but are not able
to cause systemic disease (Cardenas and Clements, 1992). One such mutant of
Salmonella Typhimurium has been used to express Campylobacter flagellin and offered
some protection from Campylobacter colonisation when administered orally to chickens
(Kane and Naehamkin, 1998). Nevertheless, a vaccine eliciting an immune response in
the chicken capable of consistently preventing Campylobacter colonisation has, thus far,
proven elusive.
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1.6.0 BACTERIOPHAGE AND THEIR PRESENCE IN THE FOOD CHAIN
1.6.1The discovery and nature of bacteriophage
Bacteriophage (phage) are viruses which exclusively infect bacterial cells. They were
independently discovered by Twort (1915) and D' Herelle (1917) although initial
observations of these viruses date back to Hankin in 1896 (Kutter, 1997; Sulakvelidze et
aL, 2001). Although D' Herelle was quickly convinced of the viral nature of phage,
many scientists believed their bactericidal effect was the result of an enzyme (Kutter,
1997; Sulakvelidze et al., 2001). Indeed during this period, leading microbiologists such
as Bordet and Gratia engaged in increasingly acrimonious arguments about the nature of
these agents (reviewed by Stent and Adelberg, 1960).
Definitive proof that phage are able to multiply at the expense of their host came when
Ellis and Delbruck (1939) performed their classic one-step growth curve. They went on
to explain how Bordet and Gratia misinterpreted phage-induced bacterial death as an
autolysis event. Delbruck elegantly demonstrated that if many phage attack one
bacterium simultaneously, they lyse their host without replication (lysis from without).
However, if a single phage infects a cell it multiplies inside its host until the progeny lyse
the host from the inside and diffuse into the culture medium (lysis from within or "lytic
infection"). A more detailed examination of the intracellular replication of E. coli phage
T4 was undertaken in 1951 by Doermann (1951). This series of experiments determined
that phage replication within the host cell could be divided into four phases (Fig. lA).
However, although lytic infection was beginning to be characterised, it became clear that
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Figure 1A. Bacteriophage One-step Growth Curve.
Ina one-step growth curve, phage are mixed with their hosts and allowed to adsorb. Any
unadsorbed phage are inactivated by specific antisera and the culture is diluted 1,000 fold
to ensure progeny phage cannot initiate secondary replication cycles. Following
adsorption, the phase where mature progeny cannot be isolated from intracellular
fractions is called the eclipse period. Eventually, mature viruses begin to accumulate in
the cell but are not detected in the extracellular medium (latent period) until the cells lyse
and release their progeny (rise period). The difference between the initial and final
number of plaques is known as the burst size and can be estimated on a per-cell basis.
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the typical model of lytic replication (adsorption, penetration, replication and release)
was not followed by all phage. These "temperate" phage appeared to persist as a
heritable, quiescent element inside their host until an unknown trigger caused them to
revert to the lytic cycle and begin accumulating progeny. It was not until 1950 that
Lwoff and Gutmann discovered that temperate phage DNA can be replicated in the form
of a "prophage" inserted into the host chromosome (Lwoff and Gutmann, 1950). It was
later discovered that temperate phage DNA may either integrate into the host
chromosome through site-specific recombination (e.g. phage A) or remain as an
autonomous episome (e.g. phage F116). The infected host cell, termed lysogenic, is
immune to superinfection by phage of the same type (Fig. IB). The dormant phase of
lysogeny is usually maintained by a phage-encoded repressor protein which binds to the
promoters of specific genes which are part of the lytic pathway, preventing their
transcription. DNA damage or a change in the metabolic state of the host can trigger the
lytic pathway by cleavage of the repressor protein by enzymes synthesised de novo by the
host. Ionising radiation triggers the global transcription of genes involved in the
protective SOS response in E. coli. The protein RecA is one product of this response and
cleaves the cl repressor of phage A allowing the lytic cascade to commence.
1.6.2 Bacteriophage prevalence and use in the human food chain
Bacteriophage are regarded as the most abundant forms of life on the planet with an
estimated 1031 present in the biome at anyone time (Rohwer and Edwards, 2002).
Their presence throughout the food chain has been widely documented with some phage
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Figure 1B. Bacteriophage infection via lytic and lysogenic pathways.
Infection in both pathways is initiated by the adsorption of the virion onto the host
cell surface and injection of the viral genome into the cytoplasm (1). Once the
phage genome has entered the cell (2), viral replication may proceed via the lytic
pathway. This occurs when transcription of phage DNA results in the formation
of new virions and eventual lysis of the host cell (6). Alternatively, the phage may
integrate into the host genome to form a prophage (3). The prophage element is
replicated along with the host chromosome and confers immunity of the lysogenic
bacterium to superinfection by phage of the same immunity group (4). Induction
results in the excision of the prophage from the host chromosome (5) and initiation
of the lytic cycle (6).
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being potentially beneficial (Kennedy and Bitton, 1987) and others being detrimental to
the food industry (Sanders, 1987).
Undoubtedly the greatest problems caused by phage in food relate to products requiring
one or more fermentation steps. The infection of bacterial starter cultures, particularly in
the dairy industry, is the cause of significant economic loss through spoilage, lost
production time and decontamination (Sanders, 1987). The logistics of fermentation in
the dairy industry have historically made it susceptible to phage infection for four
reasons:
1. Fermentation is usually performed in open vats, allowing phage easy access to
their hosts via multiple infection routes.
2. Only a limited number of bacterial strains are used in starter cultures. Should a
phage infect the dominant strain there are few bacteria left to assist in
fermentation.
3. Dispersion of phage particles throughout the product is facilitated by the use of
multiple mixing steps which encourages secondary infections.
4. The high throughput of products in modem factories results in a very high density
of host. As many as 1018 bacterial cells may be produced on a daily basis and the
opportunities for phage multiplication in a host population of this size is clear.
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The development of strategies to control phage infection in fermentation has mainly
focussed on either elimination of external sources of contamination; developing bacterial
strains resistant to infection or the addition of inhibitory agents during processing.
Aside from the burden of disrupted fermentation in the dairy industry, beneficial
applications of phage have been devised. Pseudomonads are a primary cause of food
spoilage at low temperature (Jay, 1992). Psychrophilic phage, capable of active
replication on Pseudomonas hosts at temperatures as low as 1°C, have been isolated from
fresh meat, poultry and fish (Kennedy and Bitton, 1987). Moreover, Greer (1986) has
demonstrated that phage co~ld actively control Pseudomonas growth when applied to the
surface of contaminated beef products.
Phage usually exhibit a greater resistance to physical and chemical inactivation than
. vegetative bacterial cells (Kennedy and Bitton, 1987). This has allowed their use in
various situations to monitor pollution both in the environment and in the food chain.
Due to their general association with faecal contamination, phage of colifonns have
received particular attention in this area (Kennedy and Bitton, 1987). Phage are cheap
and sensitive indicators of faecal pollution in foods and have been useful in the detection
of contamination in food products exposed to environmental waters, especially shellfish
(Kennedy and Bitton, 1987). Bacteriophage have also been used to monitor the faecal
contamination of groundwater (Leclerc et al., 2000).
The use of phage in the food chain is not limited to prevention of food spoilage. Phage
have been effectively implemented to limit the growth and presence of food-borne
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pathogens on fruit (Leverentz et al., 2001), in livestock (Smith and Huggins, 1983) and
poultry (Barrow et al., 1998). To date, most research on the potential of phage to control
bacterial populations has focussed on humans and domestic animals, often known as
"phage therapy".
1.7.0 BACTERIOPHAGE THERAPY
It was D' Herelle who first sought to harness the potential of phage to treat bacterial
infections. In 1919 he performed the first successful phage therapy trial on patients
suffering from bacterial dysentery (Sulakvelidze et al., 2001). This early success was
repeated by Bruynoghe and Maisin in 1921 in the treatment of skin infections caused by
Staphylococcus ssp. (Kutter, 1997; Sulakvelidze et aL, 2001; Summers, 2001).
However, the therapeutic successes with phage were not matched by an understanding of
how or why bacterial death occurred. Indeed, an extensive review of phage therapy. in
the 1930s, conducted by the American Medical Association, concluded that phage were
likely to be enzymes rather than viruses (Eaton and Bayne-Jones, 1934). Enthusiastic
entrepreneurs and medics were keen to exploit phage therapy which resulted in a number
of commercial products. However, D' HereIIe himself tested twenty such products, some
of which he concluded contained no active phage at all (Kutter, 1997). The generally
poor efficacy of commercial phage preparations led to widespread criticism and
disagreement about this new technique. The re-examination of early phage therapy trials
by present day virologists suggests many of the failures could be attributed to one or
more of the following factors:
30
ha ter 1
1. Paucity of understanding of the heterogeneity and ecology of both the phage and
bacterium involved.
2. Failure to select phage of high virulence against the target bacteria present in the
patient.
3. Use of single phage in infections involving mixtures of different bacteria.
4. Emergence of resistant bacterial strains.
5. Failure to appropriately characterise or titre phage preparations.
6. Failure to neutralise gastric pH prior to oral administration.
7. Inactivation of phage by specific and non-specific host immune responses.
8. Liberation of endotoxins leading to toxic shock in the patient.
9. The scarcity of reliable bacteriology laboratories to correctly identify the
pathogens causing an infection.
(modified from Kutter, 1997)
These factors, along with the discovery of antibiotics in the 1940s and the ensuing
Second World War led to the sidelining and subsequent abandonment of phage therapy in
the West. However, research and practical application of phage therapy continued in
various institutes of Eastern Europe and the old U.S.S.R. The most famous of these are
the Bacteriophage Institute in Tbilisi, Georgia and the Polish Academy of Sciences in
Wroclaw, Poland.
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1.7.1 Reappraisal of phage therapy
The renaissance of phage therapy in the West was initiated by a series of veterinary
experiments by Smith and Huggins in the 1980s. They found that E. coli infections of
calves, lambs and piglets could be cleared or severely retarded by the oral dosing of
cocktails of lytic coliphage (Smith and Huggins, 1983). Emerging multidrug resistant
(MDR) bacteria causing clinical and veterinary infections has led to research comparing
the efficacy of treating such infections with phage instead of antibiotics (Smith and
Huggins, 1982). The greater understanding of bacteriophage biology today has led to
some notable successes in phage therapy. Berchieri et al. (1991) used phage isolated
from human sewage to successfully treat experimental Salmonella Typhimurium
infections in chickens. In a demonstration of the potential benefits of phage over
chemotherapy, Biswas et al: (2002) were able to prevent the death of mice inoculated
with vancomycin-resistant Enterococcus faecium by intraperitoneal injection of
bacteriophage. Work by Cerveny et al: (2002) showed that bacteriophage could protect
mice which had been intravenously injected with over ten times the lethal dose of Vibrio
vulnificus. Bacteriophage are imbued with several traits which give them unique
advantages over antibiotics. Phage are both self-replicating and self-limiting, they will
only persist as long as susceptible hosts are present. They can be targeted more
specifically than antibiotics which not only limits widespread phage resistance but
prevents the disruption of commensal microflora often seen with broad-spectrum
antibiotics. The selection of phage which adsorb to bacterial virulence determinants has
shown that mutants which are resistant to phage infection are also less virulent (Smith
and Huggins, 1983). The long-term use of phage to treat human infections in Eastern
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Europe with few ill effects demonstrates that, unlike some antibiotics, phage can be
applied without the development of toxicosis or allergy. Phage may be used
prophylactically, therapeutically and in the sanitising of surfaces. Producing antibiotics
at a high concentration and purity is difficult and expensive, requiring substantial capital
investment in manufacturing and development. Conversely, phage are very cheap to
produce and purify and require only basic fermentation and purification equipment.
Another disadvantage of antibiotics is their diffusion from the site of administration.
Antibiotics become less effective with time as their power to penetrate deep into tissues is
limited by their initial concentration. However, as bacteriophage multiply in the presence
of their host, their penetrative power is only limited, in theory, by the presence of their
hosts. Bacteriophage are able to circulate in the bloodstream following both oral and
parenteral administration and can effectively pass through the blood-brain barrier
(Barrow and Soothill, 1997). A key advantage over antibiotics is the ability of phage to
mutate to evade bacterial resistance mechanisms making them far more versatile agents.
1.7.2 Potential drawbacks of phage therapy
1.7.2.1 Safety in mammalian and avian species
Data from the extensive human phage therapy trials of Eastern Europe and the veterinary
trials recently performed in the West suggest that phage are innocuous to mammals and
avians (Barrow and Sooth ill, 1997; Sulakvelidze et at, 2001). This is supported by the
ubiquity of these organisms in the environment (Bergh et at, 1989) and their regular
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consumption in foods without notable adverse effects. The main problem from a
therapeutic perspective is not the damage the phage can cause the animal but vice versa.
When phage are administered to the subject, especially intravenously, the
reticuloendothelial system (RES) often sequesters the virions before they are able to
achieve maximal effect on the target bacterial population (Barrow and Soothill, 1997).
One report indicated phage may become resistant to RES sequestration by serial passage
and selection for virions which do not evoke a strong immune response (Merril et aL,
1996). However, the efficacy of this technique was recently challenged by Barrow and
Sooth ill (1997) and may be too time-consuming for clinical applications. Phage have
been shown to elicit humoral immunity in humans which presents another barrier to
phage therapy (Kucharewicz-Krukowska and Siopek, 1987; Barrow and Sooth ill,
1997). The nature of the humoral response to phage has not been fully determined but
will undoubtedly playa major part in defining the breadth of scenarios in which phage
therapy can be applied. If phage are shown to induce a cell-mediated response by the
host, which allows the development of immunological memory, repeated use of phage
for subsequent infections may prove ineffective (Barrow and Soothill, 1997).
The liberation of endotoxins following the death of bacterial cells is a major concern with
antibiotic chemotherapy. This process, known as the Herxheimer reaction, may also
OCcurwith bacteriophage-mediated lysis. Whilst antibiotics will diffuse from the site of
administration and gradually lose potency, bacteriophage will penetrate the tissues of the
subject in increasing numbers and potentially liberate more endotoxin. The replication of
phage in susceptible populations of bacteria within a subject would not be under the
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control of the therapist and may present a considerable obstacle to the widespread use of
phage therapy. Data from the phage therapy institutes in Poland and Georgia may prove
invaluable during an assessment of these risks.
1.7.2.2 Development of bacterial resistance to phage infection
Natural selection for resistance in bacterial populations is a problem akin to both
antibiotic and phage therapeutics. Although bacterial resistance to phage infection is an
inevitable consequence of widespread phage therapy, such resistance is thought to occur
at a markedly lower frequency than that for antibiotics (Carlton, 1999).
1.8.0 MECHANISMS OF PHAGE RESISTANCE
The means by which bacteria have evolved resistance to phage are as diverse as those for
antibiotics. Such resistance mechanisms should not be confused with lysogeny where
short-tenn immunity to phage of the same group is granted by the resident prophage. The
initial adsorption of the phage to the host cell can be prevented by alteration, loss or
concealment of receptor sites. Bacteriophage often utilize highly conserved structures on
the host cell surface as their receptors (e.g. phage A uses maltose binding protein on E.
cob). This introduces a counter-evolutionary pressure on the host cell since a mutation in
. a vital gene may be either lethal or render the bacterium incapable of competing
Successfully in its ecological niche. Baggeseo et at. (1997) demonstrated that the loss of
the lipopolysaccharide receptor in strains of Salmonella Enteritidis altered the phage type
of the bacterium but did not prevent infection by other phage suggesting the use of an
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alternate receptor. Deveau et al. (2002) found that phage resistant strains of lactococci
produced greater amounts of extracellular polysaccharide than sensitive strains, which
possibly obscured receptor sites. Other structures which have been implicated as phage
receptors include lipopolysaccharide (Nesper et al; 2000), outer membrane proteins (Ho
and Siauch, 2001) and pili (Roncero et al., 1990).
1.8.1 Restriction modification
After the phage successfully adsorbs to the host cell and injects its genetic material into
the cytoplasm, it has to contend with possible attack by host restriction enzymes.
Bacterial genomes sometimes encode methylases which modify the host DNA by
covalently bonding a methyl group to specific cytosine or adenine residues in a particular
recognition sequence. Such methylases recognise the same DNA sequences as their
respective restriction endonucleases, rendering the modified bacterial DNA impervious to
digestion within the bacterium. However any foreign DNA entering the cell which does
not possess the same methylation pattern will be subject to digestion. Indeed the term
"restriction" was originally derived from the ability of these enzymes to limit the host
range of some bacteriophage. Nevertheless, bacteriophage have evolved methods of
eVading such resistance mechanisms. For example, the genome of coliphage T7 encodes
a protein which binds to Type I restriction endonucleases of the host, leading to
irreversible inactivation of these enzymes. An alternative approach by phage T4 is to
methylate its own DNA to prevent cleavage. Even in the absence of such
countermeasures, host restriction modification is not an absolute method of protection.
Evolutionary selection of point mutations in recognition sequences on the phage DNA
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may render host restriction enzymes ineffective. Negligence by host endonuc1eases also
occurs where there is a high multiplicity of infection and the host is overwhelmed by
viral DNA. Only one phage genome need survive digestion and it will be modified with
the host's methylation pattern and be able to infect other cells of the same strain ad
libitum.
No matter which mechanism is used, the development of phage resistance can be
minimised by using a cocktail of different phage which are able to infect the bacterium in
diverse ways. Antibiotics were used successfully in this way for many decades, although
it is generally accepted that multiple drug resistance in bacterial pathogens is becoming
more common. However, unlike resistance to antibiotics, phage resistance may not be
entirely disadvantageous and can be combated more easily. Altering or entirely losing a
phage receptor site may render the host bacterium immune to phage infection but could
also reduce pathogenicity or the ability to compete in an ecological niche (Smith and
Huggins, 1983). Phage typing schemes have been successfully applied to numerous
pathogenic bacteria with few, if any, strains being universally resistant to infection.
Moreover, previous work has demonstrated that the development of resistance to one
phage may result in susceptibility to infection by others (Baggesen et al., 1997). As
such, the co-evolutionary relationship between a virus and its host can be worked to the
advantage of the phage therapist in ways which are not available to the chemotherapist.
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1.9 TRANSDUCTION
The bacteriophage-mediated movement of DNA from a donor bacterial cell to a recipient
is known as transduction and is arguably the greatest obstacle to the widespread use of
phage therapeutically. Currently, there are two known mechanisms of transduction,
generalised and specialised. Generalised transduction is possible with both lytic and
temperate phage and has the potential to transfer any part of the donor chromosome to the
recipient cell. The digestion of the host chromosome constitutes a part of the lytic phase
in several phage families. After replication of the phage genome is complete, the viral
DNA is translocated and packaged into a preformed protein shell, the prohead (Fujisawa
and Morita, 1997). The mechanisms of DNA packaging vary between phage but
proceeds either through recognition of specific sequences (such as the pac genes in 1'7); a
pure "head full" mechanism where DNA of a certain size is packed into the prohead (e.g.
T-even phage) or, in the case of phage J.1, a combination of both (Fujisawa and Morita,
1997). Host DNA fragments of a similar size to the phage genome may be accidentally
packaged into proheads of T-even phage. With Salmonella phage P22, some regions of
the host chromosome may resemble pac sites on the phage genome and be accidentally
packaged into the prohead (Singleton and Sainsbury, 1999). The phage resulting from
such events, called transductants, are able to infect other host cells but in many cases
cannot complete their lytic cycle. Once injected into the donor cell, the DNA may either
be digested by restriction endonucleases; undergo recombination and stably integrate into
a host chromosome or plasmid (complete transduction) or "persist as an extra-
chromosomal element, which is usually lost after several divisions of the host cell
(abortive transduction).
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Specialised transduction is undertaken only by temperate phage whose genomes are
incorporated into the host chromosome. The integration of temperate phage genomes
into the host chromosome is the result of a single site-specific recombination event. For
example, phage A integrates at the att sites in-between the gal and bto genes of E. coli
(Lewin, 1997). Aberrant excision of the integrated prophage may result in DNA
surrounding the gal or bio genes being incorporated into a prohead instead of part of the
A genome. Infection of a recipient cell by the transductant may then lead to stable
integration of that gene fragment into the host chromosome. Alternatively, the DNA
could be degraded as with generalised transduction. Whether or not the transducing
phage is fully-functional and capable of both lysis and lysogeny depends on the viral
gene(s) 'sacrificed' during the acquisition of bacterial host DNA.
Transduction is generally a rare event, occurring at a frequency of 10-7 to 10-5 depending
on the phage and host systems (Singleton and Sainsbury, 1999). Successful (i.e. stable)
transduction events occur more frequently with closely related bacterial strains and
decline with genomic distance. Nevertheless, there are many examples of genes derived
from phage which are stably integrated into the chromosomes or plasmids of pathogenic
bacteria. Historically, toxin production has been the most widely recognised bacterial
characteristic linked to bacteriophage infection (Bishai and Murphy, 1988). Examples
include the toxins of Clostridium botulinum, Corynebacterium diptheriae, Vibrio
cholerae and Streptococcus pyogenes (Waldor, 1998). However, more recent work has
demonstrated that phage are able to influence bacterial pathogenicity by encoding
products resulting in a wide diversity of virulence determinants. Examples include the
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toxin-coregulated pili of V. cholerae; fibrinolysin in Staphylococcus aureus and serum
resistance in Shigella dysenteriae (Waldor, 1998). Widespread use of phage for
therapeutic purposes would undoubtedly lead to an increase in transduction frequency.
Specialised transduction can be eliminated by only using lytic phage. However,
generalised transduction is much more difficult to control and remains an unresolved
issue of concern in the scientific community.
1.10 CAMPYLOBACTER BACTERIOPHAGE
Very little information is available for phage of campylobacters. Over 170 phage for this
genus have been reported and most are classified as members of the Myoviridae and
Siphoviridae families (Table lA). Thus far, there has been no evidence of lysogeny in
the Campylobacter genus. Indeed the recently-completed genome sequence of C. jejuni
NCTC 11168 was unusual among bacteria in that it contained no phage-like elements or
insertion sequences (Parkhill et al., 2000). Whilst phage therapy of Salmonella in
chickens has achieved some success (Berchieri et at, 1991) the primary use of
Campylobacter phage has been in typing schemes (Frost et at, 1999). Phage used in
such typing schemes either originated from abattoir effluent or poultry faeces (Grajewski
et at, 1985; Sails et al.,1998). The Campylobacter phage typing scheme adopted by the
PHLS in the UK is the result of comprehensive trials with the 170 Campylobacter phage
reported to date. A total of sixteen phage were selected for this scheme on the basis of
producing reproducible lytic profiles whilst providing the greatest discriminatory power
between Campylobacter strains. These sixteen phage were also characterised with
respect to their morphological and genetic characteristics. They were found to all be
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Family or Group Genera Type Member Particle Envelope GenomeMorphology
Cllticoviridae Cllticovirus PM2 icosahedral No supercoiled dis DNA
Cystoviridae Cystovirus 06 icosahedral Yes 3 segments dis RNA
Inovirus coliphage fd
Inoviridae Plectrovirus Acholeplasma phage rod No circular sis DNA
Levivirus coliphage MS2
Leviviridae Allolevirus coliphage Qbeta icosahedral No 1 (+)strand RNA
Lipahrixviridae Lipl(hrixvirus Thermopr<teus phage 1 rod Yes linear Il's DNA
Miaovirus coliphage 0Xl74
Spirovirus Spiroplasma phages
Miaoviridae Mac-I phage icosahedral No cirwlar sis DNA
Myoviridae coliphage T4 tailed phage No linear dis DNA
Plasmaviridae Plasmavirus Acholeplasma phage pleiomcrphic Yes Circular dis DNA
Podoviridae coliphage T7 tailed phage No linear Il's DNA
Siphoviridae lambda phage group coliphage lambda tailed phage No linear dis DNA
Sulpholobus shibatae virus SSV-I lemon-shaped No circular dis DNA
Tectiviridae Tectivirus phagePRDl icosahedral No linear dis dna
Table 1A. Current names and attributes of bacteriophage families
recognised by the International Committee on the Taxonomy of Viruses
(Cann, 1993).
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members of the Myoviridae family and possessed unusually large genomes (up to 320 kb
in size). Phage typing schemes such as this provide a cheap and easy method of
discriminating between bacterial strains and requires only minimal equipment. In
addition to phage typing, the potential to exploit bacteriophage as biocontrol agents has
prompted interest from several companies wishing to develop and use phage therapy to
control bacterial pathogens, including Campylobacter, in humans and animals. These
include BioPhage Inc. (www.biophage.com); Intralytix (www.intralytix.com); and Phage
Therapeutics International Inc. (www.phagetx.com). However, the results of their
endeavours are not yet known.
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CHAPTER2
GENERAL MATERIALS AND METHODS
2.0 SOLUTIONS
All solutions were prepared in reverse osmosis (RO) water. Chemicals were obtained
from Fisher Scientific (Loughborough, Leicestershire) and biochemicals from Sigma
Gillingham, Dorset) unless otherwise stated. All media were prepared using RO water
and sterilized at 15 psi for 20 min unless otherwise stated.
2.0.1 Magnesium sulphate solution
A 1 M stock solution of MgS04 was prepared and filter sterilized using a sterile 0.2 J.1m
pore cellulose acetate membrane filter (Minisart™, Sartorius, Gottingen, Germany). This
was stored at room temperature and pressure (RTP) until required. For suspension of
Campylobacter cells, a 10 mM MgS04 solution was prepared by adding 100 J.11of the 1
M stock solution to 10 ml of sterile RO water.
2.0.2 Maximum recovery diluent (MRD)
MRD, a peptone saline diluent, was used for all serial dilutions of bacterial cell
suspensions unless otherwise stated. MRD medium (CM733, Oxoid, Basingstoke, UK)
was dissolved in 500 ml of RO water and sterilized according to the manufacturer's
instructions. Final quantities of ingredients were: peptone (1 g 1"1); NaCI (8.5 g 1"1) pH
7.0.
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2.0.3 Phosphate buffered saline (PBS)
Five PBS tablets (BR14a, Oxoid) were dissolved in 500 ml of RO water and sterilized
according to the manufacturer's instructions. PBS was stored at RTP until required.
Final quantities of constituents were: NaCI (8 g rl), KCI 0.2 g r', disodium hydrogen
phosphate (1.15 g r'),potassium dihydrogen phosphate (0.2 g rl) pH 7.3.
2.0.4 SM Buffer (SM)
SM buffer was used for all bacteriophage dilutions unless otherwise stated. SM was
prepared by adding Trizma base (2-amino-2-hydroxymethyl-l,3-propanediol, 3 g), NaCI
(2.9 g), MgS04.7H20 (1.0 g) and gelatin (5 ml ofa 1% solution) to 500 ml ofRO water.
The pH of the solution was adjusted to 7.5 with concentrated hydrochloric acid. This was
sterilised by autoclaving at 15 psi for 20 min.
2.0.5 Tris acetate EDTA buffer (TAE) pH 8.0
A lOX TAE buffer stock solution was prepared by adding Trizma base (48.4 g); glacial
acetic acid (10 ml) and EDTA (2.92 g) to 1 IofRO water. This solution was diluted 1:9
in RO water when required.
2.0.6 Tris EDTA buffer (TE) pH 7.5
A lOX TE buffer stock solution was prepared by adding Trizma base (12.1 g) and EDTA
(3.7 g) to 1 1ofRO water. This solution was diluted 1:9 in RO water when required.
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2.0.7 Tris borate EDTA buffer (TBE) pH 8.0
A 5X TBE butTer stock solution was prepared by adding Trizma base (54.0 g); boric acid
(27.5 g) and EDTA (2.93 g) to 1 Iof RO water. This solution was diluted 1:4 in RO
water when required.
2.1 BACTERIAL STRAINS AND THEIR STORAGE
Campylobacter reference strains obtained from the National Collection of Type Cultures
(NCTC) are listed in Table 2A. Typically, strains were subcultured on Columbia blood
agar plates (CBA, 2.3.1.1) and incubated for 24 h at 42°C in microaerobic conditions
(2.3.3.3). These subcultures were stored on a short term basis «1 month) under
microaerobic conditions at 4°C. For long term storage a sterile cotton swab was used to
harvest blood plate growth after 24 h. This swab was then transferred to a cryovial
containing 1 ml of glycerol storage medium (2.3.1.2) and frozen at -80°C until required.
Resuscitation was performed by thawing the cryovial contents then using the swab to
inoculate a fresh plate of CBA which was then incubated under microaerobic conditions
at 42°C for 24 - 48 h.
2.2 BACTERIOPHAGE STOCKS AND THEIR STORAGE
Campylobacter bacteriophage reference strains used by the Central Public Health
Laboratories (CPHL, Colindale, London) in their phage typing scheme were obtained
from the NCTC and are listed in Table 2B. Bacteriophage stocks were propagated using
a modification of the agar overlay technique described by Sam brook et al. (1989)
(2.3.6). Bacteriophage stocks were stored in 8M butTer (2.0.4) at 4°C unless stated
otherwise.
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Campylobacter species Reference number Source
Ci jejuni NCTC 11168 NCTC
C.jejuni NCTC 12658 NCTC
C.jejuni NCTC 12659 NCTC
C.jejuni NCTC 12660 NCTC
C.jejuni NCTC 12661 NCTC
C.jejuni NCTC 12662 NCTC
C.jejuni NCTC 12663 NCTC
C.jejuni NCTC 12664 NCTC
Ci jejuni NCTC 12665 NCTC
C.jejuni NCTC 81176 NCTC
C.jejuni PTI NCTC
C.jejuni PT2 NCTC
C.jejuni PT5 NCTC
C.jejuni PT6 NCTC
C.jejuni PT19 NCTC
C.jejuni PT33 NCTC
C.jejuni PT35 NCTC
C.jejuni PT44 NCTC
C. coli NCTC 12666 NCTC
C. coli NCTC 12667 NCTC
C. coli NCTC 12668 NCTC
C.lari NCTC 11352 NCTC
Table 2A. Names of bacterial strains used.
Names of bacterial strains used in experiments. NCTC = National Collection of Type
Cultures (Colindale, London, UK).
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Bacteriophage Reference Propagating strain
~1 NCTC 12673 C.jejuni NCTC 12661
~2 NCTC 12674 C.jejuniNCTC 12661
~3 NCTC 12682 C. coli NCTC 12667
~4 NCTC 12676 C. jejuni NCTC 12663
~5 NCTC 12678 C. jejuni NCTC 12664
~6 NCTC 12680 C.jejuni NCTC 12665
~7 NCTC 12671 C. jejuni NCTC 12660
~8 NCTC 12681 C. coli NCTC 12666
~9 NCTC 12669 C. jejuni NCTC 12658
~10 NCTC 12683 C. coli NCTC 12668
~11 NCTC 12679 C. jejuni NCTC 12664
~12 NCTC 12677 C. jejuni NCTC 12663
~13 NCTC 12672 C. jejuni NCTC 12660
~14 NCTC 12675 C. coli NCTC 12668
~15 NCTC 12684 C. jejuni NCTC 12659
~16 NCTC 12670 C. jejuni NCTC 12662
Table 2B. Names of bacteriophage strains used.
Names of bacteriophage strains used in experiments. The Campylobacter host typically
used in the propagation of each phage is shown in the far right column. NCTC =
National Collection of Type Cultures (Colindale, London, UK).
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2.3 METHODS FOR THE CULTIVATION OF BACTERIAL STRAINS AND
PROPAGATION OF BACTERIOPHAGE
2.3.1 Growth media
Unless otherwise stated, all media were prepared in RO water and sterilized at 15 psi for
20 min. Following sterilization, all media were tempered to sooe and dispensed (15 - 20
ml) in to sterile Petri dishes. The Petri dishes were then dried in a laminar flow cabinet
for 10 h before storage in the dark at 4°C for up to one month.
2.3.1.1 Columbia blood agar (CBA)
Columbia blood agar base (CM 331, Oxoid) was prepared and sterilized according to the
manufacturer's instructions. Laked horse blood (SR48, Oxoid) was added to a final
concentration of 5% v/v before dispensing into Petri dishes.
2.3.1.2 Glycerol storage medium (GSM)
Nutrient broth No.2 (NB2, 2.3.1.6) supplemented with 20% v/v glycerol was dispensed
(500 J.ll) into 2 ml cryovials and sterilised according to the manufacturer's instructions.
Following sterilisation the cryovials were stored at RTP until required.
2.3.1.3 FBP growth supplement
FBP consisted of FeS04.7H20 (10% w/v), sodium pyruvate (10% w/v) and sodium
metabisulphite (10% w/v) in RO water. The solution was heated to sooe and stirred
continuously on a heated magnetic stirring platform until the ingredients had dissolved.
The solution was then either used immediately or stored at -20oe until required.
48
Ch fer 2
2.3.1.4 Modified charcoal cefoperazone deoxycholate agar (CCDA)
Blood free Campylobacter selective agar base (Lab 112, Lab M, Bury, UK) was prepared
and sterilized according to the manufacturer's instructions. Following sterilization,
Campylobacter selective supplement (Pl. 450, Pro lab diagnostics, Cheshire, UK) was
added according to the manufacturer's instructions to give a final concentration of the
following constituents: cefoperazone (32 mg rl), amphotericin B (10 mg rl). The
medium was then dispensed into sterile Petri dishes. CCDA was used in the primary
isolation of Campylobacter from all sources.
2.3.1.5 Nutrient agar (NA)
Nutrient agar (CM 3, Oxoid) was prepared and sterilized according to the manufacturer's
instructions and dispensed into Petri dishes.
2.3.1.6 Nutrient broth number 2 (NB2)
Nutrient broth number 2 (CM 67, Oxoid) was prepared and sterilized according to the
manufacturer's instructions and used within 24 h of preparation. Where stated,
Campylobacter growth was optimized by the addition of the FBP supplement (2.3.1.3) to
a final concentration ofO.05% v/v.
2.3.1.7 NZCYM base medium (NZB)
NZCYM broth (0688-17-0, Difco, Oxford, UK) supplemented with 1.2% wlv Agar No. 3
(Ll3, Oxoid) was prepared and sterilized according to the manufacturer's instructions
and dispensed into Petri dishes. NZB was used as the growth support medium for
Campylobacter strains used in bacteriophage propagation.
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2.3.1.8 Plate count agar (PGA)
Bacto™ Plate Count Agar (0479-01-1, Difco) was prepared and sterilized according to
the manufacturer's instructions and dispensed into Petri dishes.
2.3.1.9 Rappaport-Vassiliadis soya peptone broth (RVS)
RVS broth (CM 866, Oxoid) was prepared and sterilized in 10 ml volumes according to
the manufacturer's instructions and stored at RTP for up to 48 h before use. RVS was
used for the selective enrichment of Salmonella ssp. from faeces.
2.3.1.10 Top layer agar (TLA)
NZCYM broth (0688-17-0, Difco) supplemented with 0.6% w/v Agar No.3 (L13, Oxoid)
was prepared and sterilized according to the manufacturer's instructions. Volumes (500
ml) of this medium were stored at RTP for up to one month. When required, the TLA
was reheated in a microwave and tempered to 50°C in a water bath before dispensing 5
ml volumes into sterile universal tubes. The 5 ml TLA aliquots were stored in a water
bath at 50°C for up to one hour before use.
2.3.1.11 Xylose-Lysine desoxycholate agar (XLO)
XLD medium (CM 469, Oxoid) was prepared in 500 ml volumes and heated until
reaching boiling point where upon it was tempered to 50°C and dispensed into sterile
Petri dishes.
2.3.2 Preparation of McFarland turbidity standards
The McFarland standards (McFarland, 1907) uses mixtures of 1% w/v anhydrous BaCh
and a 1% v/v H2S04 to form a turbid suspension from the white precipitate (BaS04)' A
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McFarland scale was prepared by mixing the solutions in the volumes given in Table 2C.
The standards were shaken thoroughly before use and stored for no longer than six
months.
2.3.3 Bulk cultivation of Campylobacter ssp.
2.3.3. 1 Cultivation on solid media
Columbia blood agar (CBA, 2.3.1.1) was used for growth of all pure Campylobacter
cultures unless otherwise stated. A sterile cotton swab was used to harvest growth from
broth or plate cultures and then used to uniformly inoculate the surface of a CBA plate.
Plates were inverted and placed in a gas jar and incubated at 42°C for 18 - 24 h in
microaerobic conditions (2.3.3.3) unless otherwise stated.
2.3.3.2 Cultivation in broth
Nutrient broth No. 2 (NB2, 2.3.1.6) was used for growth of Campylobacter ssp. in all
cases. During growth curves and other situations requiring access to the same culture at
multiple time points, FBP supplement addition was necessary to butTer oxygen tension in
the broth and prevent erratic growth. During standard overnight (15 - 20 h) incubation of
cultures, the addition ofFBP was not necessary. A loopful of biomass was taken from a
fresh blood plate culture and used to inoculate a flask of sterile NB2. Flask aeration was
maintained at five times the broth volume (lOOml of broth in a 500 ml flask unless stated
otherwise). The flask was transferred to a gas jar and the internal atmosphere adjusted to
microaerobic conditions (2.3.3.3). Gas jars were secured in a shaking platform incubator
at 42°C and 150 rpm unless otherwise stated.
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McFarland Scale No. 1% BaCh (ml) 1% H2S04 (ml)
0.5 0.05 9.95
1.0 0.1 9.9
2.0 0.2 9.8
3.0 0.3 9.7
4.0 0.4 9.6
5.0 0.5 9.5
6.0 0.6 9.4
7.0 0.7 9.3
8.0 0.8 9.2
9.0 0.9 9.1
10.0 1.0 9.0
Table 2C. McFarland turbidity standards
The McFarland standards are prepared by mixing different ratios of 1% w/v anhydrous
BaCh and a 1% v/v H2S04 to form a turbid suspension from the white precipitate
(BaS04).
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2.3.3.3 Establishment of a microaerobic atmosphere
Rubber-sealed 3.5 I evacuable gas jars were used for all growth conditions requiring a
modified atmosphere. Modification of the jar's atmosphere was achieved by evacuating
the chamber to -20 Hg and replacing with an anaerobic gas mixture (5% H2, 10% C02,
85% N2) to give a final microaerobic atmosphere consisting of approximately 7% 02,
3.3% H2, 6.6% CO2 and 82.2% N2.
2.3.4 Speciation and enumeration of Campylobacter
2.3.4.1 Morphology
Colonies on CCDA plates (2.3.1.4) conforming to the description of typical
Campylobaeter growth on this medium were subcultured on CBA (2.3.1.1). Typical
colonies are defined as grey, moist, flat and spreading (Bridson, 1998). Subcultures
were Gram stained and examined by light microscopy for typical spiral morphology
(Smibert, 1984). Motility was examined by suspending a small quantity of culture in 30
III of MRD (2.0.2) on a clean glass slide. The cell suspension was overlaid with a cover
slip and examined by light microscopy for the typical darting and corkscrew motility
characteristics of Campylobaeter (Smibert, 1984).
2.3.4.2 Biochemical speciation
Biochemical tests on Campylobaeter isolates focused on (a) confirmation of the isolate
being a member of the Campylobaeter genus (catalase and oxidase tests) and (b)
Identification of C.jejuni using the hippurate test.
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2.3.4.2. 1 Catalase test
This test detects the presence of catalase, an oxidoreductase which catalyses the
formation of H20 and 02 from H202. The presence of catalase was determined by
suspending one colony in 30 J.11of MRD (2.0.2) on a clean glass slide. Thermophilic
Campylobaeter species are catalase positive (Stern et al., 1992). Ten microlitres of 30%
H202 solution was added to the slide and overlaid with a cover slip. The formation of
bubbles under the cover slip indicated a catalase positive reaction.
2.3.4.2.2 Oxidase test
This is a test used to detect the presence of cytochrome C and its associated oxidase
(Stern et al., 1992). To do this, 0.1 g of oxidase reagent (tetra methyl-p-
phenylenediamine dihydrochloride) was dissolved in 10 ml of sterile RO water. The
solution was used to wet a sterile swab which, in tum, was used to harvest growth from
the surface of an overnight CBA plate (2.3.1.1). A positive result was indicated by the
development of a deep blue colour within 10 sec. No colour change or a slight blue tinge
was considered negative. All members of the Campylobaeter genus are oxidase positive.
2.3.4.2.3 Hippurate test
Hippuricase is an enzyme only found in C. jejuni which hydrolyses hippurate
(C6Hs.CO.NH.CH2.CO£) to benzoate (C2Hs02) and glycine (C2HsN02). A 1% w/v
solution of sodium hippurate was prepared in RO water, filter sterilized, dispensed into
sterile 1.5 ml Eppendorftubes in 500 J.11volumes and stored at -20°C (Stern et al., 1992).
Upon thawing, the hippurate vials were heavily inoculated with growth from an overnight
CBA plate (2.3.1.1) and incubated aerobically at 37°C for 2 h. Hippurate activity was
detected by the addition of 100 J.11of 7% w/v 1,2,3-triketohydrindene monohydrate
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(ninhydrin reagent). A positive result was indicated by the development of a deep blue
colour. No colour change or a mild bluellilac colour was considered negative.
2.3.4.3 Additional confirmation and speciation
When required, further confirmation and speciation tests were implemented. These
consisted ofa latex agglutination test (Campylobacter Test Kit, DR0150, Oxoid) and the
API Campy kit developed by biolvlerieux. Both were used according to the
manufacturer's instructions.
2.3.4.4 Enumeration of Campylobacter ssp. in pure culture
Campylobacter enumeration was performed essentially as described by Miles and Misra
(1938) unless otherwise stated. Briefly, a cell suspension was serially diluted in ten fold
steps down to a dilution of 10-1°. Five drops (10 J.1I) of each dilution were spotted onto
the surface of CCDA plates (2.3.1.4) without the selective supplement. CCDA was used
instead of CBA (2.3.1.1) as colonies on the latter tended to spread and be difficult to
count. Plates were left to dry for 30 min then inverted and incubated in microaerobic
conditions (2.3.3.3) at 42°C. Plates were examined for growth at 24 h and 48 h if further
incubation was required. Dilutions giving rise to 3 - 30 colonies were used for
enumeration. The number of colony forming units (cfu) per 10 J.11 of the undiluted
suspension was calculated by dividing the mean number of colonies for a particular
dilution by the dilution factor. This was then multiplied by 100 to convert to cfu per ml.
2.3.5 Propagation of Bdellovibrio ssp.
A single colony of E. coli K12 from a nutrient agar plate (2.3.1.5) was used to inoculate
100 ml of Tripticase Soy Broth (211768, Difco) and incubated for 24 h at 30°C. An
aliquot of this culture (3 ml) was mixed with 1 ml of approximately 106 pfu ml"
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Bdellovibrio bacteriovorous 109J prepared in HEPES Ca buffer (HEPES 5.94 g r', CaCh
0.294 g rl pH 7.8). This suspension was then added to 50 ml of HEPES Ca buffer and
incubated aerobically for 48 h at 30°C in an orbital shaking incubator (50 rpm). The
resulting lysate was filtered through a 0.45 J.1mpore size filter (Sartorius) and stored at
4°C for up to four weeks.
2.3.6 Propagation of bacteriophage
Bacteriophage isolates were subjected to a minimum of three rounds of serial plaque
purification (2.3.6.1) prior to storage at 4°C. The Campylobacter strain used for the
propagation of the phage was subcultured on CBA (2.3.1.1). The resulting growth of five
plates was harvested into 10 ml volumes of 10 mM MgS04 suspension (2.0.1) of which
ten 500 J.11volumes were dispensed into sterile 1.5 ml Eppendorf tubes. Phage
suspension (100 J.11)was then added to each Eppendorf tube and incubated aerobically at
3~C for 20 min to allow for phage adsorption. The suspension was then added to 5 ml
of molten TLA (2.3.1.10) tempered to 50°C and briefly mixed before pouring onto NZB
(2.3.1.7). Plates were swirled to ensure an even distribution ofTLA on the surface of the
base agar. After allowing the agar to set (10 min RTP) the plates were incubated at 42°C
for 24 h in microaerobic conditions. Following incubation the plates were examined for
lysis compared with a control lawn of the host bacterium. Bacteriophage were eluted
from the TLA by the addition of 5 ml ofSM buffer (2.0.4) to the surface of the plates and
gently shaking (60 cycles min-I) on an orbital platform shaker for 18 - 20 h at 4°C. The
eluate was pooled and filtered through a 0.45 J.1mpore membrane filter (Sartorius) and
stored at 4°C until required.
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2.3.6.1 Serial plaque purification
Single plaques resulting from bacteriophage infection were excised from top layer agar
using the cut off tip of a sterile polypropylene 1000 ul-capacity micropipette. The agar
plug was transferred to 200 ).11of SM buffer (2.0.4) and phage were allowed to elute from
the plaque over 24 h at 4°C. An aliquot of the eluate (100 JlI) was then used for
bacteriophage propagation (2.3.6) and repeated selection of individual plaques. Serial
plaque purification was performed a minimum of three times for each bacteriophage
isolate prior to storage at 4°C.
2.3.6.2 Purification of Bacteriophage particles using CsCI density gradient
centrifugation
Purification of bacteriophage particles was performed using the CsCI density gradient
centrifugation technique (Sam brook et al., 1989). CsCI was added to a 109 pfu mrl
suspension of phage to a final concentration of 1.5 g ml", This suspension was then
subjected to centrifugation at 70,000 rpm at 4°C for 24 h in a Beckman TL-lOO
ultracentrifuge using a TLA 100.3 rotor. Formation of a thin blue band following
centrifugation indicated the location of concentrated phage particles. This was extracted
by piercing the centrifuge tube with a hypodermic needle at a level just below the blue
band. The concentrated phage particles were siphoned off into a fresh Eppendorf tube
prior to titration and storage at 4°C.
2.3.6.3 Concentration of bacteriophage stocks
Bacteriophage stocks were concentrated using the centrifugation technique described by
Sambrook et al: (1989). Briefly, the filtered phage lysate eluates (2.3.6) were subjected
to centrifugation at 40,000 g for 2 h in a Beckman JA20 rotor using a Beckman J2-2l
centrifuge (Beckman, High Wycombe, UK). Following centrifugation, the supernatant
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was discarded and the pellet resuspended in 1 ml of SM buffer (2.0.4). The centrifuge
tube was stored at 4°e for 24 h to allow any phage attached to the surface of the tube to
elute into the buffer solution. The phage eluate was then transferred to sterile Eppendorf
tubes prior to enumeration (2.3.6.4) and storage at 4°e.
2.3.6.4 Enumeration of bacteriophage in purified Iysates
Unless otherwise stated, bacteriophage were enumerated using the surface droplet
technique (Salama et al., 1990a). This technique is a modification of the protocol
devised for bacterial enumeration by Miles and Misra (1938). Briefly, the bacteriophage
suspension was decimally diluted in ten fold steps in SM buffer (2.0.4) down to 10-8•
Lawns of the host Campylobacter strain were prepared by adding 500 JlI of a 109 cfu mrl
in 10 mM MgS04 (2.0.1) to 5 ml of molten TLA (2.3.1.10) tempered to 500e and poured
onto the surface of NZB (2.3.1.7). After allowing 5 min for the TLA to set, the plates
were inverted in a rrc incubator and the lids slightly opened to allow the surface of the
plates to dry for 20 min. Following drying, the plates were inoculated with 5 drops (10
JlI) of each dilution and left to dry for 20 min. The plates were then incubated
microaerobically at 42°C for 18 - 20 h before examining for plaque formation. Dilutions
giving rise to 3 - 30 plaques were used for enumeration. The number of plaque forming
units (Pfu) per 10 l11 of undiluted suspension was calculated by dividing the mean number
of plaques for a particular dilution by the dilution factor. This figure was then multiplied
by 100 to convert to pfu ml".
2.3.6.5 Determination of Campylobacter susceptibility to phage infection
To determine the susceptibility of a Campylobacter strain to phage infection, each strain
was cultured on eBA (2.3.1.1) prior to suspension in 10 mM MgS04 (2.0.1). Lawns of
each strain were prepared for bacteriophage inoculation as described in 2.3.6. The
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bacteriophage isolates were plaque purified (2.3.6.1) and titres adjusted to 107 pfu mrl
(titres determined on the propagating strain) by dilution in SM buffer (2.0.4). Three
drops (10 J.11)of. each phage suspension were dispensed onto the surface of each
Campylobacter lawn and left to dry for up to 30 min. Following drying the plates were
inverted and incubated in microaerobic conditions (2.3.3.3) for 24 h before examination
for plaques.
2.4 ANALYSIS OF BACTERIAL AND VIRAL PROTEINS
2.4.1 Protein quantitation
2.4. 1. 1 Bradford Coomassie Plus
Standard protein quantitation was performed using the Coomassie Plus® Kit (BioRad),
based on the Bradford Coomassie protein quantitation assay. The binding of Coomassie
dye in an acidic solution is accompanied by an absorbance shift from 465 nm to 595 om,
changing the colour from redlbrown to blue. Protein standards were prepared by diluting
a 2 mg mrl bovine serum albumen (BSA) suspension in the same diluent as the sample
(e.g. PBS, 2.0.3) to give concentrations of 50 Jig, 100 Jig, 200 J.1g,500 Jig and 1000 Jig
ml". Samples were diluted to give a reading predicted to be within the expected standard
range. Volumes of the samples and standards (500 ul) were dispensed into 1 ml cuvettes
and each mixed with an equal volume of Coomassie Plus® reagent. Absorbance at 595
om was measured compared with a 'blank' (Coomassie Plus® reagent plus diluent) using
a Cecil CE2021 spectrophotometer (Cecil Instruments Ltd, Cambridge). All standards
and samples were tested in duplicate with the mean value used to calculate protein
concentrations from a standard curve plotted using Microsoft Excel XP.
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2.4.1.2 Bicinchoninic acid (BCA)
The bicinchoninic acid (BCA) assay has been shown to produce more accurate estimates
of protein concentration in bacterial membrane preparations than other techniques based
on the Bradford assay. In these circumstances, protein quantitation was performed using
a method based on the BCA assay (BCA Protein Assay, Pierce biotechnology, Rockford,
Illinois, USA). Protein reduces Cu2+ to Cu+ in an alkaline medium (the biuret reaction).
A water-soluble complex is formed when two molecules of BCA chelate one cuprous
cation, causing a strong absorbance shift to 562 nm which is almost linear with increasing
protein concentrations over a broad working range (20-2,000 ug ml"). The BCA
'working reagent' was prepared in a sterile test tube according to the manufacturer's
instructions and mixed (2 ml) with sample (0.1 ml) before incubating for 30 min at 37°C.
Subsequently, all tubes were cooled to RTP before measurement of absorbance against
the blank at 562 nm using a Cecil CE2021 spectrophotometer. Protein standards were
prepared in the range of20 - 2000 Ilg ml" from a 2 mg ml" stock ofBSA provided by
the manufacturer. All standards and samples were tested in duplicate with the mean
value used to calculate protein concentrations from a standard curve plotted using
Microsoft Excel XP.
2.4.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDs-
PAGE).
All protein gels were prepared using the protocols described by Sam brook et aL (1989)
using a Mini Protean II kit (Biorad) unless otherwise stated. Separating gels were
prepared at 12% and stacking gels at 5% unless otherwise stated. Separating gels were
prepared in quantities of S'ml per gel cast by mixing ingredients in the following order:
sterile RO water (1.9 ml); 30% w/v acrylamide, 1% w/v bisacrylamide (1.7 ml); I.SM
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Tris, pH 8.8 (1.3 ml); 10% w/v SDS (0.05 ml) ; 10% ammonium persulphate (0.05 ml);
N, N, N', N'-tetramethylethylenediamine, TEMED (0.002 ml).
Once poured into the east, the gel was allowed to set at RTP for 10 - 15 min under a
layer of water saturated butanol. Following polymerization the butanol was removed and
the exposed surface of the gel was washed with sterile RO water. Filter paper was
inserted into the gel cast to remove traces of RO water. Volumes (3 ml) of stacking gel
were prepared by mixing ingredients in the following order: sterile RO water (2.1 ml);
30010w/v acrylamide, 1% w/v bisacrylamide (0.5 ml); 1.5M Tris, pH 6.8 (0.38 ml) ; 10%
w/v SDS (0.03 ml); 10% ammonium persulphate (0.03 ml); N, N, N', N'-
tetramethylethylenediamine, TEMED (0.003 ml).
A well-forming comb was inserted into the stacking gel after pouring and left to set at
RTP for 10 - 15 min. Following polymerization of the stacking gel, the comb was
carefully removed and each of the wells was washed five times with sterile RO water to
remove any unpolymerised acrylamide. The electrophoresis chamber was then
assembled and flooded with running buffer (25 mM Tris, 250 mM glycine
(electrophoresis grade) pH 8.3, 0.1% SDS).
Protein samples were prepared by mixing 5X loading buffer (250 mM Tris.CI, pH 6.8;
10% w/v SDS; 0.5% w/v bromophenol blue; 50% v/v glycerol; 5% v/v ~-
mercaptoethanol) with the sample in a 1:4 ratio (buffer:sample). Samples were then
boiled for three min before loading 10 - 20 J.11 per well on the gel. Electrophoresis was
performed at 200 V for 30 - 40 min unless otherwise specified.
2.4.3 Staining of 50S-PAGE gels
Following electrophoresis (2.4.2), the acrylamide gels were removed from the easts and
the stacking gel excised using a sterile scalpel blade. The gel was briefly washed in RO
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water to remove running buffer and then either stained (Coomassie blue, 2.4.3.1; silver
stain, 2.4.3.2) or prepared for electroblotting to a solid support (2.4.4).
2.4.3.1 Coomassie blue staining
Polyacrylamide gels were stained using Coomassie blue according to the method
described by Sambrook et al: (1989). Gels were immersed in 50 ml of Coomassie blue
stain (Coomassie Brilliant Blue R250, 0.125 g; methanol.Hg) (1:1 v/v), 45 ml; glacial
acetic acid, 5 ml) for 1h with gentle agitation on an orbital platform shaker. The staining
solution was then removed and the gel rinsed with RO water before immersion in
destaining solution (methanol, 40% v/v; glacial acetic acid, 10% v/v). The destaining
solution was replaced every 30 min until protein bands were visible.
2.4.3.2 Silver staining
Silver staining was performed using the Plus One Silver Staining Kit according to the
manufacturer's instructions (pharmacia, Milton Keynes, UK). The gel was initially
placed in a fixing solution (ethanol, 400/0v/v; glacial acetic acid, 10% v/v) for 30 min.
Removal of the fixative was immediately followed by addition of the sensitizing solution
(ethanol, 30% v/v; gluteraldehyde, 0.125% w/v; sodium thiosulphate, 0.2% w/v; sodium
acetate, 0.5 M) for 30 min. The gel was then washed for 3 x 5 min in RO water prior to
initiation of the silver reaction by immersion in the staining solution (silver nitrate, 0.25%
w/v; formaldehyde, 0.015% v/v) for 20 min. The gel was then washed for 2 x 1 min in
RO water and developed by immersion in a solution containing 0.25 M sodium carbonate
and 0.007% formaldehyde. Development of the silver stain was arrested using 0.04 M
EDTA solution.
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2.4.4 Transfer of proteins from 50S-PAGE gels to solid supports
Proteins separated using SDS-PAGE (2.4.2) were transferred onto a solid polyvinylidene
difluoride (PVDF) membrane using a SemiPhor semi-dry electroblotting chamber
according to the manufacturer's instructions (Pharmacia). Briefly, the PVDF membrane
was immersed in 1000/0methanol for 5 min, rinsed in RO water then immersed for 5 min
in transfer buffer (39 mM glycine, 48 mM Tris, 0.037% w/v lauryl sulphate
(electrophoresis grade), 20% v/v methanol). The gel was then placed on top of the
membrane with air bubbles in-between them being removed using a glass rod. Pieces of
blotting paper cut to match the size of the gel were pre-soaked for 5 min in transfer butTer
before being placed either side of the gel and membrane to form a "Transphor
Sandwich". The anode and cathode plates of the SemiPhor chamber were liberally
flushed with transfer buffer prior to centrally placing the Transphor sandwich in-between
them. Protein transfer was performed at a current of 32 rnA for 1 h. Following transfer,
the PVDF membrane was stored in-between pieces of filter paper in the dark at 4°C until
required.
2.4.5 Western blotting
A PVDF membrane containing proteins electrotransferred from an SDS-PAGE gel
(2.4.2) were immersed in 10 ml of blocking solution (Tris ButTered Saline, TBS
containing 2% w/v skimmed milk powder) for 30 min at 37°C. The membrane was then
rinsed in 10 ml of washing butTer (TBS containing 0.05% v/v Tween 20 (P-7949, Sigma)
for 5 min on a gyratory platform shaker at 60 rpm. After rinsing, the membrane was
transferred to a heat-sealable plastic bag. To this bag was added 10 ml of blocking
solution containing 5 J.LI a 111000dilution of primary antibody (polyclonal antisera raised
in rabbits against acid-glycine extractable proteins from C. jejuni, obtained from Dr. P.
Connerton). The plastic bag was sealed and incubated at 37°C for 1 h. Following
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incubation the membrane was immersed for 3 x 5 min in washing buffer prior to
transferral to a new heat-sealable bag. To this bag was added 10 ml of blocking buffer
containing 2 ~l of the secondary antibody (goat anti-rabbit IgG alkaline phosphatase
conjugate) prior to sealing and incubation at 37°C for 1 h. Following incubation the
membrane was immersed for 3 x 5 min in washing buffer and 1 x 5 min in TBS prior to
transferral to a square Petri dish (Sterlin UK). The membrane was then immersed in 10
ml of developing solution (50 ~l 5-bromo-4-chloro-3-indolyl phosphate, BCIP; 50 ~l
nitroblue tetrazolium, NBT; in 10 ml TBS) and incubated in the dark at RTP until the
desired level of development was achieved. The membrane was then washed for 3 x 5
min in RO water prior to photographic recording using a HP Scanjet 4c digital scanner
and associated PC software.
2.4.6 Profiling of bacteriophage proteins
Bacteriophage proteins were separated on a 12% SDS-PAGE gel (2.4.2) and stained
using Coomassie blue (2.4.3.1). Selected bands were excised from the gel and sent for
mass spectrometry sequencing by Dr. Kevin Bailey at the Queen's Medical Centre,
Nottingham. Polypeptides resulting from a tryptic digest of the bands were spray ionized
and sequenced using a Micromass Q-TOF-2 working on a Matrix-assisted Laser
Desorption Ionisation Time-of-Flight (MALDI-TOF) system. The peptide fingerprints
were used to interrogate the ExPasy database (www.expasy.org) for protein
identification.
2.5 ANALYSIS OF BACTERIAL AND VIRAL NUCLEIC ACID
2.5.1 Extraction of bacterial chromosomal DNA
Chromosomal DNA was extracted using the protocol determined by (Pitcber et al.,
1989) Briefly, l.5 ml of overnight broth culture (2.3.3.2) was transferred to a l.5 ml
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Eppendorf tube and the cells pelleted by centrifugation at 13,000 g for 2 min. The
supernatant was discarded and the pellet washed once in 1 ml of ice cold lysis buffer (25
mM Tris-HCI pH8.0, 10 mM EDTA, 50 mM sucrose). The cells were then resuspended
in 100~1 of lysis buffer and mixed with 500 ~l of GE8 solution (5 M guanidium
thoiocyanate, 0.1 M EDTA, 0.5% v/v sarkosyl). The solution was incubated for 5 min or
until the solution cleared. The lysate was cooled on ice for 2 min after which 0.25 ml of
ice cold 7.5 M ammonium acetate was added. The lysate was vortexed and incubated on
ice for 10 min. Following incubation 0.5 ml of chloroform:isoamylalcohol (24:1) was
added, the solution vortexed and SUbjectedto centrifugation at 13,000 g for 10 min. The
upper phase (850 ul) was removed and added to 540 J.11of ice cold isopropanol, mixed for
1 min and centrifuged at 13,000 g for 1 min to pellet the DNA. The pellet was washed
three times in 70% ethanol without resuspending and then air dried for 30 min. The
DNA was then resuspended in 50 J.11of sterile RO water.
2.5.2 Extraction of Bacteriophage DNA
8M buffer (2.0.4, 200 ul) supplemented with 1 mg ml" Proteinase K was added to the
same volume of a 1010 pfu ml" suspension of phage and incubated for 2 h at 55°C in
order to digest the viral capsid. All proteins were then denatured by the addition of an
equal volume of Tris-saturated phenol (PH 8.0). The mixture was vortexed until an
emulsion formed after which it was subjected to centrifugation at 5,000 g for 5 min. The
aqueous phase was removed and treated with a 1:1 mixture of equilibrated
phenol:chloroform prior to repeating the vortex and centrifugation steps. The upper
phase was then treated once with an equal volume of chloroform and, following
centrifugation, was mixed with 100 ul of 7.5 M ammonium acetate and 1 ml of ice-cold
absolute ethanol. The DNA was left to precipitate for 1 h prior to centrifugation at
13,000 g for 5 min. The resulting pellet was then washed three times (without
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resuspending) in 70% vtv ethanol and air dried at 37°C for 30 min. Finally, the pellet
was resuspended in 100 JlI ofTE buffer (2.0.6) and stored at 4°C until required.
2.5.3 Preparation of plasmid DNA
A single white colony was transferred to 5 ml of LB broth supplemented with 50 JIgml"
ampicillin and incubated at 37°C overnight shaking at 100 rpm. Following incubation,
plasmids were extracted from the cells using a QIAprep® Miniprep kit according to the
manufacturer's instructions (QIAGEN ltd, West Sussex).
2.5.4 Digestion of DNA using endonucleases
Typically, preparations of genomic (2.5.1, 2.5.2) and plasmid (2.5.2) DNA were digested
in volumes of 20 ul. Digestion of DNA by restriction enzymes was carried out using the
conditions recommended by the enzyme supplier (promega Ltd, Southampton, UK).
Digestions were performed at 3rC for 2 h using approximately 0.5 - 2 units of enzyme
per I ug of DNA using the appropriate restriction buffer unless stated otherwise.
2.5.5 Preparation of agarose gels
Agarose gels were prepared at a concentration of 0.8 - 2% w/v by suspending agarose
powder (Hi-pure low EEO agarose, Biogene, Cambridge, UK) in TAE buffer (2.0.5) and
heating in a microwave oven until the suspension had cleared. The suspension was then
cooled to .....50°C and ethidium bromide added to a final concentration of 1 JIg ml". The
suspension was then poured into a mini gel cast (Anachem, Luton, Bedfordshire) and
allowed to set following insertion of 1.S mm well combs. After the gel was set, the well
combs were removed and the gel transferred to an electrophoresis chamber flooded with
TAE buffer (2.1.5).
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2.5.6 DNA sample preparation for agarose gel electrophoresis
DNA extracts were mixed with loading butTer (glycerol, 50% v/v; EDTA, 0.025 M pH
8.0; bromophenol blue, 0.01% w/v) in a ratio of 4:1 (sample:buffer) and loaded on the
gel. Typically, electrophoresis was performed at 70 V for 30 - 45 min. The progress of
electrophoresis was monitored using the migration of the bromophenol blue dye in the
loading butTer. On completion of electrophoresis the gel was removed from the buffer
tank and photographed using a Pharmacia SE 400 digital imaging system.
2.5.7 Detection of Bdellovibrio ssp. using peR.
Bdellovibrio were detected using the genus specific primers described by Jurkevitch
and Ramati (2000). The base sequence of each primer was as follows:
FORWARD PRIMER842 (5' -CGWCACTGAAGGGGTCAA-3')
REVERSE PRIMER 343R (5' - ATTCCCCTGCGACAGAG - 3 ')
Each PCR reaction was performed in 50 J.11volumes consisting of sterile RO water (38
J.11);lOX PCR buffer (ABgene, 5J.11);MgCh [25 mM], (1 J.11);dNTP mixture [25 mM],
AB-0241, ABgene, (1J.11);primer 842, 1 J.1gml", (0.5 J.11);primer 343R, 1 ug ml", (0.5
J.11);DNA template (1 ul); Taq DNA polymerase, AB-01921B, Abgene, IV mrl (1 J.11).
Reaction mixtures were placed in a Techne Progene® thermocyc1er and subjected to one
heating cycle at 94°C for 240 sec to denature the DNA template. This was followed by
34 cycles of (denaturation, 94°C, 60 sec; primer annealing, 50°C, 60 sec and elongation,
72°C, 130 sec). The amplification program was completed by one final elongation cycle
at 72°C for 300 sec. PCR amplicons were then resolved on a 1% agarose gel (2.5.5).
67
2.5.8 fla typing of Campylobacter isolates
The fla typing scheme used was the specified protocol of the CampyNet jla gene typing
subcommittee (http://campynet.vetinst.skIFla.html). Campylobacter strains were
subcultured on CBA (2.3.1.1) and genomic DNA extracted using the GES protocol
(2.5.1). Amplification of the jlaA gene using the polymerase chain reaction (PCR) used
the following primers:
FORWARDPRIMERA1:5' GGA TTTCGTAIT AACACAAATGGTGC3'
REVERSE PRIMER A2: 5' CTG TAG TAA TCT TAA AAC AIT ITG 3'
PCR was performed in 50 I,d volumes unless otherwise stated. Reactants were mixed in a
0.2 ml PCR tube in the following concentrations: sterile RO water (38 ul); lOX PCR
buffer, ABgene (5 ul); MgC}z, 50 mM (1 ul); dNTP mixture, 25 mM, (1 ul); primer AI,
1ug ml", (0.5 ul); primer A2, 1ug ml", (0.5 ul); DNA (1 ul); ABgene Taq DNA
polymerase, IU ml" (1 ul). Reaction mixtures were placed in a Techne Progene@
thermocycler and subjected to one heating cycle at 94°C for 60 sec to denature the DNA
template. This was followed by 30 cycles of (denaturation, 94°C, 30 sec; primer
annealing, 45°C, 60 sec and elongation, 72°C, 120 sec). The amplification program was
completed by one final elongation cycle at 72°C for 300 sec. Following amplification,
the PCR product was digested using restriction endonuclease DdeI (Promega) and
resolved on a 1% agarose gel (2.5.5).
2.5.9 Preparation of Campylobacter for pulsed field gel electrophoresis
(PFGE)
Agarose plugs were prepared by first adding 25 JlI of a 20 mg ml" stock of Proteinase K
(prepared in RO water) to 400 Jll of an approximately 109 cfu ml" suspension of
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Campylobacter strain in PBS and mixing by gentle inversion. A 400 ~I volume of
molten 1% PFGE-grade agarose (BioRad, Hemel Hempstead, Hertfordshire) prepared in
TE buffer (2.0.6) was subsequently added to the cell suspension and mixed by gentle
pipetting before dispensing into plug moulds (BioRad) and allowed to set at room
temperature and pressure (RTP) for 10 - 15 min. The plugs were then transferred to 5 ml
of lysis buffer (50 mM Tris, 50 mM EDTA, pH 8.0, 1% w/v sarcosine, 0.1 mg ml"
Proteinase K) and incubated for 15 min at 54°C in an orbital shaking incubator (150 rpm).
Following lysis, the plugs were washed a total of four times (once in sterile RO water,
three times in TE buffer), all washing steps taking place for 15 min at 54°C in an orbital
shaking incubator (ISO rpm).
2.5.9.1 Maerorestrietion profiling of Campylobaeter genomes using PFGE
Macrorestriction profiling was carried out essentially as described by Ribot et al: (2001).
For restriction digestion, a 2 mm slice was cut from each agarose plug (2.5.9) with a
sterile scalpel and transferred to an Eppendorf tube containing IX restriction buffer
solution (buffer A for SmaI; buffer L for KpnI, both obtained from Roche, Lewes, East
Sussex) and incubated at RTP for 5 min. This pre-digestion solution was removed by
pipette and replaced with 200 J.11of 1 x restriction buffer solution containing 40U of
endonuclease (either SmaI or KpnI, Roche, Lewes, East Sussex) prior to incubation at
30°C (SmaI) or 3'PC (KpnI) for 2 h. Following incubation the plug slices were
transferred to an Eppendorf tube and washed in 200 J.11of 0.5X TBE buffer (2.0.7) for 5
min before loading onto a 1% agarose (PFGE grade) gel prepared in 0.5X TBE buffer.
The gel was then subjected to electrophoresis for 18 h in O.5X TBE buffer using a
BioRad CHEF-DR® II system with a switch time of 6.75 - 38.35 sec (gradient = 6 V em-
I). This allowed optimal resolution of digestion fragments in the 50 - 400 kbp range.
Following electrophoresis the gel was stained for 20 min in staining solution (RO water,
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200 ml, containing 50 J1gmrl EtBr) and visualised using a Pharmacia SE 400 digital
imaging system under U.V. illumination.
2.5.10 Preparation of bacteriophage for Pulsed Field Gel Electrophoresis
(PFGE)
Bacteriophage were prepared for PFGE using a modification of a bacterial protocol
devised by Liu and Sanderson (1996). Briefly, an aliquot (10 ul) of a 1010 pfu ml"
suspension of phage was diluted in 40 ul of TE buffer (2.0.6). This was mixed with an
equal volume of 1.4% molten agarose (pFGE grade) in TE buffer and dispensed into plug
moulds (BioRad). The plugs were allowed to set at room temperature then transferred to
Petri dishes containing 5 ml of lysis buffer (100 mM EDTA, 10 mM Tris pH 7.2, 1%
Sarkosyl w/v, 0.1 mg ml" Proteinase K). The plates were incubated at 55°C for 18 h with
gentle shaking to lyse the phage capsids and digest the protein components. The lysis
solution was discarded and Proteinase K was inactivated by addition of 5 ml of I mM
Phenylmethylsulfonyl fluoride (PMSF) in wash buffer (50 mM EDTA, 20 mM Tris pH
7.2) and incubated for 1 h at room temperature with gentle shaking. The plugs were then
washed three times for 20 min each with successive changes of wash buffer at room
temperature with gentle shaking. A 2 mm slice of each plug was then inserted into the
wells of a 1% w/v agarose gel. The gel was run using a BioRad CHEF DRII system in
0.5 TBE (2.0.7) for 18 h at 200 V with a switch time of 30 - 60 sec. Lambda
concatomers (BioRad) were used as markers.
2.5.10.1 Macrorestriction profiling of bacteriophage genomes using PFGE
For restriction endonuclease digests a 2 mm slice of each plug was incubated at 37°C
overnight with IOU of restriction enzyme (Table 4E) in 100 J.lI of digestion buffer
prepared according to the manufacturer's instructions (promega). The plug digests were
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then transferred to a 1% w/v agarose gel (2.5.10) and run using BioRad CHEF DRlI
system as described above but with a switch time of2 - 10 sec for better resolution of the
smaller DNA fragments. PFGE gels were stained for 20 - 30 min in a TBE solution
containing 1 ug ml" ethidium bromide before photographing under U.V. illumination
using a Pharmacia SE 400 digital imaging system.
2.5.11 Cloning and sequencing of bacteriophage DNA
Bacteriophage genomic DNA was extracted as described in 2.5.l. Following extraction,
the DNA was digested using endonuclease DraI (pharmacia). Reagents were mixed in
20 ul volumes containing the following: sterile RO water, 16 ,.11; lOX One-Phor-All
buffer (Pharmacia), 2 J.l1; DraI (IOU J.lrl), 1 J.l1; DNA (approximately 1 ug ml"), 1 ul,
This mixture was then incubated at 37°C for 90 min.
Following digestion, the endonuclease was inactivated by heating at 70°C for 10 min.
The products of the digest were then added to a tube of Ready-To-Go pUC18 (27-5266-
01, Pharmacia) and incubated overnight at 16°C according to the manufacturer's
instructions. The Ready-To-Go kit uses plasmid pUCI8 pre-digested with SmaIto allow
cloning of any fragment digested with an enzyme giving blunt ends (e.g. DraI). The kit
also contains T4 DNA ligase so the cloning reaction is one-step. The ligation product (2
J.lI)was then added to chemically competent E. coli cells (18 J.l1)obtained from the TOPO
TA Cloning® Kit (E. coli TOP I0 One Shot@, Invitrogen, California) and transformation
performed according to the manufacturer's instructions.
The transformed cells were diluted in 250 J.lIof Luria-Bertani (LB) broth (244610, Difco)
and incubated at 3rC for I h. Following incubation, volumes (50 J.11and 200 J.11)of cell
suspension were spread onto Luria-Bertani Agar (LBA) plates supplemented with 50 J.1g
ml" ampicillin, 50 J.11of a 2% w/v solution of 5-bromo-4-chloro-3-indolyl-~-D-
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galactopyranosine (X-gal), and 50 J.lI of a 100 mM solution of isopropyl-~D-
thiogalactopyranoside (IPTG). The plates were incubated aerobically at 37°C for 24 h
prior to selection of successful transfonnants using blue/white screening.
2.6 METHODS FOR THE RECOVERY OF CAMPYLOBACTER AND
BACTERIOPHAGEFROMRETAil POULTRY
2.6.1 Protocols for the Isolation of Campy/obaeter from chicken skin
2.6.1. 1 Protocol A
For each sampling location on the carcass a cotton-tip swab was moistened in maximum
recovery diluent (MRD, 2.0.2) and used to wipe the surface of the skin. The swab was
then used to inoculate a plate of CCDA (2.3.1.4) prior to streaking for single colonies.
The plates were incubated in microaerobic conditions (2.3.3.3) at 42°C and examined for
typical colonies (2.3.4.1) after 24 and 48 h.
2.6. 1.2 Protocol B
For each sampling location on the carcass a cotton-tip swab was moistened in MRD
(2.0.2) and used to wipe the surface of the skin. The swab was then used to inoculate a
plate of modified Blaser-Wang selective agar (CBA, 2.3.1.1) with selective supplement
SR98 (Oxoid) prior to streaking for single colonies. The Blaser-Wang supplement was
added according to the manufacturer's instructions to give final concentrations of the
following constituents: vancomycin (0.01 mg ml"); polymixin B (2.5 IV ml");
trimethoprim (0.005 mg ml"); amphotericin B (0.002 mg ml") and cephalothin (0.015
mg ml"), The plates were incubated in microaerobic conditions (2.3.3.3) at 42°C and
examined for typical colonies after 24 and 48 h.
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2.6. 1.3 Protocol C
A section of skin from each sampling site was weighed (lOg) and macerated into 0.2 -
0.5 cm2 sections using clean flame-sterilised scissors. These sections were then added to
90 ml of Park and Sanders broth (tryptone,. 10 g r', peptone P, 10 g rl; glucose, 1 g r',
yeast extract, 2 g r',sodium citrate, I g r',NaCI, 5 g r', sodium metabisulphite, 0.1 g r',
sodium pyruvate, 0.25 g rl) containing selective supplement A (vancomycin, 0.1 g;
trimethoprim, 0.1 gin 50 ml Brucella broth, 0495-17-3, Difco) and incubated in a 250 ml
capacity flask at 32°C for 2 h. Following incubation, 7.5 ml of antibiotic supplement B
was added (cefoperazone, 0.032 g; cyclohexamide, 0.1 gin 50 ml Brucella broth) and the
suspension was incubated at 38°C for a further 2 h. After this period, incubation
continued at 42°C for 40 h before streaking for single colonies onto the surface of a
CCDA plate (2.3.1.4). All incubation steps were performed under microaerobic
conditions (2.3.3.3) in a shaking platform incubator (100 rpm).
2.6.2 Detection of Campy/obaeter on chicken skin using Exeter enrichment
A 25 ml aliquot of carcass rinse fluid (2.6.3) was diluted in 225 ml of modified Exeter
broth (Nutrient broth 25 g r',CMI, Oxoid, Basingstoke; sodium metabisulphate 250 mg
}"I;sodium pyruvate 250 mg rl; ferrous sulphate 250 mg rl; trimethoprim 10 mg r',
rifampicin 5 mg rI,polymyxin B 2500 IU r', cefaperazone 15 mg r', amphotericin B 2
mg }"1; lysed horse blood (SR48, Oxoid) 10 ml rl) and incubated aerobically at 37°C for
48 h. Subsequently, an aliquot of the broth (10 J11) was streaked onto CCDA agar
(2.3.1.4) and incubated in a microaerobic atmosphere at 37°C for 48 h (2.3.3.3).
Presumptive Campylobacter growth was confirmed using standard morphological and
biochemical tests (2.3.4.1).
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2.6.3Isolation of Campylobacter from broiler carcass rinses
. Each whole chicken carcass was transferred to a sterile polythene bag containing 300 ml
of buffered peptone water (CM509, Oxoid). The carcass was vigorously shaken inside
the bag for approximately 2 min. An aliquot of this rinse fluid (25 ml) was transferred to
a sterile 500 ml flask for enrichment using the Exeter method (2.6.2). In parallel to
enrichment, three volumes of carcass rinse (0.5 ml each) were spread-plated onto
modified CCDA agar (2.3.1.4) and incubated in microaerobic conditions (2.3.3.3) for 24
h at 42°C before examination for growth. Presumptive Campylobacter colonies were
confirmed using morphological (2.3.4.1) and biochemical (2.3.4.2) assays.
2.6.4 Methods for the Isolation of Campylobacter bacteriophage from
chicken skin
Sections of chicken skin (10 cm2) were cut from standard class retail chicken thigh
portions using flame-sterilised scissors. Ten chicken skin sections were used for the
assessment of each recovery protocol. The skin sections were inoculated with 107 pfu of
Campylobacter bacteriophage +2 and left to dry for 30 min prior to implementing the
recovery method. Unless otherwise stated, enumeration of bacteriophage was performed
using the Miles and Misra method described in section 2.3.6.4.
2.6.4. 1 Protocol I
Cotton-tip swabs were moistened in SM buffer (2.0.4) and used to wipe the surface of the
inoculated skin five times. The swab was then snapped off into 5 ml of SM buffer and
left at 4°C for 24 h. Following this period the swab was removed and the SM buffer
filtered through a 0.45 prn pore size membrane filter (Sartorius). Decimal dilutions of
the filtrate were made in SM buffer down to 10-8 and used to inoculate the lawn of a host
bacterium in a Miles and Misra titration series.
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2.6.4.2 Protocol II
Each chicken skin section was transferred to a sterile 50 ml capacity Falcon tube
containing 20 ml of SM buffer (2.0.4). The tube was gently inverted approximately 20
times prior to filtration using a 0.45 J.1mpore size membrane filter. Decimal dilutions of
the filtrate were made in SM buffer down to 10-8and used to inoculate the lawn of a host
bacterium in a Miles and Misra titration series.
2.6.4.3 Protocol III
Each chicken skin section was transferred to a sterile filter stomacher bag (BA604l1STR,
Seward, Norfolk, UK) containing 10 ml of SM buffer (2.0.4). The skin was stomached
for 5 min using a LabBlender 400™ (Seward) and then filtered through a 0.45 J.1mpore
size membrane filter. Decimal dilutions of the filtrate were made in SM buffer down to
10-8 and used to inoculate the lawn of a host bacterium in a Miles and Misra titration
series.
2.6.4.4 Protocol IV
Each chicken skin section was transferred to a sterile filter stomacher bag (Seward)
containing 10 ml of SM buffer (2.0.4). The skin was stomached for 5 min using a
LabBlender 400™ and the resulting stomachate subjected to centrifugation at 2.5 g for 10
min at RTP prior to filtration through a 0.45 um pore size membrane filter. The filtrate
was then diluted in ten fold steps down to 10-4in SM butTer. Aliquots of each dilution
(lOO J.11)were transferred to a sterile Eppendorf tube and mixed with 400 J.11of PTI4
suspension and subsequently incubated aerobically for 30 min at 42°C. After incubation,
the suspension was added to 5 ml of NZCYM overlay agar (TLA, 2.3.1.10), gently
shaken and added to pre-warmed (42°C, 30 min) NZCYM base agar (NZB, 2.3.1.7).
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Plates were incubated microaerobically at 42°C for 24 h and subsequently examined for
the presence of plaques.
2.6.4.5 Protocol V
Each chicken skin section was transferred to a sterile filter stomacher bag (Seward)
containing 10 ml of SM buffer (2.0.4). The skin was stomached for 5 min using a
LabBlender 400TM. An aliquot of this stomachate (l ml) was transferred to a sterile
Eppendorf tube containing 100 ,.11 of chloroform and inverted approximately ten times.
The suspension was then subjected to centrifugation at 13, 000 g for 5 min and the titre of
phage in the supernatant was then determined using the method of Miles and Misra
(1938).
2.6.5 Isolation of bacteriophage from whole retail chicken carcasses
An aliquot (1 ml) of carcass rinse fluid (2.6.3) was subjected to centrifugation at 13, 000
g for 5 min to remove debris and bacterial cells. The supernatant was subsequently
filtered through a 0.45 J.1mpore-size membrane filter (Sartorius) into an Eppendorftube.
Volumes of filtrate (100 J.11)were then mixed with 400 J.11ofa 109 cfu ml" suspension of
C. jejuni NCTC 12662 phage type 14, PTI4, and incubated aerobically at 42°C for 30
min. Following incubation, the suspension was mixed with 5 ml of molten NZCYM top
layer agar (2.3.1.10) which had been held at 50°C. The molten agar was then evenly
poured on the surface ofNZCYM base agar (2.3.1.7) and left to set at room temperature
and pressure (RTP) for approximately 10 min. The plates were then inverted and
incubated in a microaerobic atmosphere (2.3.3.3) at 42°C for 24 h before examining for
plaques.
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2.6.6 Survey of Campylobacter and bacteriophage prevalence in retail
chicken portions
Three different classes (free-range, standard and economy) of chilled (4°C) chicken
thighs were purchased from a single supermarket over a two-week period. Two different
classes (standard and economy) of frozen (-20°C) chicken thighs were purchased from
the same supermarket over a one-week period. One hundred samples of each class of
fresh meat and seventy-five portions of each class of frozen meat, representing a range of
poultry producers, were screened for the presence of Campylobacter (2.6.1.2) and phage
(2.6.4.4).
2.6.7Recovery of bacteriophage from the surface of retail chicken products
overtime
Sections of chicken skin (10 cm2) were cut from standard class retail chicken thigh
portions using clean, flame-sterilised scissors. Each section of skin was inoculated with
100 ).11of a 108 pfu ml" suspension of Campylobacter bacteriophage and left to dry for 1
h. Triplicate skin sections were inoculated for each sampling point. Following
inoculation, the skin sections were individually sealed in sterile containers and stored at
4°C (fresh chicken) or refrozen at -20°C (frozen chicken). Frozen chicken portions were
defrosted for 24 h at 4°C prior to inoculation. Samples were initially taken 1 h after
inoculation then at 24 h intervals thereafter for up to ten days. Bacteriophage recovery
from both fresh and frozen samples was performed using the method described in section
2.6.4.4.
2.6.8Preparation of chicken skin for Campylobacter inoculation
Commercial Ross broiler chickens reared free of Campylobacter were obtained from a
registered supplier (P. D. Hook, Oxfordshire). At 30 days of age the broiler chickens .
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were sacrificed using a UK Home Office Schedule I method then manually plucked and
the skin removed. The breast skin from each bird was cut into 2 cm2 sections using
flame-sterilised scissors and transferred to sterile Petri dishes.
2.6.9 Bacteriophage activity on the surface of chicken skin stored under
fresh and frozen conditions
Sections of chicken skin (2.6.8) were inoculated with a combination of phage and
Campylobacter titers in the form of a simple 3 x 3 matrix to obtain multiplicities of
infection (MOl) ranging from 0.001 to 100,000 (Table 6A). Each specific MOl
combination was inoculated in triplicate for each sampling time point. The skin was
inoculated with the Campylobacter suspension, and following a 30 min drying period, the
phage were inoculated. A further 30 min period was allowed for the phage inoculum to
dry before incubation at 4°C (fresh) or -20°C (frozen). The initial (day 1) samples were
enumerated immediately following the final 30 min drying period and thereafter on days
three and five for fresh samples and day five only for frozen samples. At each sampling
point, the skin sections were transferred to sterile filter stomacher bags, homogenised in
20 ml MRD (2.0.2) and the Campylobacter and bacteriophage populations enumerated
using the methods described in sections 2.3.4.4 and 2.3.6.4 respectively.
2.7 TRANSMISSION ELECTRON MICROSCOPY (TEM)
The negative staining technique uses an electron-opaque staining solution to coat the
sample. The stain does not usually penetrate the sample and so areas not in contact with
the stain are easily permeable to transmitted electrons, appearing "bright" on a
phosphorescent screen. The contrast between light and dark areas is used to determine
the structure of the particle. To perform negative staining TEM, 8 J.11of a 108 pfu ml"
suspension of phage was added to the surface of a glow-discharged carbon coated
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pioloform grid. The specimen was fixed for 2 min by exposure to gluteraldehyde vapour.
Excess sample was removed and the grid washed with a drop of double distilled water.
Negative staining was performed by adding one drop of 0.5% w/v uranyl acetate to the
grid surface, removing excess stain immediately. The grids were allowed to air dry for
20 min then observed using a JOEL 100CX transmission electron microscope.
2.7.1 On-grid Immunogold labelling
An aliquot (10 ul) of vesicle suspension was allowed to adsorb to the surface ofa carbon-
coated pioloform grid for 5 min. This was followed by washing the grid for 1 min with a
drop of phosphate buffered saline (PBS, 2.0.3) followed by thrice washing with PBS
containing 1 mg ml" bovine serum albumen (PBS-BSA). Following the final washing
step, excess wash fluid was removed and immediately replaced by 15 ul of primary
antibody prior to incubation at RTP for 25 min. Subsequently, the grid was thrice
washed for 1 min with PBS-BSA after which excess wash fluid was removed. A 15 fll
drop of appropriate anti-antibody-gold conjugate was then placed on the grid surface and
incubated at RTP for 20 min. Incubation was followed by thrice washing in PBS and
fixation by exposure to a IS fll drop of 0.5% v/v gluteraldehyde in PBS for 2 min. The
grid was then washed thrice in double distilled water (DDW) for 1 min. Negative
staining was then performed by adding a drop of 0.5% w/v uranyl acetate (made in
DDW) to the grid and immediately draining excess stain with blotting paper. The grid
was then flushed with three drops ofDDW and allowed to dry at RTP for 30 min prior to
examination using a JOEL CXlOO transmission electron microscope.
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2.8 PREPARATION OF CAMPYLOBACTER MEMBRANE VESICLES
2.8.1 Protocol A.
Cells from a 1 I overnight culture of Campylobacter in Nutrient Broth No. 2 (NB2,
2.3.1.6) were removed from the growth medium by centrifugation at 10,000 g for 20 min
at 4°C. Subsequently, over a period of2 h, 240 g of ammonium sulphate was added to the
supernatant prior to centrifugation at 20,000 g for 120 min. The supernatant was then
discarded and the pellet was suspended in 16 ml ofTris Buffer A (50 mM Tris, pH 9.5;
0.5 mM dithiothreitol, DTT). This suspension was then dialyzed overnight against 6 1of
the same buffer. Membrane vesicles were then pelleted by centrifugation at 27,000 g for
40 min prior to resuspension in 1.5 ml ofTris Buffer B (50 mM Tris, pH 7.2) and storage
at -20°C.
2.8.2 Protocol B
A 1 I overnight culture of Campylobacter in NB2 (2.3.1.6) was subjected to
centrifugation at 10,000 g for 10 min to pellet bacterial cells. Membrane vesicles in the
supernatant were concentrated by further centrifugation (2.5 g for 30 min) through a 30
kDa molecular weight cut-off filter (PL-30, Millipore, Bedford, USA). The retentate was
resuspended in 5 ml of phosphate buffered saline (PBS, 2.0.3) and stored at -20°C.
2.9 OUTER MEMBRANE PREPARATION FROM CAMPYLOBACTER
An aliquot (20 ml) of a 100 ml overnight Campylobacter culture in NB2 (2.3.1.6) was
subjected to centrifugation at 3, 000 g for 25 min to pellet bacterial cells. These cells
were then resuspended in 1.5 ml of ice-cold N-2-Hydroxyethylpiperazine-N'-2-
ethanesulfonic acid (HEPES) buffer (10 mM HEPES, pH 7.4) prior to centrifugation at
13,000 g for 3 min. The resulting pellet was resuspended in 1 ml of HEPES buffer before
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rupturing of the cells by sonication. Subsequently, the suspension was subjected to
centrifugation at 13,000 g for 3 min. The supernatant was decanted and outer membrane
fragments pelleted by centrifugation at 10,000 g for 40 min at 4°C. The pellet was
resuspended in 200 J.11HEPES butTer to which was added 200 III of 2% w/v sarkosyl
(prepared in HEPES butTer). This suspension was then incubated at RTP for 30 min prior
to centrifugation at 15,600 g for 30 min. The resulting pellet was washed (without
resuspending) with 0.5 ml of HEPES butTer and resuspended in 25 III of HEPES before
storage at -70°C.
2.10 BACTERIOPHAGE ADSORPTION AND REPLICATION IN VITRO
2.10.1 Adsorption time course
Campylobacter cells grown in 1 1 NB2 (2.3.1.6) were subjected to centrifugation at
10,000 g for 10 min and the pellet resuspended in 10 mM MgS04 (2.0.1) to a density
equivalent to McFarland No.3 (2.3.2), approximately 109 cfu ml", The actual titre of
Campylobacter colony forming units was determined by plating serial dilutions of each
suspension on CCDA without antibiotics (2.3.1.4). Phage suspension (1 ml of a 108 pfu
ml" stock) was added to 9 ml of Campylobacter MgS04 suspension to give a multiplicity
of infection (MOl) of 0.01 and incubated at 42°C in microaerobic conditions. During
incubation, 1 ml aliquots of this suspension were taken at regular time points. Bacterial
cells in each sample were pelleted by centrifugation at 13,000 g for 3 min prior to
enumeration of bacteriophage in the supernatant using the Miles and Misra technique
(2.3.4.4).
2.10.2 Bacteriophage replication In liquid culture
A suspension of Campylobacter host cells was prepared by subjecting a 1 I overnight
culture (2.3.3.2) to centrifugation at 10,000 g for 10 min and resuspending the pellet in 9
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ml of fresh broth to a density equivalent to McFarland No.3 (approximately 109 cfu ml")
(2.3.2). To this cell suspension, a sample (1 ml) of a 109 pfu ml" suspension of
bacteriophage was added to give an MOl of 0.1 (108 pfu ml"). The suspension was
incubated for 15 min in microaerobic conditions (2.3.3.3) to allow for phage adsorption
before diluting 1:100 by the addition of fresh NB2 broth (2.3.1.6, 990 ml) containing the
FBP supplement (2.3.1.3).
Following dilution, the culture was incubated microaerobically at 42°C and shaken at 100
rpm. Samples (1 ml) were taken at regular intervals and phage titres recorded as
described previously (2.3.6.4). Campylobacter titres were determined by washing the
pellet 3 x in MRD then resuspending in 1 ml of MRD and spotting serial dilutions on a
CCDA plate according to the methods of Miles and Misra (2.3.4.4). The burst size was
calculated using the following formula:
Where:
{P-xl
[I-x]
P =maximum phage titre after lysis complete (pfu ml")
1: = number of phage from the original inoculum which did not adsorb
I = titre of the original inoculum (pfu ml")
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2.10.3 Bacteriophage adsorption to Campylobacter membrane vesicles and
whole cells
Campylobacler cells were harvested from overnight Columbia blood agar plates (2.3.3.1)
using a sterile cotton-tip swab and resuspended in 20 ml of 10 mM MgS04 solution
(2.0.1). Membrane vesicles were prepared either using the precipitation technique
(protocol A, 2.8.1) or molecular filtration technique (protocol B, 2.8.2). Aliquots (0.5
ml) of a 109 pfu ml" suspension of bacteriophage in SM buffer (2.0.4) were then mixed
with 4.5 ml volumes of either membrane vesicles, whole cells (109 cfu ml") or diluent
(l0 mM MgS04, 2.0.1, or Nutrient broth No.2, NB2, 2.3.1.6). Each suspension was then
incubated aerobically at 31'C. Aliquots (lOO J.11)were taken from each suspension at
regular time points and diluted in 900 J.11of corresponding diluent (MgS04 or NB2). The
diluted samples were then subjected to centrifugation at 40 t 000 g for 60 min at 4°C.
The titre of phage in the supernatant of each sample was then determined on lawns of
susceptible bacteria using the technique of Miles and Misra (2.3.6.4).
2.10.4 Replication of bacteriophage In the presence of membrane vesicles
A 1 I overnight culture of Compylobacter in NB2 (2.3.3.2) was subjected to
centrifugation at 10 , 000 g for 10 min. The pellet was then thrice washed in 50 ml
volumes ofNB2 prior to resuspension in 9 ml ofNB2. This suspension was then divided
in to two 4.5 ml volumes. Membrane vesicles were collected from the culture
supernatant using the molecular filtration technique (2.8.2) prior to resuspension in 4.5
ml of NB2. Subsequently, aliquots (I ml) of 108 pfu ml" phage suspension were each
mixed with either the membrane vesicle or whole cell suspensions. Following phage
treatment, the suspensions were incubated aerobically at 37°C for 1S min. After
incubation, the 'phage plus vesicles' suspensions were briefly mixed with the 4.5 ml of
uninfected Campylobacter suspension prior to transfer to 200 ml of NB2 containing the
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FBP supplement (2.3.1.3). The 'phage plus whole cells' suspension was briefly mixed
with 4.5 ml ofNB2 prior to transfer to 200 ml ofNB2 + FBP. All the preparations were
then incubated in microaerobic conditions (2.3.3.3) at 42°C in a gyratory platform
incubator set to 100 rpm. The negative control consisted of 1 ml of phage suspension
diluted in 9 ml of NB2 which, following a 15 min 'adsorption' period was incubated in
200 ml ofNB2 under identical conditions to all other preparations. At regular time points
during incubation, 1 ml aliquots were taken from each culture and subjected to
centrifugation at 13 t 000 g for 5 min. Bacteriophage in the supernatant were enumerated
on lawns of susceptible bacteria using the surface droplet technique (2.3.6.4). Pellets
from samples containing whole cells were thrice washed in MRD (2.0.2) prior to
enumeration of Campylobacter cells on charcoal agar using the Miles and Misra
technique.
2.11 BACTERIOPHAGE THERAPY TRIALS
2.11.1 Source and treatment of broiler chicks prior to commencing trials
One day old commercial Ross broiler chickens reared to be free of Campylobacter were
obtained from a registered supplier (p.O. Hook Hatcheries Ltd, Oxfordshire) and
transported to a single environmentally controlled room at the experimental avian house
at the Sutton Bonington campus of the University of Nottingham. The birds were
provided with water and food ad libitum and otherwise treated in accordance with UK
Home Office regulations: Animal (Scientific Procedures) Act, 1986. At fifteen days of
II
age (DOA) the birds were assigned to experimental groups at random with respect to
their live weights. Each of these experimental groups was housed in separate
environmentally-controlled rooms and individually housed in wire cages. Unless
otherwise stated, voided excreta was collected daily from 15 - 19 DOA to examine for
Campylobacter and Salmonella colonisation prior to commencing each trial. Chicks
84
Ch ter2
positive for either organism were culled using a UK Home Office Schedule I method and
removed from the group.
2.11.2 Isolation of Salmonella ssp. from chick excreta.
The isolation of Salmonella ssp. was performed according to the method approved by
ISOIBSI (Salmonella Monograph, Oxoid). Fresh voided excreta (1 g) was resuspended
in 9 ml of buffered peptone water (BPW CM509, Oxoid). A pre-enrichment step was
performed by incubating this suspension aerobically for 16 - 20 h at 3rC. An aliquot of
faecal suspension (1 ml) was subsequently added to 10 ml of Rappaport - Vassiliadis
(RV) broth (2.3.1.9) for selective enrichment and incubated for 18 - 24 h at 45°C.
Following incubation, a 10 ul loopful of suspension was used to inoculate a plate ofXLD
selective agar (2.3.11) and streaked for single colonies before incubation at 37°C for 18-
24 h. Colonies on XLD were compared with positive controls for characteristic
Salmonella growth on this medium (red colonies with black centres (Bridson, 1998).
Positive controls consisted of excreta specimens inoculated with 102 cfu g-l Salmonella
enteritidis strain WFOI(a human faecal isolate).
2.11.3 Preparation of Campylobacter for broiler chick oral inoculation.
Campylobacter strains were grown on Columbia blood agar (CBA, 2.3.1.1) and harvested
into phosphate buffered saline (PBS, 2.0.3) using a sterile cotton tip swab to give a final
titre of approximately 108 cfu ml" by comparison with turbidity standards (2.3.2). The
actual Campylobacter titre was determined on CCDA agar plates using the Miles and
Misra technique (2.3.4.4). Each chick was dosed once with approximately 1 ml of
Campylobacter suspension by oral gavage.
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2.11.4 Preparation of bacteriophage for broiler chick oral inoculation.
Bacteriophage were propagated using the plate lysate method (2.3.6) and concentrated by
centrifugation (2.3.6.3). The phage suspension was diluted in 10 mM phosphate buffer
(PB) to give a final titre of approximately 109 pfu ml" (titre determined on propagating
host). Unless otherwise stated, the gastric pH of the birds was neutralised by
administration of phage in PB containing 30% w/v CaC03• Each chick was dosed with
approximately 1 ml of phage suspension 48 - 72 h following Campylobacter
administration.
2.11.5 Campylobacter colonisation and phage therapy trials
At approximately 15 - 20 days of age the broiler chicks were separated into their
respective treatment groups and their excreta monitored daily for the presence of natural
Campylobacter and Salmonella. Any chicks found to be colonised with these organisms
prior to oral dosing were sacrificed and removed from the trial. Campylobacters were
prepared on CBA (2.3.1.1) and suspended in PBS (2.0.3) to give a titre of approximately
108 cfu ml", The chicks were dosed with ....1 ml of Campylobacter suspension by oral
gavage. Negative controls were dosed with PBS only. Unless otherwise stated, three
days after Campylobacter inoculation, the appropriate chick group was dosed with ....1 ml
of approximately 109pfu ml" of bacteriophage prepared in 10mM PB containing antacid
(30% w/v CaCOl). Unless indicated otherwise, at 24 h intervals, random representatives
of each treatment group were sacrificed using a UK Home Office Schedule I procedure
and transported to the laboratory for dissection (2.11.6).
2.11.6 Sacrifice and dissection procedure for broiler chicks.
Broiler chicks were sacrificed at specific time points using a United Kingdom Home
Office Schedule I approved method and transported to the laboratory. Immediately
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following sacrifice the chicks were transferred to individual sealed polythene bags and
then stored at 4°C until dissection. All dissections were performed within 6 h of chicken
death. Where multiple organs were assessed for Campylobacter presence, the intestinal
organs were always the last to be removed to reduce the possibility of contamination and
care was taken to remove individual organs as aseptically as possible. Wherever
practicable, ligatures were tied around organs prior to their removal. Dissection
implements were thoroughly cleaned and flame-sterilised between each organ excision.
The dissection area was sprayed with a chemical disinfectant (VirkonTM, Suffolk, UK)
before and in between dissections. Virkon™ was prepared at 1% w/v and used according
to the manufacturer's instructions.
2.11.7 Enumeration of Campy/obaeter and microflora in broiler chicken
caeca
Following broiler chicken dissection (2.11.6), the caecal contents (1 g) were transferred
to a sterile plastic universal tube (Sterilin) and diluted 1:9 in MRD and resuspended by
vortex mixing for approximately 2 min. The resulting suspension was then decimally
diluted in the same diluent down to 10·s. Each dilution series was performed in duplicate.
Volumes (100 ul) of each dilution were spread plated onto CCDA (2.3.1.4) containing
2% agar, and incub.ated under microaerobic conditions (2.3.3.3) at 42°C. The plates were
examined for typical Campylobacter colonies after 24 h and 48 h incubation. This
procedure was repeated on plate count agar (PCA, 2.3.1.8) with incubation in aerobic,
anaerobic and microaerobic conditions at 3rC to determine the total aerobic, anaerobic
and microaerophilic populations in the caeca respectively. Generation of an anaerobic
atmosphere was achieved using a rubber-sealed gas jar containing an AnaeroGen TM
sachet (AN0035, Oxoid). Bacterial titres were calculated as described in section 2.3.4.4.
87
Ch ter2
Presumptive Campylobacter colonies were Gram stained to confirm morphology
(2.3.4.1) prior to biochemical speciation (2.3.4.2)
2.11.8 Enumeration of Campylobacter bacteriophage in broiler chicken
caeca
Caecal contents were weighed (1 g) then transferred to a sterile universal tube and
resuspended in 9 ml of 5MB diluent (2.0.4) using gentle inversion and pulse vortex
mixing for up to 5 min. This suspension was then incubated at 4°C for 24 h with gentle
agitation to allow phage to elute into the buffer. An aliquot of the eluate (1 ml) was then
transferred to an Eppendorf tube and subjected to centrifugation at 10, 000 g for 3 min to
remove bulk debris. The supernatant was then transferred to a fresh Eppendorf tube and
subjected to a further centrifugation step at 13,000 g for 5 min prior to filtration using a
0.2 um-pore membrane filter (Sartorius) to remove any remaining bacterial cells. The
resulting filtrate was then decimally diluted in SM buffer down to 10-6. Bacteriophage
were subsequently enumerated using the Miles and Misra technique using a lawn of host
bacteria cells (2.3.6.4).
2.11.9 Detection of Campylobacter In non-Intestinal organs of broiler
chickens
Following dissection of the chicken (2.11.6), a small section of each organ was excised
and aseptically transferred into a sterile universal tube containing 10 ml of maximum
recovery diluent (MRD, 2.0.2) and homogenised for 2 min using a Taurex food
homogeniser. Volumes (100 JlI) of homogenate were spread plated in triplicate onto
CCDA agar plates (2.3.1.4) containing a total of2% w/v agar (to prevent swarming) and
incubated in microaerobic conditions (2.3.3.3) at 42°C. The plates were examined for
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typical Campylobacter colonies after 24 h and 48 h incubation. Presumptive
Campylobacter colonies were Gram stained to confirm typical morphology (2.3.4.1).
2.11.10 Measurement of relative protease activity in chicken caeca
The caecal contents (I g) were transferred to a sterile plastic universal tube (Sterilin) and
diluted 1:9 in MRD (2.0.2) and resuspended by vortex mixing for approximately 2 min
An aliquot of this suspension (1 ml) was then transferred to an Eppendorf tube and
subjected to centrifugation at 10, 000 g for 3 min to remove bulk debris. The supernatant
was then transferred to a fresh Eppendorf tube and subjected to a further centrifugation
step at 13, 000 g for 5 min prior to filtration through a 0.2 um-pore membrane filter
(Minisart, Sartorius) to remove any remaining bacterial cells. The EnzChek® Protease
Assay Kit (E-6638, Molecular Probes, Leiden, Netherlands) was used to determine the
total protease activity in these samples according to the manufacturer's instructions using
a Victor 1420 multilabel photoluminometer (perkin-Elmer UK Ltd) with excitation and
emission wavelengths of 485 nm 530nm respectively. This kit is based on the protease-
catalysed hydrolysis of a casein protein substrate labelled with green fluorescent dye
(BODIPY® FL). Once the dye is released, an increase in fluorescence is recorded which
is proportional to the total protease activity in a sample. A standard curve of protease
activity was generated using concentrations of trypsin (1 - 5 J.1gml") as directed by the
manufacturer.
2.12 DATA TRANSFORMATION AND STATISTICAL ANALYSIS
All statistical analyses were performed using the data analysis add-in for Microsoft
Excel™ XP. Unless otherwise stated, 811 bacterial and bacteriophage titres were
transformed to 10gJOvalues prior to the application of significance tests.
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Significant differences between two data groups was assessed using the Student's t- test.
For three or more data groups, a single factor analysis of variance (ANOVA) test was
applied. For all statistical tests, the confidence limit was set at 95% with the assumption
that the data possessed a normal distribution and the variance between different data sets
was equivalent.
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SURVIVAL AND ISOLATION OF CAMPYLOBACTER
BACTERIOPHAGE ON RETAIL POULTRY PRODUCTS
3.0 INTRODUCTION
Studies of several Campylobacter outbreaks in humans have shown undercooked poultry,
specifically chicken, to be the source of infection (Istre et al.; 1984; Murphy et al.,
1995; Evans et al., 1998). Campylobacters readily colonise many species of poultry but
the dissemination of the bacteria from these birds is exacerbated during slaughter, as
negative flocks are often mixed with positive flocks leading to large-scale cross
contamination (Newell et al., 2001). As up to 76% of flocks sent to slaughter are
Campylobacter positive (Humphrey et aL, 1993), the control of contamination remains a
major challenge to the industry. Whilst post-processing treatment and storage conditions
may reduce Campylobacter contamination on broiler carcasses, in some cases these
treatments are considered to have a negligible impact on human exposure to this
organism (Jacobs-Reitsma, 2000). A recent survey in the UK demonstrated that 83.3%
of samples taken from retail chicken were Campylobacter positive (Kramer et al., 2000).
In addition, Campylobacter is able to survive on kitchen surfaces for several hours after
contamination (Cogan et al., 1999) leading to cross contamination events in the home.
Campylobacter bacteriophage have previously been isolated from sewage and abattoir
effluent (Salama et al., 1989). Some of these phage isolates have been utilised in typing
schemes to complement various other typing methods (Grajewski et al., 1985; Salama
et aL, 1990b; Frost et al., 1999). The lytic capability and host specificity of phage also
present the opportunity of using them to reduce the numbers of campylobacters
emanating from animal sources and subsequently reduce cross contamination during
processing. Generally, a reduction in the numbers of campylobacters entering the human
food chain is likely to have a beneficial effect on the disease burden (Rosenquist et al.,
2003). As a first step towards implementing these strategies it was necessary to establish
if bacteriophage were already present on retail poultry in order to gauge the possible
impact of intervention and to establish if these strategies would be introducing any new
biological elements into the human food chain.
To date there have been no reports of the isolation of Campylobacter phage from retail
chicken products. The aims of this study were to establish and validate recovery methods
for Campylobacter and bacteriophage from poultry meat samples, and to determine the
incidence of phage from fresh and frozen retail poultry in the UK. The ability of a subset
of phage isolates to survive on the surface of fresh and frozen poultry products was also
investigated.
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3.1 RESULTS
3.1.1 Evaluation of methods for Campylobacterisolation from chicken skin
Three protocols (A, B and C, 2.6.1) were compared for their ability to isolate
Campylobacter cells from various sites on the surface of fifty standard medium weight
broiler chicken carcasses (Fig. 3A). Briefly, areas of chicken skin were wiped with a
sterile swab which was subsequently used to inoculate plates ofmCCDA (protocol A) or
Blaser - Wang Agar (protocol B). For protocol C, 10 g of chicken skin from each
sampling location were macerated and enriched for Campylobacter using the Park and
Sanders method. Each isolation method was used on different areas of skin within the
same sampling zones on individual carcasses (Fig. 3A). Care was taken not to sample the
same skin area twice. Presumptive Campylobacter colonies (n = 5) recovered using each
method from each carcass were confirmed using morphological (2.3.4.1) and biochemical
(2.3.4.2) assays. The efficacy of each isolation protocol for each sampling site is
presented in Table 3A. Direct plating onto Blaser-Wang agar (protocol B) was
consistently less successful in Campylobacter isolation than either of the other methods.
However, this medium also resulted in the fewest number of contaminants. Overall,
enrichment (protocol C) was the most successful method, isolating Campylobacter from
234 of the 300 sites tested (78%) compared with 210 (70%) for direct plating onto CCDA
(protocol A). However, it should be noted that some samples positive by direct plating
were not positive by enrichment and vice versa. The cavity, neck skin, thigh and back
were the sites most likely to harbour campylobacters with the mean recovery from the 50
chickens sampled of77% (39), 76% (38), 72% (36) and 71% (35) respectively
93
Cavity
area
Breast
Neck
skin
Thigh Wing
Back
Figure 3A. Diagram of carcass sampling sftes.
Diagram indicating the sites sampled on a standard retail broiler chicken carcass to
determined the efficacy of three Campylobacter recovery protocols.
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Recovery Protocol Back Breast Cavity Neck Skin Thigh Wings
A (direct plating CCDA) 36 (72) 22 (44) 40 (80) 40 (80) 37 (78) 36 (72)
B (direct plating BW) 30 (60) 26 (52) 33 (66) 31 (62) 28 (56) 28 (56)
C (enrichment) 40 (80) 33 (66) 42 (84) 43 (86) 41 (82) 35 (70)
Table 3A. Recovery of Campylobacter from broiler chicken carcasses.
Table showing the recovery ofCampylobacter spp. from six sites on the surface of fifty
retail broiler chicken carcasses. Recovery is given as the number, and the percentage in
parentheses, of Campylobacter positive samples.
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(calculated from positive samples using all methods). Of the isolated colonies which
were confirmed using morphological and biochemical assays, 98% were hippurate
positive (C. jejum) with the remainder likely to be C. coli based on previous reports
(Kramer et al., 2000; Jorgensen et al., 2002).
3.1.2 Evaluation of Campylobacter bacteriophage isolation methods.
Campylobacter jejuni NCTC 12662 Phage Type 14 (PTI4) was supplied by the Central
Public Health Laboratory (CPHL, Colindale, London) and used as the host in all primary
phage isolation and recovery from chicken skin. PT14 is sensitive to all the phage
employed in the current UK phage-typing scheme (Frost et al., 1999) and was
considered the most suitable strain to use for phage recovery. Bacteriophage cj.2(NCTC
12674, ATCC 35922-B2) was also supplied by the CPHL and is a constituent of their
phage-typing scheme (Frost et at; 1999). Phage +2 was used as a positive control to
estimate the recovery efficiency from chicken skin. This phage consistently gives clear,
distinct plaques on the C.jejuni PT14 propagating strain. Five protocols (I, II, III, IV and
V, 2.6.4) were compared for their ability to recover 107 pfu of Campylobacter
bacteriophage +2 from the skin surface of retail chicken thigh portions. A brief overview
of each protocol is presented below.
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PROTOCOL
I
DESCRIPTION
Chicken skin surface was swabbed and placed in 5 ml of SM buffer
overnight to allow the phage to elute. The resulting eluate was filtered
and phage in the filtrate titred using the surface droplet technique on a
lawn of susceptible bacteria.
II
Skin sections were washed in 20 ml of SM buffer prior to filtration and
titration as described for protocol I.
III
Skin sections were stomached for 5 min in 10 ml of SM buffer prior to
filtration and titration as described for protocol I
Skin sections were stomached for 5 min in 10 ml of SM buffer. The
stomach ate was then subjected to centrifugation (2.5 g, 10 min) and
IV filtration. Titration was then performed by mixing dilutions of filtrate
with host cells and transferring to molten soft agar which was overlaid
on to base agar (modified pour plate technique).
V
Skin sections were stomached for 5 min in 10 ml of SM buffer. A 1 ml
aliquot of stomach ate was treated with 100 JlI of chloroform and
subjected to centrifugation. The titre of phage in the supernatant was
determined using the Miles and Misra technique as with protocol I.
The comparative efficacy of each method in recovering bacteriophage from the surface of
inoculated chicken skin is presented in Table 3B. Recovery was less efficient using
swabbing and washing techniques (protocols I and II) with only 2.2% and 0.5% of the
inoculated phage titre recovered from the skin surface using each of these methods
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Recovery Protocol Percentage Recovery Recovery Range Standard Deviation
I (swab. filter) 2.2 0.03 - 5.21 1.8
II (wash, filter) 0.5 0.02·1.10 0.4
III (stomach, filler) 27.7 16.5 - 41.4 7.6
IV (stomach, centrifuge. filter) 67.3 59.2·73.8 4.9
V (stomach, chloroform treat) 48.6 39.6·59.9 7.9
Table 3B. Efficiency of bacteriophage recovery from chicken skin.
Table showing the recovery of Campylobacter bacteriophage ~2 from the surface of
inoculated chicken skin using five protocols. The percentage recovery of the initial
inoculum is presented along with the recovery range and standard deviation for each
method used. These results are based on ten replicates.
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respectively. In contrast, protocols III, IV and V, all of which used stomaching,
demonstrated a consistently higher percentage of recovery (27.7%, 67.3% and 48.6%
respectively) than seen with protocols I and II. The direct filtration of stomached
samples described in protocol III was often problematic due to the high fat content of the
stomachate in some samples. This was alleviated by the additional centrifugation step in
protocol IV. Chloroform treatment (protocol V) reduced the number of bacterial
contaminants and did not appear to have any adverse effects on the bacteriophage,
suggesting ~2 is not sensitive to this agent. Based on ten replications, the recovery of
bacteriophage from chicken skin was most successful and least variable using protocol
IV. Consequently, this protocol was selected for use in all subsequent phage recovery
from chicken skin.
In order to estimate the lower limit of phage detection on chicken skin, the recovery
efficiency of protocol IV was examined using Campylobacter phage ~2. Table 3C shows
the lower detection limit determined for the recovery of this phage following addition of
serial dilutions onto retail chicken skin sections as described above. Based on three
replicates, this method will reliably detect at least 103 pfu of ~2 per 10 cm2 area of
chicken skin.
3.1.3 Recovery of phage +2 from the surface of chicken skin over time.
As a prerequisite to a survey of retail chicken for the presence of Campylobacter phage it
was necessary to establish that phage could survive in situ on chicken skin under retail
storage conditions. To ensure that any incumbent Campylobacter phage would not
influence the recovery results, uninoculated samples were examined for environmental
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Inoculum (log1o pfu) Mean Recovery (log1o pfu) Average Recovery (% ± SO)
7.3 6.6 18.7 ± 4.0
6.3 6.0 42.3 ± 7.8
5.3 5.0 43.3 ±4.5
4.3 4.0 20.3 ±4.1
3.3 2.6 17.3 ± 2.5
2.3 2.0 9.6 ± 4.1
1.3 -0.2 3±5.2
Table 3e. Validation of the bacteriophage recovery method.
The left column shows the number of phage inoculated onto the surface of retail chicken
thighs (10 cm2). The central column shows the mean number of phage recovered from
the surface of the inoculated chicken skin which is also shown as a percentage ± standard
deviation in the right column. These results are based on three replicates.
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phage. If phage recovery was successful, the sample was discarded so that the results
were not influenced by the presence of natural phage. Sections of skin were then excised
from fresh and frozen chicken thighs not containing natural phage. These skin samples
were then inoculated with 107 pfu of phage +2 and, following a 1 h drying period, the
skin sections were individually stored in sterile containers and incubated at either 4°C or -
20°C. Triplicate skin sections were taken from each storage condition commencing 1 h
after inoculation and then at 24 h intervals thereafter for a period of ten days.
Bacteriophage on each skin sample were enumerated using recovery protocol IV as
described previously (2.6.4.4). Data showing the recovery of the inoculated
Campylobacter phage from the surface of fresh and frozen chicken thigh skin over a ten
day period are presented in Figure 381. Phage recovery remained constant at 42 - 44% of
the initial inoculated titre over a six day period for skin stored at 4°C. At day seven the
titre fell from 44% ± 0.8 to 34% ± 7.0 and continued to fall for the duration of the
experiment until reaching 17% ± 1.8 at day ten. In contrast, the recovery of phage from
thawed frozen chicken was initially close to 100% (1 h) but following refreezing and
subsequent thaw the titre fell to 22% ± 0.1. Phage recovery from chicken portions
thawed at 24 h intervals thereafter were in the range of 17 - 34% over a ten day period.
In order to determine if the presence of viable Campylobacter cells on the surface of
chicken skin could affect the recovery of inoculated phage, 5 cm2 areas of skin from each
chicken portion were also screened for the presence of Campylobacter by swabbing and
plating directly onto CCDA selective agar (2.6.1). The recovery of phage from skin without
detectable Campylobacter did not significantly differ from skin with Campylobacter
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Figure 38. Recovery of phage from chicken skin stored at 4°C and -20°C.
(I) Recovery ofphage +2 (NCTC 12674) from chicken skin stored for ten days under
fresh (4°C; 0) and frozen (.20°C; .) conditions. Triplicate 10 cm2 section of chicken
thigh skin were inoculated with 108 pfu of+2 then percentage recovery of this inoculum
(± SD) was recorded at 24 h intervals. (II) Recovery of six Campylobacter
bacteriophage chicken skin isolates exhibiting different lytic spectra. lOBpfu of each
phage were applied to fresh chicken thigh skin in triplicate and stored for ten days at 4°C.
The percentage recovery of the initial inoculum (± SD) was recorded at 24 h intervals.
Key: (A)w2; (.) w3; (6) w4; (D) wS; (X) w8 and (0) wlO. In all cases the initial
samples (day one) were collected one hour after inoculation.
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(P>0.2). This suggested that the presence of potential Campy/obaeter hosts on the
chicken skin surface did not appreciably influence the recovery of bacteriophage.
3.1.4 Campy/obaeter and bacteriophage isolation from retail chicken
portions.
In order to assess the presence of phage and their hosts on commercial products, a total of
450 retail chicken thigh portions (300 fresh, 150 frozen) were purchased from a UK
supermarket (2.6.6) .. These portions were selected on the basis of different product bar
codes and processing unit numbers to give a cross section of samples from six UK
producers. For the isolation of Campy/obaeter ssp., areas of chicken skin (10 cm2) were
wiped with a sterile swab which was used to inoculate a plate of CCDA selective agar (as
described in section 2.6.1). Presumptive Campy/obaeter colonies were Gram stained to
confirm morphology prior to biochemical speciation (2.3.4.2). Bacteriophage were
isolated from samples using isolation protocol IV described previously (2.6.4.4).
Campy/obaeter was isolated from 100% of free range chicken portions compared with
75% and 62% for standard and economy products respectively. It was noted that
Campylobaeter was isolated at a lower frequency from frozen chicken samples with 9010
of standard and 12% of economy products being positive. The majority of
campylobacters isolated (96%) were C. jejuni with the rest likely to be C. coli or C. lari
based on previous studies (Jorgensen et al., 2002). Campy/obaeter phage were
recovered from the skin of 34 fresh chicken thighs out of the 300 tested (11%). Twenty
seven (79%) of the phage-positive chicken thighs were from free-range chicken products
as compared with five (15%) and two (6%) from standard and economy products
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respectively. A one way ANOVA (2.12) demonstrated that the observed incidence on the
free-range product is significantly different (P<O.OO I) to that of the other products. The
mean number of phage isolated from the whole chicken skin surface was 10gIO5.7 pfu
(recovery ranged from 10gIO2.0 to 6.6 pfu). Phage recovery from frozen chicken thighs
was unsuccessful. Given the 80% reduction in the recovery of phage ~2 from inoculated
frozen samples (Fig. 3BI) this result was not unexpected.
3.1.5 Variation in the rates of recovery of phage Isolates from chicken skin.
The relative recovery of representative phage isolates (characterized on the basis of lytic
spectrum, genome size and morphology, see Chapter 4), from the surface of inoculated
chicken skin were examined using recovery protocol IV (2.6.4.4). The phage used in this
experiment (w2, w3, w4, w5, w8 and wIO) represented lytic spectrum classes I to VI
respectively (Chapter 4). The recovery of these phage following inoculation onto
chicken skin and incubation at 4°C showed considerable variation when recorded at 24 h
intervals over a ten day period (Fig. 3BII). At least 90% of the phage w5 inoculum could
be recovered over the full course of the experiment compared with only 2% of the w3
inoculum. However, the recovery of all phage from the surface of frozen chicken did not
differ significantly from the pattern recorded for phage ~2 (Fig. 381). High recovery
titres were recorded prior to freezing (ranging from 84% for w3 to 98% for w5), at which
time the recovery decreased to 18% - 30% and thereafter remained stable for the rest of
the time course.
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3.2 DISCUSSION
The efficacy of Campylobacter isolation methods has been debated since this organism
was successfully isolated from human stools in the 1970s (Skirrow, 1977). None of the
current methods for the isolation of Campylobacler from food have been universally
approved and implemented, making it difficult to compare the prevalence of this
organism in different geographical areas. In the present study, enrichment using the Park
and Sanders method recovered Campylobacler from the largest number of samples.
However, the time, expense and man-hours required to apply this method make it
impractical for larger studies. Direct plating onto CCDA recovered Campylobacter from
marginally fewer sites than enrichment but resulted in less contamination, and proved to
be far quicker and cheaper. Direct plating onto Blaser-Wang medium resulted in minimal
contamination but the recovery of Campylobacter was appreciably less than the other
methods. Sub-lethally injured Campylobacter cells are reported to be sensitive to
polymyxin but not other antibiotics in selective media (Corry et at, 1995b). As the
Blaser-Wang agar contained polymyxin this may explain the lower sensitivity of this
medium in Campylobacter isolation.
There was a wide variation in the efficacy of the protocols used to recover bacteriophage
from chicken skin. Generally, swabbing or washing the surface of the skin was less
effective than more vigorous treatments such as stomaching. This may indicate that the
bacteriophage become closely associated with the skin following inoculation.
Association with chicken skin is known to protect Campylobacter from chemical
decontamination procedures in slaughter houses (Whyte et al., 2001; Yang et al., 2001)
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and is likely to provide non-specific protection for phage as well. Chloroform is known
to inactivate certain phage which are members of the Tectiviridae family as well as
certain Plectiviruses and Ionoviruses. This is thought to occur by the disruption of the
hydrophobic bonds which maintain capsid protein integrity (Ackermann and DuBow,
1987). Chloroform did not appear to have any appreciable effect on the recovery of
Campylobacter bacteriophage ~2.
The successful isolation of Campylobacter phage from 34/300 fresh retail chicken
samples demonstrated that the methods developed in this study are practically applicable.
Since the detection limit of the recovery method was determined to be 103 pfu/lOcm2 of
chicken skin, isolation of phage from these products implies that at least this many
bacteriophage have survived retail poultry processing and packaging. The phage isolated
in this study are likely to originate from the caecal contents of chickens, particularly since
Campylobacter phage have previously been recovered from abattoir effiuent and chicken
excreta (Grajewski et at, 1985). Contamination of carcasses from chicken intestinal
contents both preceding and following abattoir processing has been reported previously.
The Campylobacter phage isolated in the present study were from fresh chicken thighs
within their prescribed shelf life. However, survival experiments demonstrated that
bacteriophage can be recovered up to ten days following inoculation, which is well
beyond their stated shelf life. Phage ~2 could be efficiently recovered from the surface of
frozen retail chicken which had been thawed prior to phage application. However,
subsequent freeze and thaw resulted in a fall in the recovery by almost 80%. Birds
produced for freezing are scalded at a higher temperature (Humphrey et at, 1988) and
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that, together with the subsequent freeze-thaw is known to change the skin surface
structure (Adams and Moss, 1995). The results in the present study suggest that phage
may not attach as well to skin surfaces following such treatment, leading to higher initial
recovery rates (99.8%). The subsequent fall in recovery is likely the result of reduced
phage viability on freezing, to which members of the Myoviridae family are particularly
susceptible (Ackermann and DuBow, 1987).
The lytic spectra of the individual phage isolates (Chapter 4) revealed similarities in host
range. Phage exhibiting the same lytic spectrum were placed in one of eight host range
classes. The host ranges of all the retail poultry isolates differed markedly from the lytic
spectrum of the ,2 positive control (Chapter 4). The similarity in lytic profiles of phage
isolated from different chicken samples may suggest some form of selection has taken
place. This may reflect the ability of the bacteriophage to survive on the chicken surface
during processing and their ability to survive the storage conditions applied. Previous
studies suggest that certain Campylobacter jla-types are able to survive abattoir
processing better than others (Newell et aL, 2001), and this may be a factor in
determining the survival of any predator phage that are associated with them.
Free-range chickens are subjected to greater environmental exposure than
conventionally-reared birds and are therefore more likely to encounter a wider range of
campylobacters and their phage. A significantly greater percentage of free-range products
were phage positive compared with standard and economy classes which may, in part, be
explained by the frequency of Campylobacter positive carcasses originating from the
free-range sector. Greater exposure to the environment consistent with organic and free
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range fanning practices is purportedly the cause of a generally higher incidence of
Campylobacter in these types of flocks (Bald et aL, 2001). The probability of phage
isolation will increase with the presence of a susceptible host, thus chickens with higher
rates of carriage of campylobacters are more likely to be a source of phage. However,
with widespread cross-contamination in the abattoir, it is likely that the Campylobacter
and phage found on a single carcass arise from more than one source. In addition to this
the recovery of phage isolates representing different lytic spectra classes inoculated onto
chicken skin show marked variation. Four of the six chicken skin isolates tested yielded
a higher rate of recovery over a 10 day period when applied to chicken skin and retained
at 4°C (Fig. 3BII) when compared with the +2 control (Fig. 3BI). Most notably phage w5
could be recovered at >90% of the inoculum throughout the course of the experiment.
Phage were only recovered from chicken samples which also harboured campylobacters,
a finding that is not surprising as the phage will originate from an environment containing
host cells. Cross contamination may occur but the numbers of phage involved could be
below the limit of detection. Survival data for phage inoculated onto chicken skin and
incubated in retail storage conditions shows a general decline, suggesting that replication
of the phage is not occurring on the surface of the samples. This is not surprising as
Campylobacter do not grow on food samples stored under these conditions and hence
will not have an active metabolism. There are multiple variables dictating the survival of
both phage and Campylobacter throughout commercial poultry production. These factors
may not necessarily allow both the phage and its host to survive at the end of processing.
The multiple cross contamination events and survival variables of Campylobacter and
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phage in the processing plant would make any attempt to correlate the phage with a host
from a common chicken source of little value.
This study has demonstrated that Campylobacter phage can survive on fresh and frozen
retail poultry products. An isolation protocol was developed and successfully
implemented to recover Campylobacter phage from 34 independent retail chicken
samples, a source previously not examined for the presence of Campylobacter phage.
The finding that phage are present on retail poultry products demonstrates that the use of
phage as a biocontrol agent would constitute a minimum intervention that would not
ultimately introduce any entity into the food product which is not already present.
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CHAPTER4
CHARACTERISATION OF BACTERIOPHAGE ISOLATED FROM
RETAil POULTRY PRODUCTS
4.0 INTRODUCTION
The characterization of the bacteriophage isolated in Chapter 3 is of paramount
importance should they be implemented in any future biocontrol strategies against
Campylobacter. Bacteriophage characterization has historically been based on
morphology, genetic similarities and host range (Ackermann et al., 1992). These
primary traits are still fundamental features used in the categorization of phage by the
International Committee on the Taxonomy of Viruses (ICTV). The binomial
nomenclature system developed from the work of Linnaeus and successfully used for
many organisms is not easily applied in viral taxonomy (Ackermann et at., 1992).
Another major problem is that, unlike bacteria, phage do not have one single conserved
gene amongst them (Ackermann et aL, 1992). As a consequence, the classification of
viruses by using, for example, a similar technique to rDNA profiling in bacteria is not
possible with bacteriophage. More recently there have been attempts to modernize
traditional bacteriophagetaxonomy, with one approach basing nomenclature on predicted
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protein homology from known phage DNA sequences combined with "signature genes"
found in particular families of viruses (Rohwer and Edwards, 2002). Nevertheless, the
traditional system prevails as the accepted standard and phage are currently ascribed to
one of twelve families (Table lA).
Although the morphology and genetic similarities between phage may provide useful
indications as to the lifestyle of the virus, the most critical aspects from a therapeutic
perspective are the host range and replication dynamics. These particular qualities were
often overlooked when phage therapy was in its infancy in the early 20th century, often
leading to failure (Summers, 2001). The work of Ellis and DelbrOck on the growth of
phage in the 1930s, in particular the "one step growth curve" (Ellis and Delbruck,
1939), forms the cornerstone of modem phage therapy models (Payne and Jansen,
2001).
Proceeding from this principle, the lytic activity of the bacteriophage isolates from
Chapter 3 against Campylobacter hosts from three sources was investigated.
Subsequently, a subset of phage exhibiting different lytic profiles and the broadest host
range were selected for further characterisation which consisted of examining:
• Virion morphology using negative staining transmission electron microscopy
• Phage replication dynamics (adsorption efficiency, replication time)
• Major phage proteins using SDS PAGE and mass spectrometry sequencing
• Genome attributes (genome size, nature of the nucleic acid, macro restriction profiles,
sequencing of cloned fragments)
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The aim of these analyses was to collate information on different aspects of the phage
isolates prior to selection of the most suitable candidates for therapeutic interventions in
broiler chickens.
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4.1 RESULTS
4.1.1 Host range and lytic profiling
The success of bacteriophage therapy in an industrial scenario is more likely if the viruses
applied have a broad host range within the targeted bacterial genus. With the aim of
selecting the most suitable candidates for future in vivo therapeutic endeavours, 34 phage
isolated from retail poultry (see Chapter 3) were screened against a total of 109 strains of
Campylobacter. The phage isolates were screened for lytic activity against two groups of
campylobacters (A and B) by using the surface droplet technique (2.3.6.5). Group A (n =
11) consisted of National Collection of Type Cultures (NCTC) strains used as
propagating hosts for difTerentphage in the Campylobacter phage typing scheme adopted
in the UK (Frost et al., 1999). Group B (n = 18) consisted of a subset of campylobacters,
which were isolated contemporaneously with the bacteriophage (Chapter 3), that
possessed different major flagellin gene (f/aA) profiles. A subset of bacteriophage
exhibiting the greatest host range with groups A and B were subsequently sent to the
Central Public Health Laboratories (CPHL, Colindale, London) to be profiled using 80
different clinical Campylobacter isolates (Group C).
4.1.1.1 Results using Group A
The results using the eleven host strains of Campylobacter from the NCTC separated the
phage isolates into eight lytic spectrum classes (Table 4AI). None of these classes
corresponded to the profile of the positive control, NCTC phage ,2. The only strains to
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Bacteriophage Class
CPIIL PT (REtl, I II III IV V VI VII VIII ~2
PT I (C605)
PTl (C682) + + + + +
PT5 (C856) + +
PT6 (CS94) + +
GROUP A PTU (NCTC 12661) + + + + + + + + +PTU (NCTC 12662) + + + + + + + + +
PTI9 (CI1288) + + + + (+) .
PT33 (CI312) +
PT35 (CI35SJ)
PT44 (CIOI3I) +
NCTC 11168 + (+)
ELA TYPED ISOLA TES
I + + + + +
1 + + + + +
7 + + + + +
12 +
17
19 + + + + +
29 + (+) . +
31
33 + +
GROUP B 3435
39 . (+)
77 + + + + +
190 . (+) .
191
191
193
194
TOT AL STRAINS INFECTED 4 II 11 10 10 10 1 4 7
Table 4A I. Phage lytic spectra using group A and B
Campylobacter hosts
Lytic spectra of 8 phage isolates belonging to different lytic spectra classes. Lytic
activity against group A and B hosts are shown as + (clear lysis of host); (+)
(opalescent lysis) and - (no lysis). The total number of strains lysed by each lytic
class [+ and (+)] is given at the bottom of the table.
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be infected and confluently lysed by all phage were NCTC 12661 and NCTC 12662, both
of which were CPHL phage type (PT) 14. Campylobacter strains of phage types 1 and
35 were not lysed by any of the phage isolates.
4.1.1.2 Results using Group B
A subset (n = 60) of Campylobacter isolates from retail chicken thigh portions were
typed using the restriction fragment length polymorphism patterns of the flaA gene (jIa
typing,2.5.8). Campylobacters exhibiting differentjla types (n = 18) were selected as a
representative panel of strains isolated from retail chicken. An example of the
differences in fla type observed among a subset of these isolates is presented in Figure
4A.
In contrast with the lytic activity recorded against the NCTC strains, no one fla type was
lysed by all of the phage. Of the eighteenjla types used, eight were not lysed by any of
the bacteriophage (jIa types 17,31,34,35, 191, 192, 193 and 194). The phage isolates
could be ascribed to eight distinct lytic spectra according to their ability to infect the
combined panel of hosts from groups A and B (Table 4AI).
4.1.1.3 Results using Group C
Only two patterns of lytic activity were observed when the subset of phage were tested
against 80 human Campylobacter isolates. The first consisted of isolates wI, w2, w6 and
w7, the second consisted ofw3, w4, w5, w8-18 (Table 4AII). Seventeen of the
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Figure 4A. flaA profiles of campylobacters isolated from retail chicken.
Agarose gel showing the flaA amplicons from campylobacters isolated from retail
chicken when digested with endonuclease Ddel. Eight unique restriction profiles could
be discerned from the eleven Campylobacter strains shown here. The strain reference is
shown at the top of each lane along with a 100 bp marker (M) on the far right of the
figure.
I J 6
Phaqe type Class I Class II Phaae type Class I Class II Phaae type Class I Class II
1
·
-
31 + - 61 - .
2
·
+ 32
·
+ 62
·
-
3 + + 33 + · 63 · -
4 + + 34 · - 64 · -
5
·
- 35 · - 65 + +
6 + - 36 + - 66 + +
7
-
- 37
·
+ 67 (+) -
8
-
+ 38 + · 68 - -
9 + + 39 - - 69 (+) +
10
·
- 40 (+) - 70 + +
II + - 41 · · 71 + +
12
·
+ 42 · - 72 + -
13 + + 43 - - 73 - -
]4 + + 44 - - 74 - -
15 + - 45 - - 75 + +
16 + + 46 - + 76 - +
17
-
+ 47 + + 77 + -
18
-
+ 48 + - 78 + -
19
-
+ 49 - - 79 - +
20 + - 50 - - 80 + -
21
-
-
51 - -
22
- -
52 - -
23
·
-
53 - +
24
·
-
54 + +
25 + + 55 + +
26 + - 56 + +
27 + + 57 (+) -
28 + - 58 - -
29 - - 59 - -
30 + + 60 (+) -
STRAINS INFECTED 38 31
Table 4A II. Lytic spectra classes obtained using group C
Campylobacter hosts
Lytic spectra of8 phage isolates belonging to different lytic spectra classes against
human Campy!obacter isolates (group C hosts). Only two lytic patterns were
observed for these hosts (I and II).
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eighty strains tested (21%) were infected and lysed by all of the isolates whilst twenty
nine (36%) were not lysed by any.
4.1.2 Morphological analysis by Transmission Electron Microscopy (TEM)
Morphological analysis of bacteriophage is one of the key criteria used in the
classification of viruses by the ICTV. Previously characterised Campylobacter phage
were found to be members of the Myoviridae family with unusually large genomes (Sails
et al., 1998). Elucidating the morphology of phage isolated in the present study would
provide important indications as to their lifestyle and thus potential use in phage therapy.
The physical structure of the bacteriophage isolates was determined by negative staining
transmission electron microscopy (2.7). Representative electron micrographs taken of
phage isolates from different lytic spectra are presented in Figure 4B. All the phage had
icosahedral heads and rigid contractile tails, suggesting they were all members of the
Myoviridae family. As with the phage characterised by Sails et al. (1998), differences in
the head and tail dimensions of the phage isolated in the present study suggested these
isolates could be subdivided. A summary of these measurements with observed standard
deviations is presented in Table 4B.
4.1.3 Profiling of bacteriophage proteins
With the aim of further confirming the differences between the lytic spectra of the phage
isolates, bacteriophage suspensions were subjected to SDS-PAGE to obtain profiles of
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AFigure 4B. Electron micrographs of phage isolated from fresh chicken skin
representing eight lytic spectra classes.
The icosahedral head and rigid contractile tail are typical features of phage from the
Myoviridae family. A = w2, B = w3, e = w4, D = w5, E = w8, F = wlO, G = w19, H =
w20. The bar represents 250 nm. All electron micrographs were taken at 100, 000 x
magnification using a JOEL 100 ex transmission electron microscope.
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Ll!lc Class Genome Size (kbl Restriction Pattern Head diamete,. nm :t SO Diamete,. nm:t SO Length. nm :t SO n
1 150 I 85: 1.8 16:3.6 103: 1.9 6
II 190 lDlCut 83: 1.3 20:2.8 124:2.9 5
III 190 lDlCut 92±4.3 19±2.4 116±5.8 S
IV 195+ 135 2 91: 1.9 20±2.8 1l2± 3.8 6
V 230 lDlCut 89:4.0 21±2.4 130:3.3 6
VI 230 3 88±4.5 21±2.4 125:2.1 7
VII U U 90:2.4 19: l.S 115:3.6 6
VIII U U 91:2.6 19:2.1 116:2.7 5
Table 48. Morphological and genetic characteristics of phage grouped
according to their lytic spectra.
Genome sizes were ascertained by Pulsed Field Gel Electrophoresis (PFGE).
Genomes of phage which failed to yield defmed bands on a PFGE gel are labeled U
(unable to determine). Digestion of the phage genomes with endonuclease Hhal
yielded 3 RFLP patterns. Genomes refractory to digestion with Hhal are designated
"uncut", Morphological features were observed by negative staining electron
microscopy. Measurements of phage structure dimensions are recorded as the mean
(nm) ± standard deviation for n numbers of phage examined from each lytic class.
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their major proteins (2.4.2). This technique has previously been used to assist in the
discrimination of Listeria phage (Zink and Loessner, 1992).
4.1.3.1 SDS PAGE
Attempts were made to purify the Campylobacter bacteriophage isolates using a CsCI
gradient (2.3.6.2) prior to separation by SDS-PAGE (2.4.2). Purification was attempted a
minimum of four times per isolate but was unsuccessful for all phage derived from retail
poultry despite several changes to the protocol. However, one phage isolated from
chicken faeces as part of another study (gift from Ms. Catherine Loc-Carrillo) was
successfully purified. This CsCl-purified sample was separated along with non-purified
isolates by SDS-PAGE.
The protein profiles of six bacteriophage isolates representing a subset of the different
lytic spectrum classes is presented in Figure 4C. This subset was selected from lytic
spectrum classes which could be characterised according to their genome size and
restriction pattern when digested with endonuclease Hhal (Table 4B). The protein
profiles of these phage all possessed a single protein (about 34 kDa) in common which
corresponds to a band from the host cell-only preparation. This is presumed to be the
major outer membrane protein of C. jejuni although this protein appears to be smaller
than published values (Logan and Trust, 1982). The other major band visibly differs in
size with respect to the individual bacteriophage isolates (black arrows). There were also
differences in the profiles of higher molecular weight bands although these were more
difficult to see (blue arrows). In order to gain insight into the identity of the major
121
c w5 w8 w10 kDa
- 97
- 66
- 45
- 30
Figure 4C. Bacteriophage protein profiles
A 12% SDS-PAGE gel showing the migration profiles of proteins present in concentrated
bacteriophage plate lysates of phage w2, w3, CP6, w4, w5, w8 and wIO compared with a
host-ceIl-only preparation (C). Representative molecular weight markers are shown at
the far right of the gel. The black arrows and blue arrows highlight proteins of varying
sizes which differ between phage isolates. Phage w2, w3 and CP6 were selected for
MALDI-TOF sequencing.
w3 w4
w2 w3 CP6
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variable proteins, the bands of two non-purified (w2, w3) isolates and one purified (CP6)
isolate were selected for sequencing by MALDI-TOF (2.4.6). Each of these major bands
was in the range of 35 - 40 kDa in size (Fig. 4C). Constraints on project resources
prevented the further sequencing of other protein bands from w2, w3, CP6 or phage
representing different lytic spectra.
4.1.3.2 Mass Spectrometry sequencing of proteins
The primary mass spectrometry 'finger prints' obtained from tryptic digests of w2, w3
and CP6 are presented in Figure 4D. None of the fingerprints matched anything in the
ExPasy protein mass spectrum database (2.4.6). The black arrows on each fingerprint
(Fig. 40) indicate the tryptic fragments selected for fragmentation (sequence) analysis.
Sequences were obtained from five of the nine fragments (indicated by an *). Table 4C
summarises the homology searches performed on these sequences using the BLAST
search engine for protein short or near exact sequences (NCBI). Four out of the five
protein sequences exhibited homology with viral proteins, with 40% specific to phage
proteins. Interestingly, a fragment sequenced from w2 is almost exactly the same (92.3%
identity) as a fragment from the CsCl-purified bacteriophage CP6 (Table 4C).
Interrogation of the NCBI database using the BLASTp search engine revealed that these
sequences exhibited homology with an as-yet uncharacterised phage-related protein from
Clostridium acetobutylium. In addition, the w2 fragment exhibited homology with
gpI6.1, a protein of unknown function found in temperate Staphylococcus phage ,ETA.
The CP6 fragment exhibited homology to a 19.3 kDa protein of unknown function in
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Figure 40. Mass spectrometry fingerprints of phage proteins.
MALDI-TOF mass spectrometry 'fmgerprints' of the major protein band from
concentrated phage plate lysates ofw2, w3 and CP6 when resolved on a 12% SDS PAGE
gel. Each phage protein was digested with trypsin and spray-ionised prior to fmgerprint
analysis. Selected tryptic digests (~) were selected for fragmentation (sequencing)
analysis. Sequences were obtained from 5/9 fragments tested (*).
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virulent Lactococcus phage LL-H. Interestingly, the second fragment sequence from
CP6 showed homology with E. coli colicin immunity protein. This 9.9 kDa protein is
encoded by the cei gene on the ColE7 plasmid and binds to the colicin produced by the
bacterium to prevent autolysis (Chak et aL, 1991). The remaining sequences for w2, w3
and CP6 showed some general homology to eukaryotic virus proteins of unknown
function.
4.1.4 Analysis of the phage genome
The type of nucleic acid a virus possesses is now an important component of phage
taxonomy. Such data is important not only for the classification of viruses but also
provides information about their lifestyle. In order to determine the nature of the nucleic
acid present in the phage isolates, genomic preparations (2.5.2) were first treated with
RNase for 30 min at 31'C to digest the genome should it be composed of RNA.
Subsequently, the genomic preparations were digested with a selection of endonucleases
(2.5.4) in order to differentiate between genomes composed of single stranded and double
stranded DNA (restriction endonucleases cleave only dsDNA). A 1% agarose gel
showing the results of bacteriophage subjected to these treatments is presented in Figure
4E. The nucleic acid was not digested when treated with RNaseA indicating that the viral
genome did not consist of RNA. In addition, digestion with C/oI (and other
endonucleases tested, Table 4E) revealed the DNA was double stranded. These data
supported the former indications that the phage isolates were members of the Myoviridae
family (Table 4D).
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Figure 4E. Restriction profiles of RNase-treated bacteriophage genomic
extracts.
A 1% agarose gel showing the migration of genomic preparations from bacteriophage
w2, w3, w4, w5, w8 and wlO after treatment with RNase (A) and digestion with
endonuclease Cfoi (B). AIHindIII digest markers are shown at the far right of the figure
(M) with sizes shown in base pairs (bp).
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Family or Group Genera Type Member Particle Envelope GenomeMorpholoQY
Corticoviridae Corticovirus PM2 icosahedral No s~led dis DNA
Cvstoviridae Cvstovirus 06 icosahedral Yes 3 segments dis RNA
lnovirus coliphage fd
lnoviridae Plectrovirus Acholeplasma phage rod No circular sis DNA
Levivirus coliphage MS2
Leviviridae Allolevirus coliphage Qbeta icosahedral No 1 (+)strand RNA
Lipothrixviridae Lipothrixvirus Thermoproteus phage I rod Yes linear dis DNA
Microvirus coliphage 0X 174
Spirovirus Spiroplasma phages
Microviridae Mac-I phage icosahedral No circular sis DNA
Myoviridae coliphageT4 tailed phage No linear dis DNA
Plasmaviridae Plasma virus Acboleplasma phage .pleiomorphic Yes Circular dis DNA
Podoviridae cohphage T'I tailed _ll_h~ No linear dis DNA
Siphoviridae lambda phage group coliphage lambda tailed phage No linear dis DNA
Sulpholobus shibatae virus SSV-I lemon-shaped No circular dis DNA
Tectiviridae Tectivirus phagePRDI icosahedral No linear dis dna
Table 40. Current names and attributes of bacteriophage families
recognised by the International Committee on the Taxonomy of Viruses
(ICTV).
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Endonuclease Recognition site
TaqI T/CGA
DpnI GAffC
Ssp I AAT/AAT
MseI TITAA
HaellI GG/CC
DraI TIT/AAA
MboI /GATC
HindIII AlAGCTI
Pst I CTGCAIG
EcoRI G/AATIC
EcoRV GAT/ATC
C:foI GCG/C
Hhal GCG/C
Table 4E. Endonucleases used on bacteriophage DNA preparations
which were unable to produce discriminatory restriction patterns on a
pulsed field gel.
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4.1.4.1 ~ole genome analysis of phage isolates by Pulsed Field Gel
Electrophoresis(PFGE)
PFGE has been used in a previous study to determine the genome size of Campylobacter
bacteriophage (Sails et al., 1998). It allows the separation of DNA fragments greater
than 50 kb in size by periodically alternating the orientation of the electrical field
imposed on the gel. A method for the preparation of phage genomic DNA for PFGE was
modified from standard protocols for the preparation of bacterial genomic DNA (2.5.10).
A pulsed field gel showing the genome sizes of bacteriophage representing six lytic
spectra classes is presented in Figure 4F. The phage genome sizes ranged from 150 kb to
230 kb. Phage w5 was unusual in that it appeared to have two bands present (135 kb and
195kb). A minimum of six successive rounds of plaque purification performed at the
University of Nottingham and the Central Public Health Laboratories failed to separate
this phage into two clones with single bands.
As the genomes of the phage isolates were previously determined to consist of dsDNA,
they could be discriminated on the basis of their susceptibility to restriction
endonucleases. Genomic digests were performed using thirteen different endonucleases
(fable 4E). Of the restriction enzymes used, only treatment with Hhal and its
isoschitsomer C/oI yielded discriminatory profiles when the digests were separated by
PFGE. Other restriction enzymes used either did not cleave the phage DNA or cleaved
too frequently which resulted in a smeared pattern on the gel. The phage could be
ascribed to three categories according to the susceptibility of their genomic DNA to
digestion with endonuclease Hhal (Fig. 4G).
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Figure 4F. Genome size of bacteriophage isolates.
Pulsed Field Gel of undigested bacteriophage genomic preparations representing different
lytic spectra classes (w2 w3, w4, w5, w8, wIO). Lambda concatomer markers (M) are
shown flanking the phage DNA, sizes given in kilo base pairs (kbp).
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Figure 4G. Bacteriophage macrorestriction profiles.
Gel showing restriction fragments generated from digesting phage genomes with
endonuclease Hhal. Lanes are as follows: M = A IHindlII marker; 1 = undigested w2; 2
= digested w2; 3 = undigested w3; 4 = digested w3; 5 = undigested w4; 6 = digested w4;
7 = undigested w5; 8 = digested w5; 9 = undigested w8; 10 = digested w8; 11 =
undigested wIO; 2 = digested wIO.
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4.1.4.2 Phage DNA sequence analysis
The sequencing of genomic DNA fragments from the phage isolates would allow
interrogation of databases for homologous sequences from phage genes of known
function. This may assist in identification of the phage and also provide information on
the GC content of the genome and possibly the Iifecycle of the virus. To this end,
bacteriophage DNA was extracted (2.5.2) and digested using endonuclease DraI (2.5.4).
The digestion products were then cloned into plasmid vector pUC18 using a Ready-To-
GOTMcommercial cloning kit (27-5266-01, Pharmacia) according to the manufacturer's
instructions by Dr. P. Connerton. Successful transformant colonies, selected on the basis
of blue/white screening, were incubated overnight in LB broth (2.5.11) supplemented
with ampicillin (50 Jig ml") prior to plasmid extraction (2.5.3) using a QIAprep®
Miniprep kit (QIAGEN Ltd, West Sussex). Plasmid preparations were then digested with
a combination of EcoRI and BamHI endonucleases (2.5.4) to cleave the plasmid DNA at
sites flanking the insertion site. Plasmid digests showing inserted fragments when
resolved on a 1% agarose gel (2.5.6) were sent for sequencing using a CEQ® 2000 dye-
terminator cycle system (Beckman Coulter) at the Plant Sciences Department, University
of Nottingham. Sequences obtained from phage DNA inserts into a pUC18 vector
(2.5.11) were used to interrogate the National Center for Bioinformatics Information
(NCB I) database using the BLAST search engine. Campylobacter host DNA was present
in 6121 of plasmid inserts, which was unsurprising considering that the DNA arose from
non-CsCI purified filtered bacteriophage lysates. Of the unique DNA sequences, 6/15
possessed translated amino acid sequences showing identity to the deduced primary
structure of proteins from phage infecting other bacterial genera (Table 4F).
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Sequence A from phage w2 showed significant homology to a primase-helicase from
coliphage T4. Primase-helicase is encoded by genes gp61 and gp41 respectively in phage
T4 and is required for the synthesis of primers for Okazaki fragments and unwinding of
the phage DNA during replication (Miller et at, 2003). Supporting this was additional
homology with primase gene gp41 from coliphage RB49 (Desplats et al., 2002) and a
DNA helicase gene from phage Le-Nu (Brandt et at; 2001). Primase-helicase is part of
the core replisome in phage T4 (Miller et aL, 2003).
Sequences from phage w5 exhibited some general homology with proteins found in
eukaryotic viruses (HIV, Entomopoxvirus and TT virus) along with more significant
homology to bacteriophage proteins. These included the product of gene p23 from
Myxococcus phage Mx8 (Tojo et aL, 1996), unknown and host specificity proteins from
Streptococcus phage MD2 (Duplessis and Moineau, 2001) and a hypothetical protein
(YomD) from Bacillus subtilis phage SPBc2 (Lazarevic et aL, 1998). However, none of
these proteins are sufficiently well characterised to deduce any further meaningful
conclusions.
Of the sequences used to interrogate the database, those from phage w8 produced the
most significant matches. The first of the two sequences produced a Score of 134 bits
and E-value of 5 x 10.31 for homology with phage T4 topoisomerase. This enzyme is
composed of three subunits in phage T4, the products of genes gp39, gp52 and gp60
(Miller et al., 2003). T4 possesses a Type II topoisomerase which is capable of relaxing
positive or negative supercoiling in DNA (Lewin, 1997). The second sequence had high
homology with the prohead proteases of phage KVP40 (Matsuzaki et al., 1998),
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cyanophage S-PM2 (Hambly et al., 2001) and phage T4 (Miller et at, 2003). In all
these cases, the enzyme is transcribed from gene gp21 which, in phage T4, is responsible
for degrading scaffolding proteins to create space in the cavity of the prohead during
virion formation (Miller et aL, 2003).
4.1.5 Replication dynamics
The dynamics of phage replication in vitro are useful indicators of their possible efficacy
in vivo. All the phage in the present study were isolated from retail poultry using a strain
of Campylobacter (C. jejuni NCTC 12662 PTI4) susceptible to many different types of
phage. This is useful as it allows the direct comparison of the replication of phage from
different lytic spectra classes using a common host.
4.1.5.1 Adsorption to host cells
A time course was performed to determine the dynamics of attachment of phage
representing six different lytic spectra to their host in vitro (2.10.1). As the first step in
all phage replication, the ability to adsorb and the efficiency of this process will greatly
influence the therapeutic potential of phage. The titre of the phage in the control
experiment without host cells showed no appreciable differences throughout the time
course indicating that any non-specific attachment of the phage to the polypropylene test
tube was negligible.
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All phage, regardless of the lytic spectrum, attached to the host cell with similar
efficiency with the exception of phage wS, which did not demonstrate any appreciable
adsorption over the time course. An example of the adsorption data from one of these
isolates (phage w2, lytic spectrum class II) to the host Campylobaeter (C. jejuni NCTC
12662) over a 90 min period is presented in Figure 4H. Approximately 90% of the phage
adsorbed to the host within the first 30 sec of exposure. No further changes in adsorption
occurred for the remainder of the time course. The adsorption experiments were repeated
using Campylobaeter species/strains not permissive to infection by any of the phage (C.
eoliNCTC 12666, C. eoliNCTC 12667, C. eoliNCTC 12668 and C.lariNCTC 11352).
No fall in titre was recorded, compared with the controls, using any combination of phage
with any of these hosts indicating that phage do not attach to the non-permissive strains
tested here. An example of the adsorption data from one of these isolates (phage w2,
lytic spectrum class II) to Campylobaeter strains not permissive to infection is presented
in Figure 41.
4.1.5.2 Analysis of bacteriophage replication: one step growth
The replication of bacteriophage isolates from different lytic spectra classes in liquid
culture was determined using a one step growth experiment (2.10.2). This was performed
by preparing a suspension of Campylobaeter host cells from a 1 I overnight culture by
centrifugation at 10, 000 g for 10 min and resuspending the pellet in 9 ml of fresh broth
to a density equivalent to McFarland No.3 (approximately 109 cfu ml"). To this cell
suspension was added 1 ml ofa 109pfu mrl suspension of bacteriophage to give an MOl
ofO.l (108 pfu ml"), The suspension was incubated for 15 min in microaerobic
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Figure 4H. Adsorption of phage w2 to host cells
Graph showing the adsorption of phage w2 in the presence of host cells (c. jejuni NCTC
12662 PTI4) (---) over a period of90 min compared with the control (-) containing
phage particles only. These results are based on six replicates.
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Figure 41. Adsorption of phage w2 to non-host cells
Graph showing the adsorption of phage w2 in the presence of non-host cells (c. coli
NCTC 12667) (--) over a period of120 min compared with the control (-) containing
phage particles only. These results are based on six replicates.
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conditions to allow for phage adsorption before diluting 1:100 by the addition of fresh
NB2 broth (990 ml) + FBP (2.3.1.3). Following dilution, the culture was incubated
microaerobically at 42°C and shaken at 100 rpm. Samples (1 ml) were taken at regular
intervals with phage and Campylobacter titres being recorded as described previously
(2.3.6.4 and 2.3.4.4).
The data for the replication of phage w2 when exposed to its host (C. jejuni NCTC
12662) in liquid culture over a 2 h period is presented in Figure 41. As in the adsorption
study (4.1.5.1) there was an initial fall in phage titre compared with the control.
However, the 'one step' growth curve originally defined by Ellis and Delbruck (see
Chapter 1) was not observed. Instead of the expected rapid increase in free phage present
in the supernatant following the latent period there appeared to be a gradual increase from
the 60 min time point onwards. Extending the incubation time to 300 min resulted in the
phage titre stabilising at 10glOO.S- 1.2 higher than the baseline at approximately 120 min.
This pattern was similar for all the bacteriophage examined (w2, w3, w4, w8, wIO, +2)
with the exception of phage wS which did not show any increase in virion concentration.
Extending the incubation period for over 24 h did not significantly alter the bacteriophage
yield. The growth of the Campylobacter host cells during this period did not differ
appreciably from the control (Fig. 4K). Repeated alterations in the experimental protocol
outlined above failed to result in a one step growth curve. These alterations are presented
below.
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Figure 4J. Campy/obaeter 'One-step' growth curve
Graph showing changes in the titre unadsorbed phage w2 when incubated with host C.
jejuni NCTC 12662 PT14 (---) and without host ~-) in liquid culture. The latent period
(a) was determined to be approximately 45 min and the rise period (b) approximately 75
min. These results are based on six replicates.
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Figure 4K. Growth Csmpylobscter cultures infected and uninfected with
bacteriophage w2
Graph showing the growth ofCampylobacter jejuniNCTC 12662 PT14 over a 33 h
period when incubated with (---) and without ~-) 108 pfu ml" bacteriophage w2 (MOl =
0.01). These results are based on six replicates.
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4.1.5.2.1 Alterations in growth conditions and media composition
The growth of the Campylobaeter host would depend partly on the medium used and this
may have subsequently affected bacteriophage replication. Four different media were
used for bacterial growth (Brain-Heart Infusion, CM225, Oxoid; MUller-Hinton CM425,
Oxoid; Nutrient Broth, CMI, Oxoid), none of which resulted in phage replication
appreciably different from that presented in Figure 4J. Unpublished data from the CPHL
suggested that Campylobaeter host cells incubated at 3'fC rather than 42°C were more
susceptible to phage infection (Dr. J. Richardson, pers. comm.). However, incubation at
the lower temperature did not appear to significantly affect phage replication.
4.1.5.2.2 Alteration of adsorption conditions and treatment of host cells
In the original replication protocol, dilution of the host/phage suspension immediately
following the adsorption period was necessary to limit the probability of unadsorbed free
phage initiating new replication cycles. If dilution was not performed there would be a
continual release of viral progeny and skewing of burst size calculations. Ellis and
Delbruck were able to inactivate unadsorbed phage using antisera. Antisera was not
available for the Campylobaeter phage isolates in the present study and so several trials
were performed with experimental viricide products donated by Dr. R. Mole. Three
preparations were used, the first was based on a pomegranate extract, the second on a tea
extract and the third on ferric compounds. The commercially sensitive nature of these
products meant that the active ingredient(s) in each preparation could not be divulged.
Each viricide was applied immediately following the adsorption period so that phage
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which had successfully initiated an infection would be unaffected. However, only the
ferric compounds were effective in reducing the bacteriophage titre in suspension, but
only by loglO0.5 after 1 h and so were not potent enough to be used in the growth curve
experiments. The treatment of the host cells prior to adsorption was also altered by
taking cells from a 15 h culture (mid logarithmic growth) and thrice washing them in
MRD. This was performed to limit the number of membrane vesicles in the host cell
preparations which could potentially act as molecular decoys in phage adsorption. These
washing steps did not appear to affect the replication of Campylobacter phage on their
hosts. However, the effect of membrane vesicles on phage replication was investigated
further in Chapter 7.
The prolonged rise phase in the lifecycle of the Campylobacter bacteriophage isolates
made attempts to calculate the burst size impossible since virions will continually initiate
new infection cycles after release. The latent period of infection was determined to be
approximately 45 min (Fig. 4J) which falls within the range observed for Myoviridae
phage infecting other bacterial genera (Ackermann and DuBow, 1987).
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4.3 DISCUSSION
The lytic spectra of the individual phage isolates revealed similarities in host range,
implying that they are related. The activity of the phage against Campylobaeter isolates
recovered from the same samples was disappointing with respect to their potential as
therapeutic agents. Interestingly, only two lytic profiles were observed when the phage
were used to infect the 80 human Campylobaeter isolates. This clearly highlights the
limitations of relying on a single source of host for phage typing purposes. The greater
number of lytic spectra recorded for the bacteriophage isolates used to infect the NCTC
and flo-typed Campylobaeter strains was supported by morphological differences and
distinct protein profiles and genome sizes between the phage lytic classes. Bacteriophage
lytic activity against the NCTC strains was greatest with 73% of strains being infected by
at least one of the isolates. This was followed by infection of human strains (64%) and
poultry strains (56%). Although poultry isolates seemed least susceptible to infection, the
human isolates accounted for a larger proportion of the total number of Campylobaeter
hosts tested. Profiling phage against three sources of Campylobaeter has clear benefits
with respect to selection of the best candidates for future therapeutic endeavours.
However, it also demonstrates that caution is required with this approach as differences
between phage may not always be reflected as different lytic spectra. If lytic profiling is
to be used as the sole method for discriminating between phage isolates is it
recommended to use a panel of hosts from diverse sources to minimise bias and improve
the sensitivity of the technique.
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The electron microscopy data coupled with analysis of the genome revealed all the phage
isolates were members of the Myoviridae family. A previous study characterising
Campylobacter bacteriophage by (Sails et aL, 1998) found their isolates were also
members of the Myoviridae family with similar characteristics to the phage isolated in
the present study. Lysogeny has not yet been reported in Campylobacter and the
sequencing of the C. jejuni NCTC 11168 genome failed to demonstrate phage-like
sequences or insertion elements which might indicate the presence of a prophage
(parkhill et aL, 2000). Campylobacter phage belonging to the Siphoviridae family
(lambda like) have been reported (Firehammer and Border, 1968) but no studies thus
far have shown conclusively if these phage have a temperate lifecycle.
The physical dimensions of the phage are of particular interest when considering their use
as therapeutic agents. Campylobacters are pleomorphic organisms, with the cell
morphology changing at various stages of growth (Griffiths, 1993). During exponential
phase the cell is usually a spiral or 'gull wing' shaped slender rod with a diameter of
approximately 0.25 J.U1l and a length ranging from 2 - 3 J.U1l. In contrast, the smallest
bacteriophage isolate reported in the present study has a diameter of 0.085 urn (head) and
a length of 0.188 urn (head diameter + tai I length). Assuming the bacterial cell shape to
be cylindrical, the theoretical maximum burst size would be 105, using the entire volume
of the host cell and assuming the smallest phage dimensions and the largest host cell
dimensions respectively. This compares with a theoretical maximum burst size of 1650
for phage T4 in an average-sized E. coli host (phage dimensions: 0.065 urn x 0.190 urn;
E. coli dimensions: 0.75 urn x 3 um), However, a previous study revealed a maximum
burst size of only 444 for T4 in vitro (Hadas et al., 1997) with most cells yielding <300
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virions. If the T4/E. coli model can be extrapolated to estimate Campylobacter phage
burst sizes, the number of viral progeny per cell may well be less than ten. This has clear
implications for phage therapy if active replication is the principal method of controlling
the host bacterium population. The concentration of phage particles in vivo may become
too diffuse to have any effect on the Campylobacter population.
With the exception of phage w5, all of the phage isolates representing different lytic
spectra classes were able to rapidly and specifically adsorb to the host cell. Significant
attachment to non-host cells and polypropylene test tubes was not observed. However,
graph plots of phage replication did not indicate a one step curve typical of a lytic phage
lifecycle. The asynchronous release of phage is unlikely to be a consequence of
asynchronous attachment since the experiments presented earlier suggest adsorption is
rapid and specific using the same host at the same cell density. Interestingly, phage
replication seems to have, at most, a negligible effect on host replication when compared
with the control (Fig. 4K). Filamentous phage such as M13 may be released without cell
lysis (Turner et aL, 1998) but this type of lifestyle has never been reported for members
of the Myoviridae family.
The phenomenon of lysis inhibition has been documented in the well-studied Myoviridae
phage T4, amongst others (Miller et ai; 2003). Lysis is delayed if superinfection occurs
after five minutes of the primary phage infection (Miller et aL, 2003). The mechanism of
delay is poorly understood but the signal appears to be mediated by the rIprotein which
regulates holin assembly (Paddison et aL, 1998). Lysis inhibition itself is thought to be
the consequence of a breakdown in cellular energetics during the normal lysis period
149
Ch ter4
(Miller et al., 2003). The delay could be a mechanism used by phage to maximise host
utility, awaiting the accumulation of additional host bacteria before the release of viral
progeny. With regard to Campylobacter phage this may be a plausible explanation for
the asynchronous release of virions as the burst time would be dependent on the
bioenergetics of individual host cells. However, this is unlikely to fully explain the
asynchronous release of phage in the 'one-step growth curve' experiments in the present
study as the MOl was deliberately maintained at 0.01 to minimise multiple infections of a
single cell. Bacteriophage such as T7 are able to regulate their replication rate by
encoding a duel-function protein (T7 lysozyme). This protein forms a ternary complex
with RNA polymerase and selected promoters on the phage DNA Class II genes to
reduce the transcription of genes involved in the replication of viral DNA (Kumar and
Patel, 1997). Moreover, the inhibitory effect is influenced by the volume and metabolic
state of the host cell as well as the concentration of host ribosomes, which have been
shown to interfere with the transcription ofT7 Class III (late) genes (You et al., 2002).
Bearing this in mind, the pleomorphic nature of Campylobacter observed in liquid culture
(Griffiths, 1993) could go some way to explain the asynchronous release of phage from
infected cells.
Protein profiling has been successfully applied to Listeria phage (Zink and Loessner,
1992) and this study demonstrates its applicability to Campylobacter phage. The protein
profiles of the phage lysates revealed that at least one major protein varies between the
isolates from different lytic spectra. The results from sequencing of a selection of these
variable protein bands suggest they could be of viral origin based on homology of some
of the sequences to proteins of bacteriophage ~ETA and LL-H. However, these
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homologies were fairly weak and did not include any matches to phage capsid proteins of
which the sequenced bands were most likely to be. The fact that two of the phage (w2
and CP6), isolated using the same host, shared one protein tryptic fragment sequence is
interesting, particularly since they were isolated from different sources. Moreover, since
few genes are shared between phage (Rohwer 8Dd Edwards, 2002) this may prove
useful in sequencing the genomes of multiple phage or even identifying "signature" genes
which could be used in bacteriophage taxonomy.
PFGE has been a valuable tool in the subtyping of Campylobacter due to its sensitivity
and ability to resolve large DNA molecules. Previous work has shown that PFGE may
also be applied to Campylobacter phage. Many bacteriophage, as a consequence of their
lifestyle, are refractory to digestion with\ endonucleases. This is problematic when
\
I
searching for enzymes suitable for RFLP profiling to distinguish between phage
genomes. The endonuclease Bhal, and its isoschitsomer C/ol, were the only enzymes
which produced discriminatory RFLP profiles. The paucity of suitable enzymes for
restriction analysis is probably because the phage DNA nucleotides are modified in a
similar way to phage T4. The genome of this phage encodes DNA methyl transferases
which catalyse the conversion of cytosine to hydroxymethyl cytosine which protects its
DNA from digestion by host and phage-encoded endonucleases.
The genome sizes of all the phage isolates were larger than the average for a Myoviridae
virus (.....100 kb, source: NCBI). The sequenced strain of Campylobacter jejuni (NCTC
~-- -----_-
11168) is 1.6 Mbp and the replication of a viral genome up to 14% the size of its own
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may impose considerable stress on the host which further supports prior indications of a
small burst size.
No relevant nucleotide-nucleotide matches were obtained when interrogating the NCBI
database with randomly-cloned DNA fragments from bacteriophage lysates using the
BLASTn search engine. However when using the BLASTx search engine, which
translates the nucleotide sequence into an amino acid sequence, some significant matches
could be discerned for the translated products of genes from other bacteriophage. Of
particular interest was the homology to T4 prohead protease, topoisomerase and primase-
helicase. All of these enzymes playa role in the replication of T4 DNA and are good
candidates for a conserved sequences in the Myoviridae family. These data may prove
useful in the design of PCR primers for further characterisation of the phage genomes in
the future.
.._____
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CHAPTERS
POPULATIONS OF CAMPYLOBACTER AND BACTERIOPHAGE
ON RETAIL CHICKEN PRODUCTS AND
IN BROILER CHICKEN CAECA
5.0 INTRODUCTION
Previous studies have determined the extent to which broiler flocks are colonised with
Campylobacter (Newell and Wagenaar, 2000). However, little or nothing is known of
Campylobacter bacteriophage throughout the poultry meat supply chain. Over 170
Campylobacter bacteriophage have been isolated to date (Sails et aL, 1998). Most have
been recovered from poultry excreta or abattoir effiuent (Grajewski et al., 1985;
Salama et al., 1989). The major application of these isolates so far has been integration
into typing schemes (Grajewski et al., 1985; Salama et al., 1990b; Frost et al., 1999).
The renaissance of phage therapy seen in western countries in recent years (Kutter,
1997) has prompted several academic and commercial projects to exploit the potential of
phage to control Campylobacter in poultry production (www.intralytix.com;
http://192.211.16.121userff4/phagebiotics.html; www.phage-biotech.com).
An important step in the development of a Campylobacter phage intervention strategy in
broiler chickens is to examine natural populations of the virus and its host in vivo.
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Understanding the ability of each organism to survive in the chicken gut and throughout
the food chain is vital in the formulation of a targeted and effective phage therapy
programme.
The aim of this study was to expand on the bacteriophage isolation and survival data
reported in Chapter 3 by examining commercial broiler chicken caeca and whole retail
chicken carcasses for the presence of both phage and host. The lytic spectra of phage
from both sources was determined using 80 different phage-typed Campylobacter
reference strains originating from humans. A subset of C. jejuni strains isolated from
broiler caeca either with or without bacteriophage were discriminated using pulsed field
gel electrophoresis. The relationship between the presence of Campylobacter and
bacteriophage with the total aerobic, anaerobic and microaerobic counts in chicken caeca
was also determined.
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5.1 RESULTS
5.1.1 Isolation of Campylobacter from retail broiler carcasses
In order to assess the relationship between phage and their hosts on retail poultry
products, broiler carcasses were screened for the presence of both virus and its bacterial
host. Retail broiler carcasses (n = 688) representing six producers in the UK and one
producer in France were rinsed (2.6.3) and screened for the presence of Campylobacter
ssp. by Norpath Ltd (a UKAS-accredited commercial food microbiology laboratory).
Campylobacter isolations were performed using two BSI-approved standard methods
which consisted of enrichment using the Exeter technique (2.6.2) and direct plating of
wash fluid onto mCCDA selective agar (2.3.4.1). Campylobacter was isolated from
163/688 (24%) of samples using a combination of both methods. The Campylobacter
isolates were predominantly C.jejuni (n = ISO, 92%) with the remainder identified as C.
coli using biochemical speciation (2.3.4.3). The prevalence of Campylobacter in the
products from each supplier is presented in Table SA. There was considerable variation
in the number of Campylobacter-positive carcasses from each of the sources. At the
extremes, an average of 70% of carcasses from producer D were contaminated with
Campylobacter compared with only 3% from producer A.
ISS
Producer Total Samples Percent Total Campylobacter Isolates Percent Positive
A 60 8.7 2 3.3
B 60 8.7 4 6.7
C 60 8.7 7 11.7
0 129 18.8 90 69.8
E 120 17.4 9 7.5
F 60 8.7 20 33.3
G 180 26.0 27 15.0
H 20 2.9 4 20.0
TOTAL 689 100.0 163 100.0
Table 5A. Prevalence of Campylobacter in retail broiler carcass rinses.
Table showing the number of Campylobacter positive broiler carcasses from eight
producers based in the UK or France. The first column indicates the producer code
followed in the second column by the number of samples from each producer which is
also represented as a percentage of the total number of samples in the third column. The
fourth column shows the number of Campylobacter positive carcasses from each
producer which is also given as a percentage of the total number of samples in the fifth
column.
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5.1.2 Isolation of Campylobacter bacteriophage from retail broiler
carcasses
Aliquots (1 ml) of retail broiler carcass rinses (1.6.3) were examined for the presence of
bacteriophage (1.6.5). Of the 688 samples tested, 41 (6%) harboured bacteriophage
capable of infecting host strain C.jejuni NeTe 12662 phage-type 14 (PTI4). Of the 41
phage-positive carcasses, 35 also harboured Campylobacter. However, none of these
campylobacters were found to be permissive to infection by bacteriophage isolated from
the same carcass when using drops of phage suspension on a soft agar bacterial lawn
(2.3.6.5). Although the rinses of 41 broiler carcasses contained suspected phage which
could form plaques on PTI4, 23 such samples (56%) could not be subsequently
propagated using this strain. The lytic zones of these plaques were unusually large (>5
mm diameter). To establish whether these plaques may have been the result of infection
by a non-viral predator, DNA extractions from the plaque eluates were used in a peR
assay to detect the presence of the Gram negative predatory bacterium, Bdellovibrio
bacteriovorous (2.S.7) using the oligonucleotide primers described by Jurkevitcb and
Ramati (1000). B. bacteriovorous 109J was propagated using plate lysates with E. coli
K-12 as the host (1.3.5). The desired product size from the peR assay (approximately
830 bp) was obtained from the B. bacteriovorous 109J control but not from any of the
plaque eluate DNA extractions used (n = 12). In an attempt to visualise the agent
responsible for the lytic zones, volumes (10 J-lI) of the plaque eluates were examined by
negative staining electron microscopy (1.7). However, neither phage nor Bdellovibrio-
like organisms were observed. This may well have been a consequence of the small
volumes of sample used in electron microscopy.
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5.1.3 Isolation of Campylobacter from chicken caeca
In order to assess the relationship between phage and their hosts in the intestinal tract of
chickens, the presence and numbers of each were determined in the caeca of commercial
broilers. Broiler chickens (n = 205; mean age = 34 days ± 12 d) from three national
poultry producers representing 22 farms were dissected within 48 h of death (storage at
4°C until dissection) and the caeca removed using flame-sterilised implements with the
methods described in section 2.11.6. The caecal contents were then examined for the
presence and numbers of Campylobacter ssp (2.11.7). Of the chickens examined in this
study, 129/205 (69%) harboured Campylobacter with a mean colonisation level of 10gIO
6.7 ± 1.1 cfu g-l caecal contents. All of these isolates (129/129, 100%) were identified as
C. jejuni through biochemical speciation (2.3.4.2). Four to eight well-isolated colonies
were taken from the positive plates representing the caeca of birds with (n = 9) and
without (n = 9) bacteriophage and passaged once on Columbia blood agar plates (CBA,
2.3.1.1). DNA from these strains (n = 124) was then prepared for pulsed field gel
electrophoresis (PFGE) using the protocol described in 2.5.9. PFGE was performed by
Mrs. E. Dillion (research technician) according to the protocol devised by Ribot et al.,
2001). Sections cut from the agarose DNA blocks (approximately 2 mm) were
individually digested with either SmaI or KpnI endonucleases and resolved on a 1%
agarose gel (2.5.9.1). The macrorestriction profiles of 18 C.jejuni isolates digested with
SmaI are presented in Figure SA. The 124 single colony isolates assessed using PFGE
could be ascribed to 16 unique macrorestriction profiles on the basis of digestion with
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Figure SA. Macrorestriction profiles of Campy/obaeter isolates from
chicken caeca
A 1% agarose gel showing the macrorestriction profiles of Campylobacter strains
digested with endonuclease SmaI and subjected to PFGE. The Campylobacter strain
number is shown at the top of the gel, grouped together according to matching restriction
profiles (parentheses). Lambda concatomer markers (Kbp) are shown at far right of the
gel.
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endonuclease SmaI. These profiles could not be discriminated further by digestion with a
second endonuclease, KpnI.
Of the 22 farms tested in this study, 13 (59010)harboured Campylobacter-positive flocks.
With respect to individual farms, campylobacters were either isolated from all the birds
on a farm or none (Le. flock positivity was either 100% or 0%). No farm housed a
mixture of positive and negative birds. At least two C. jejuni strains were recovered from
the houses of 12113 (92%) positive farms with eight of these (62%) being colonised by
three or more strains. PFGE SmaI profile 4 (PSP 4) was present in all of the farms of
producers A and' B. All other macrorestriction profiles were unique to the farms
belonging to the individual producers. However, seven strains (PSP 1, PSP 2, PSP 4,
PSP 5, PSP 6, PSP 9 and PSP 12) were isolated from chickens from more than one farm
within each producer'S base. Generally, the macrorestriction profiles of campylobacters
isolated from the same bird were identical, with only three birds possessing caeca with
two or more different strains ofC.jejuni.
5.1.4 Isolation of Campylobacter bacteriophage from commercial broiler
chickens
The caecal contents obtained from the broiler chickens in section 5.1.3 were also
examined for the presence of Campylobacter bacteriophage using PT14 and
contemporary Campylobacter isolates as hosts (2.11.8). Of the 205 chicken caeca
examined, 41 (16.5%) harboured phage capable of infecting PTI4. Only four birds
possessed phage capable of infecting Campylobacter isolates originating from the same
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caecal contents as their predator. However, all of these phage were capable of infecting
PT14 and all subsequent phage purification and propagation was performed using this
strain as the host. There was considerable variation in the numbers of phage present in
the caeca of individual birds (mean presence = 10glO3.9 ± 1.2 pfu g-l caecal contents)
with an observed range from 10glO1.5 to 6.9 pfu g-l caecal contents. Interestingly,
chicken caeca harbouring bacteriophage generally contained fewer campylobacters
despite the majority of Campylobacter isolates not being susceptible to infection by
phage isolated from the same sample. Additionally, Campylobacter colonisation was
below the limit of detection (lOglO2.0 cfu g-l caecal contents) in 29/41 (71%) of birds
which also contained bacteriophage. This difference was significant (P < 0.001) using a
student's T-test (2.12). There was no apparent association between Campylobacter
PFGE macrorestriction profiles and the presence of bacteriophage in the same sample.
5.1.5 Host range of phage Isolates
In order to further characterise the bacteriophage isolates from retail poultry and chicken
caeca for their potential use in therapeutic trials, the phage were first screened for their
ability to infect ten NCTC Campylobacter strains of different phage types supplied by the
Central Public Health Laboratories, Colindale, London (CPHL). Phage exhibiting unique
lytic spectra on these strains were selected for further lytic profiling against 80 different
clinical Campylobacter isolates at the Central Public Health Laboratories, Colindale,
London using the protocol defined by Frost et aL (1999). Phage isolates (n = 16)
exhibiting different lytic spectra from retail poultry (n = 7) and intestinal (n = 9) sources
are presented in Table 58.
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The phage isolated from broiler chicken caeca generally infected a greater number of
Campylobacter strains (mean = 39 ± 11 strains) than those isolated from retail poultry
(mean = 18 ± 6 strains). In addition, there was a greater similarity between the lytic
profiles of phage isolated from retail chicken compared with broiler caeca. Analysis of
the lytic profiles from the retail chicken phage isolates revealed that 18/80 (23%) of the
different phage-typed Campylobacter strains were infected in total. Of these eighteen
strains, thirteen (72%) were commonly lysed by all the retail chicken phage isolates.
This compared with only three (4.6%) commonly lysed from the total of 59 strains
infected by the broiler phage isolates. Three Campylobacter phage types (pT3, PT14 and
PT2S) were infected by all phage, regardless of the source. Conversely, fourteen phage
types were not infected by any of the phage isolates (pTS, PT7, PT20, PT22, PT23,
PT24, PT39, PT48, PTS7, PT60, PT67, PT7S, PT77 and PT78).
5.1.6 Populations of aerobic, anaerobic and mlcroaerobic organisms in the
chicken caeca.
To investigate the possibility of other bacterial populations affecting the colonisation of
Campylobacter or the presence of bacteriophage, the total aerobic, anaerobic and
microaerobic counts of the caecal contents were determined. Enumeration was
performed using the methods endorsed by the Steering Group Report on the
Microbiological Safety of Food (2.11.7). Briefly, this consisted of spread-plating serial
dilutions of caecal suspensions
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PT PTcode Fi0 F11 F19 F2i F7 F9 F20 C1 C2 C3 C4 CS C6 C7 CB C9
1 1010 sci sci sci sci sci sci
2 3156 sci sci sci sci +1'1' sci sci
3 DEFF sci <sci <sci <sci sci sci sci sci +++ +++ sci <sci sci sd sci sci
4 FEB9 s s s s sci s s sci <sci 1'1'+ sci s sd sci sci sci
5 1A98
6 DC38 sci sci sd ++
7 1152
8 3014 <sci + + +++ <sd <set
9 DE38 sci sci <sci <sci <sci <sci <sci sci sOl
10 1C39 sci sci sci 1'+
11 FF5F sci sci sci sci
12 317E sci <sci <sci sci +++ sci sci
13 FEFF sci sci sci sci sci sci sd sci +1'+ +1'1' <sd sci sci sci sci sd
14 FFFF sd sd sci sci sci sci sci sci <sci <sci sci sci sci sci sd sci
15 DC98 sci sci sci sd +1'
16 FE99 sci sci +++ +++ sci <sci sci sci sci
17 3056 sci sci sci sci ++1' sci sci
18 3116 sci sci sci sci +++ sci sci
19 3FFF sci sci sci sci sci sci sci sci sci sci
20 DC18
21 1030
22 1A90
23 1C90
24 3016
25 FFBD sci sci sci sci sci sci sci sci sci sci sci sci sci sci sci sci
26 FC99 sci +1'+ sci <sci sci ++
27 FCDB sci +1'1' ++1' sci 1'1' sci sci
28 FFFE sci sci sci sci sci sd s sci s s
29 1012 sci sci sci sci
30 FF78 1'1'1' sci <sd 10 <sci sd <sci
31 DEBD sci sci sd sci sci sd sci + +1'+ sci <sci sci +
32 3152 sci sci sci sci <sci sci sci
33 DEB9 sci sci sci sci sci sci sci 1'+ <sci sci sci sci ++
34 1A99 sci ++ sci sci ++
35 DE99 sci sci sci <sci
36 DE98 1'1' +++ +++ 1'++ sci <sci
37 FDFF s s s s <sci s s +1'+ <sci II
38 DC99 ++ ++ +1' sci sci +1' <sci +
39 3114
40 DEB8 +++ ++1' +++ +++ sci <sci
41 1C98 sci sci sci ++
42 1091 <sci sci sci ++ 1'1' ++ +++ +
43 1898 sci + ++
44 1052 sci <sci sd sci ++
45 1011 ++ sci sci sci ++ sci <sci
46 3FFE <sci <sci <sci <sci sci sci sci sci +++ +++ sci sci sci sci sci
47 FSFF sci sci sci sci sci sci sci
48 DeB8
49 1098 ++ sci sci +
50 1AB8 sci sci sci
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51 1C18
52 1C99 sCi sCi sCi sCi ++
53 3FDF sCi scI sCi sci sci sci sci sci sci sci
54 DCDB +++ +++ +++ +++
55 DDFA sci scI sCi sci sci <sci <sci <sci sci sci
56 FF7E sci sci +++ +++ <sci ++ <sci sci sci
57 1018
58 1899 +++ ++ ++ +++
59 1090 +
60 1810
61 1AB9 sci sci +++ <sci <sci <sci sci
62 1EB9 sci +++ sci sci "t+
63 1E98 sCi sci <sci ++
64 1EB8 sci ++ <sci sci +
65 FFDF +++ +++ +++ +++ sci sci +++ sCI sci sci sci +++ <sci sci sci
66 DEDS sci +++ +++ +++ +++ sci sci
67 1C10
68 3BDF ++ sci sci sci ++ +++ sci IIcI sci +
69 1031 sci +++ +++ +++ sci +++ +++ sci sci
70 DCDA sci c+++ +++ +++ sci ++ sci scI,,,
71 DEFS sci sci sci sci + sci sci sel + <sci sci + sci ++ +++
72 FD38 sci <$cl Sel ++
73 1C30 Sel +++ +++ +
74 1811 sci sci sci sci sci sci ++
75 1E99
76 3EFF sci sci <sci sci sci sci sci sci
rt DE18
76 DC19
79 F57E sci sci sci sci +++ sci scI
80 FD3C sci <sci sel +
KEY
s shadow lysis
+ 10-25 plaques
++ 25-50 plaques
+++ 50-100 plaques
<slcw <sci (weak)
sci semi-confluent lysis
<cl slightly less than confluent lysis
cl confluent lysis
Table 58. Lytic spectra of (F)ood and (C)aeca phage isolates.
Table showing the different lytic activity of seven phage isolated from chicken and nine
phage isolated from broiler chicken caeca against eighty human Campylobaeter isolates
exhibiting different phage types (PT).
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onto Plate Count Agar (2.3.1.8) and incubating for 24 - 48 h under the different
atmospheric conditions. The total aerobic population remained relatively stable between
different birds from the various farms in the survey (mean colonisation = loglO7.4 ± 0.6
cfu g-l caecal contents). However, the microaerobic and anaerobic counts were more
variable with mean colonisation levels recorded as loglO7.5 ± 2.4 and IOglO8.9 ± 2.1 cfu
g-t caecal contents respectively. No association between either the aerobic, anaerobic or
microaerobic populations with Campylobacter or phage could be discerned.
5.1.7 Protease activity in the chicken caeca
Preliminary investigations indicated that the skin and caecal contents of birds examined
in a previous study contained a ultra-filtratable agent capable of inhibiting the growth of
Campylobacter on lawns in a concentration-dependent manner. Serial dilution of the
filtrate failed to result in the formation of isolated plaques on Campylobacter lawns using
the surface droplet technique (Salama et aL, 1990a) suggesting the agent responsible for
the inhibition of growth was not a bacteriophage. Further investigations revealed this
agent was inactive after 48 h storage at 4°C, after one freeze-thaw cycle at -20°C or after
treatment with Proteinase K. Moreover, the inhibitory activity was eliminated after
incubation with 4-amidino-phenyl-methane-sulfonyl fluoride (APMSF, a specific
irreversible serine proteinase inhibitor) but not when incubated with inhibitors of other
protease classes such as EDTA (metallo proteases) or E64 (cysteine proteases). To
determine if Campylobacter populations in the chicken caeca could be correlated with
protease activity, the EnzChek® kit (2.11.10) was used to determine the total relative
protease activity in caecal filtrates. This kit is based on the protease-catalysed hydrolysis
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of a casein protein substrate labelled with green fluorescent dye (BODIPY@ FL). Once
the dye is released, an increase in fluorescence is recorded which is proportional to the
total protease activity in a sample. The protease activity measured from the caecal
contents of the chickens was highly variable with samples producing fluorescence counts
ranging from 12,453 to 154,173. As the variety and quantity of each protease in the
chicken caeca was unknown, specific units of protease activity could not be determined
and thus the fluorescence of each sample can only be used as a guide to relative total
protease activity. A reading of 500 fluorescence units was recorded for 5 p,g mrl of
trypsin on a standard curve prepared and measured at the same time as the caecal
samples. However, high fluorescence counts (and therefore protease activity) could not
be correlated with the presence or absence of detectable Campylobacter tells. None of
the caecal contents in the present study contained any ultra-filtratable agent capable of
inhibiting Campylobacter growth using the surface droplet technique.
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5.2 DISCUSSION
Previous studies have shown that there is a high prevalence of Campylobacter in broiler
chicken flocks (Humphrey et al., 1993; Evans and Sayers, 2000; Newell and
Wagenaar, 2000) which are able to survive abattoir processing and contaminate retail
products (Newell et al., 2001). The present study demonstrates that Campylobacter
bacteriophage can also survive processing and are recoverable from whole commercial
chicken carcasses. Campylobacter was detected on 24% of products surveyed in this
study which is lower than recent published values in the UK (Kramer et aL, 2000;
Jorgensen et aL, 2002). The wide variation in the Campylobacter positivity of carcasses
from different retailers emphasises the need for representative sampling to obtain
accurate data on the prevalence of this bacterium on retail poultry meat.
Bacteriophage are obligate intracellular parasites, and thus are likely to be present on
chicken products which also harbour a greater number and diversity of their hosts. It was
interesting that samples from the poultry producer supplying the highest number of
Campylobacter-positive carcasses did not harbour any recoverable phage and the reason
for this is unclear. Certain Campylobacter fla types are known to survive abattoir
processing better than others (Newell et aL, 2001) and this may also be case for their
associated phage. This is supported by data from Chapter 3 which demonstrates the
variability in survival of phage isolates on the surface of experimentally inoculated
chicken skin. This may assist in explaining the different characteristics (e.g. host range)
of the phage isolated from retail poultry compared with those from other sources. It was
also important to note that bacteriophage isolated from broiler chicken caeca were able to
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infect a greater number of Campylobacter strains than those isolated from retail chicken
portions. Considering the overall aims of this project, efforts to isolate bacteriophage of
potential therapeutic benefit at the farm level are probably best focussed on the chicken
gastrointestinal tract. However, the ability of bacteriophage to remain viable on retail
chicken products would become important if phage were to be applied as a post-
processing treatment. This is explored further in Chapter 6.
Although the presence of Campylobacter and their phage in the chicken intestine has
been known for some time (Grajewski et aL, 1985; Salama et al., 1989; Sails et al.,
1998) there has never been any attempt to correlate naturally-occurring populations of
the two in commercial broiler chickens. The results from the present study suggest that
the Campylobacter population of the chicken caecum is generally lower when phage are
also present. Indeed, 29/41 phage positive chickens harboured Campylobacter below
detectable limits. The wide range of bacteriophage titres recorded in the caecum may
reflect the availability of hosts due to the dynamic nature of Campylobacter populations
in the chicken gut. Previous studies with Salmonella typhi and E. coli have shown that
phage do not always eliminate their prey (Alexander, 1981). Often in these cases, the
titres of predator and prey increase and decline with characteristic out of phase
population oscillations (Van Den Ende, 1973). This phenomenon has also been
described in predatory protozoa (Van Den Ende, 1973) and Bdellovibrio (Alexander,
1981). Providing such interactions occur between phage and Campylobacter in the
chicken gut, the numbers of phage recovered would vary according to which stage of the
oscillatory cycle the sample was taken from.
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There was considerable variation in the macrorestriction profiles produced by PFGE of
SmaI digested genomic DNA observed from different birds from the same and different
farms. This supports previous studies which emphasise the genetic diversity of this
bacterium even in this specialised niche (Newell and Wagenaar, 2000).
The high frequency of plaques from which phage could not be propagated was
interesting. Gram negative bacterial pathogens such as Bdellovibrio ssp. were unlikely to
be the cause of this phenomenon as they could not be detected using peR with genus-
specific oligonucleotide primer sets and were not visible by electron microscopy.
Another possible explanation is the production of a bacteriocin by a bacterial
contaminant. However, this is also unlikely as the centrifugation and filtration steps in
the phage isolation protocol should have been sufficient to remove these bacteria.
Moreover, no colonies were observed at the centre of the plaques when visualised under a
dissecting microscope. Potentially, the phage themselves may be defective in some part
of their life cycle and may only produce components capable of lysis but not complete
replication. Ultimately, this study was unable to determine what was responsible for this
phenomenon, which would make an interesting area of further research.
An interesting observation in preliminary experiments led to an investigation of a
possible lytic agent present in the skin and caeca of broiler chickens. Several studies
have shown that the chicken gut may contain organisms which are inhibitory to
Campyiobacler growth (Humphrey et at, 1989), only a fraction of which have been
characterised to any degree (Mead, 2000). This inhibition is usually due to production of
secondary metabolites or direct competition for colonisation sites in the gut (Mead,
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2000). In the present study, the total aerobic, anaerobic or microaerobic populations
showed no association with Campylobacter or phage populations. Previous studies
suggested that filtered caecal suspensions sometimes have anti-Campylobacter properties
(Humphrey et aL, 1989). However, despite these preliminary findings, dilutions of
filtered caecal suspensions in the present study failed to demonstrate any lytic activity
when used to inoculate lawns ofPT14. This indicates the 'hit or miss' nature of this lytic
phenomenon. The total protease activity of the broiler caeca was measured as this was
thought to be one possible mechanism of Campylobacter inhibition, not necessarily
resulting in cell lysis. The relative protease activity in the caeca varied appreciably from
bird to bird but no campylobactericidal activity was observed in the caecal suspension
filtrates (other than that caused by phage infection).
The most significant association between populations was with the reduced presence, or
even absence, of Campylobacter in caeca also harbouring bacteriophage. It should be
noted that only a small number of Campylobacter strains were actually sensitive to
contemporaneous bacteriophage isolates. This may be a consequence of: bias towards
recovery of certain phage and Campylobacter strains; changes in host susceptibility upon
subculture or a non-susceptible Campylobacter strain displacing the original host.
Another explanation would be that a proportion of the Campylobacter population became
resistant due to exposure to the phage. Resistance to phage infection would confer a
competitive advantage on the mutant and allow a greater colonisation of the chicken gut.
In tum, this would increase the probability of isolating a Campylobacter resistant to
infection by phage in the same sample. Previous studies have shown phage resistant
mutants of E. coli to be less virulent and less efficient colonisers than the wild type
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(Smith and Huggins, 1983). This is also supported by data in Chapter 8 and may partly
explain why fewer campylobacters were isolated from caeca also containing phage.
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CHAPTER6
APPLICATION OF HOST-SPECIFIC BACTERIOPHAGE TO THE
SURFACE OF CHICKEN SKIN LEADS TO A REDUCTION IN
RECOVERY OF CAMPYLOBACTER
6.0 INTRODUCTION
Campylobacters can be frequently isolated from the feathers and skin of broiler chickens
(Berrang et aL, 2000). Reducing this contamination would be a step towards reducing
Campylobacter presence on retail poultry meat. One common method of reducing broiler
carcass contamination involves the use of hypochlorite in scalding water carcass washes and
chilled water tanks. Previous studies have shown this treatment to be ineffective in
substantially reducing the numbers of human pathogens, including Campylobacter,
associated with the chicken skin when used under standard commercial operating conditions
(Whyte et at, 2001). Increasing the concentration of hypochlorite does marginally increase
its efficacy, but reduces the quality of the end product which is unacceptable to consumers.
Host-specific bacteriophage have been used previously in the treatment of E. coli infections
in piglets (Smith and Huggins, 1983) and more recently in Enterococcus (Biswas et at,
2002) and Vibrio (Cerveny et at, 2002) infections. Their efficacy in experimental enteric
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and systemic infections has already been demonstrated. Additionally, other studies have
shown that the spoilage of beef by Pseudomonas ssp. can be reduced by the application of
phage (Greer, 1986). However, the ability of host-specific phage to reduce the presence ofa
food-borne pathogen which is not actively replicating on the surface of food has yet to be
investigated. This study assessed the ability of specific bacteriophage to reduce the numbers
of Campylobacter on experimentally inoculated chicken skin.
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6.1 RESULTS
6.1.1 Survival of CampylobacterNCTC 12662 on the surface of chicken skin
The survival of Campylobacter bacteriophage +2 on the surface of chicken skin stored at
4°C and -20°C was determined in Chapter 3. In order to gauge the effect of phage on
populations of their hosts when stored under these conditions, the present study examined
the recovery of Campylobacter jejuni NCTC 12662 from the surface of chicken skin.
The caecal contents and skin of broiler chicks reared to be free of campylobacters were
confirmed Compylobocter-negative by the direct plating of samples onto modified
charcoal cefoperazone deoxycholate agar (mCCDA, 2.3.1.4). Sections of chicken skin (2
cm2) from these birds (2.6.8) were inoculated with 10glO6.0 cfu Campylobacter and
individually stored under fresh (4°C) and frozen (-20°C) conditions over a ten day period.
Triplicate skin sections were removed from each storage condition at 24 h intervals for
the enumeration of Campylobacter. Enumeration was performed by stomaching the skin
in MRD (20 ml) and spread-plating serial dilutions of the stomachate onto triplicate
mCCDA plates. Representatives of typical Campylobacter colonies from each sample
were sub-cultured onto Columbia blood agar plates (CBA, 2.3.1.1) before Gram staining
to con finn typical Campylobacter cell morphology (2.3.4.1).
The recovery of C. jejuni NCTC 12662 over ten days under each storage condition is
presented in Figure 6A. Campylobacter recovery at the initial time point was identical
OOglOSA cfu per section of skin) for samples stored under both conditions. However,
recovery from the fresh samples continued to gradually decline to reach a base level of
10glO5.1 ± 0.04 cfu at the end of the experiment. In contrast, the freeze-thaw treatment
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Figure 6A. Recovery of Campylobacter from chicken skin stored at
different temperatures.
Graph showing the recovery of C. jejuni NCTC 12662 from the surface of chicken skin
inoculated with 106 cfu and stored at 4°C ( • ) and -20°C(D) over a ten day period.
Recovery is presented as the mean IOglOcfu ± SD. These results are based on three
replicates.
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of the skin resulted in a fall in Campylobaeter recovery to 10glO4.2 ± 0.08 cfu on day two
compared with logto 5.4 ± 0.02 cfu for the fresh chicken skin at the same time point. In
parallel to the pattern of recovery recorded for phage from skin stored at -20°C (Chapter
3), the level of Campylobaeter recovery remained at approximately the same level for the
rest of the experiment with only a slight decline to 10giO4.1 ± 0.01 cfu on day ten.
6.1.2 Activity of phage inoculated onto chicken skin artificially
contaminated with Campylobacter
Once the independent recovery and survival of Campylobaeter and bacteriophage on
chicken skin was established, the ability of phage ~2 to reduce the number of recoverable
Campylobaeter cells on the surface of inoculated chicken skin under these conditions was
determined. Sections of chicken skin (2 cm2) from birds reared to be free of
Campylobacter (2.6.8) were inoculated with a matrix of phage and host titre
combinations (Table 6A) in triplicate prior to incubation at 4°C or -20°C.
Campylobacters and bacteriophage were recovered from the chicken skin one, three and
five days after inoculation using the methods described in section 2.6.9. Chicken skin
sections each inoculated with either bacteriophage or Campylobaeter served as positive
controls for the experimental recovery of each. Uninoculated chicken skin was used as a
negative control. The recovery of Campylobaeter from the surface of chicken skin
following treatment with different titres of bacteriophage is presented in Table 6B.
Recovery is shown as mean 10glOCampylobaeter cfu ± standard deviation for all
treatments compared with control inoculations. The statistical significance of phage
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Bacterionhaze inoculum (pfu)
~~
107 105 104~~
_g e
106 10 0.1
..s = 0.01t~ 104 1000 10 1
~ .a 102 100000 1000 10
Table 6A. Bacteriophage and Campy/obaeter inoculation matrix
Matrix showing the combinations of bacteriophage and Campy/obaeter titres used to
inoculate chicken skin. The grid shows the multiplicity of infection (MOl) for each
combination.
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treatment (2.12) on Campylobacter numbers was assessed using the one-tailed T-test with
a confidence limit of 95%.
With the lowest phage titre applied (103 pfu) there was no statistically significant
reduction in the numbers of Campylobacter recovered from fresh or frozen chicken skin
compared with the control. Campylobacter recovery from controls inoculated with 106
and 10" cfu remained consistent for the course of the experiment with recovery ranging
from 10glO5.2 - 5.4 cfu (106 cfu inoculation) and 10glO3.1 - 3.4 cfu (104 inoculation). In
all cases of the highest titre phage treatment (10' pfu) there was a significant reduction in
Campylobacter recovery by 10glO1.1 - 1.2 cfu (106 inoculation) and 10glO1.1 - 1.3 cfu
(104 inoculation). Analysis of the data using a Student T-test showed that the reduction
in numbers of recovered campylobacters was significant (P<O.OOOI). The difference in
recovery was even greater in the frozen chicken skin samples where the application of
10' pfu resulted in a reduction of 10glO2.3 and 2.5 cfu compared with the controls for
Campylobacter inoculations of 106 and 104 cfu respectively. These reductions were also
found to be significant (P<O.OOOl) using a one-tailed T-test.
6.1.3 Properties of recovered Campylobacters
One explanation for the recovery of Campylobacter cells from phage-treated skin could
be the in situ selection for a sub-population of resistant bacteria. To determine if this was the
case, campylobacters recovered from phage-treated and control chicken skin sections
were used to produce lawns on NZCYM plates (2.3.1.7). These lawns were then re-
inoculated with decimal dilutions of the phage ~2 suspension used in the original skin
inoculation using the surface droplet technique (2.3.6.4). All of the campylobacters
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recovered from phage-treated and control chicken skin remained sensitive to cP2. The
titres obtained on lawns of these bacteria did not differ significantly from those obtained
on the original host strain (P = 0.2). The PFGE patterns produced by SmaI digestion of
the genomic DNAs of the recovered Campylobacter strains (2.5.9.1) were
indistinguishable from the inoculated strain (Fig. 6B).
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Figure 68. Macrorestriction profiles of Campylobacter from phage treated
chicken skin
A 1% agarose gel showing the macrorestriction profiles of whole genome preparations
from Campylobacter colonies recovered from chicken skin treated with bacteriophage
(AI - A6). DNA digestion was performed using endonuclease SmaI prior to resolution
of genomic fragments by PFGE. The profiles of campylobacters recovered from skin not
treated with bacteriophage (B1 - B6) and from campylobacters not inoculated onto
chicken skin (Cl - C3) are also shown. Lambda concatomer size markers (Kbp) are
presented to the far right of the gel.
181
Ch ter6
6.2 DISCUSSION
Recent studies have demonstrated the widespread contamination of retail poultry
products with Campylobacter (Jacobs-Reitsma, 2000; Kramer et al., 2000; Berrang et
ai; 2001; Jorgensen et al.; 2002). Investigations into the survival of clinical
Campylobacter isolates stored in suspension at different temperatures noted a 10glO3.0
cfu ml" drop in viable cells upon freezing (Chan et al., 2001). Data from the present
study suggests this may not be the case for campylobacters on the surface of chicken skin
where the reduction was closer to 10gIO1.0 or 10glO2.0 for skin stored respectively at 4°C
and -20°C. It is therefore likely that chicken skin has a protective effect on the
Campylobacter cells. The protective effect may extend to different types of chemical and
physical carcass decontamination methods (Humphrey and Lanning, 1987). This is
further supported by studies with Salmonella which suggested the chicken skin provides
an environment conferring non-specific protection to bacteria from potentially harmful
treatments (Humphrey and Lanning, 1987; Whyte et aL, 2001). Such protection is
most likely to stem from the presence of feather follicles and folds on the epidermal
surface. Together with naturally-occurring oils and fats, this may offer some protection
from ice crystal formation which is known to be a major cause of damage to cells
undergoing the freezing process. Antecedent reports suggest that chicken carcasses can
be contaminated with up to 109 cfu Campylobacter (Jorgensen et al.; 2002). Since the
infective dose of Campylobacter for humans is thought to be ~ 500 cells (Black et al.,
1988), the fact that enhanced survival of Campylobacter on chicken skin was occurring
under these conditions is of importance to food safety.
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Supporting the data collated in Chapter 3, the present study demonstrated the ability of
phage to survive on the surface of chicken skin for a period of at least ten days when
stored under either fresh or frozen conditions. This is important when considering the
potential efficacy and environmental impact of phage biocontrol on animals that carry
Campylobacter. Phage of Campylobacter along with their hosts can potentially survive
on the retail product until well after its prescribed shelf life. This may have an important
influence on the opinions of the general public should Campylobacter phage therapy in
poultry be commercialized.
A high titre of Compyloboeter-specific bacteriophage applied to the surface of chicken
skin inoculated with Campylobacter significantly reduced the number of recoverable host
cells. This reduction was consistent over the course of the experiment with a fall in
recovery of 10glO1.0 cfu for inoculated skin stored at 4°C. A larger reduction would be
desirable if this practice was to yield commercial benefit in the future as a sole control
measure. However, in its current state it could contribute to the overall reduction when
applied with other decontamination practices. There was a significantly greater reduction
in Campylobacter recovery associated with the combination of freezing and phage
treatment. Countries such as Iceland routinely freeze Campylobacter positive carcasses
in an attempt to reduce contamination. Combining this freezing with phage treatment
could result in further reductions in Campylobacter prevalence on broiler carcasses.
It is generally accepted that campylobacters do not replicate when incubated at 4°C. Our
data support this since the number of campylobacters which could be recovered from the
surface of the skin stored at this temperature fell over time. There was also no increase in
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bacteriophage numbers on any of the chicken skin samples inoculated with
Campylobacter. Recovery of bacteriophage on all of the samples declined with time but
did not differ significantly from the control. In the absence of active replication, the
phage are unlikely to reduce the number of Campylobacter cells in situ. Consequently
the most likely explanation for the observed reduction in Campylobacter recovery is that
upon inoculation a proportion of the phage successfully adsorb to the surface of the
bacteria but do not replicate until the bacterium itself increases its metabolic activity.
This is supported by the data in Chapter 4 showing there is no reduction in either
bacteriophage or Campylobacter titre when the phage is mixed with a non-permissive
host in suspension, suggesting that non-specific adsorption or lysis by the phage is not
taking place. This has implications for using phage as decontaminating agents as only
populations of specifically susceptible bacteria would be affected. Effective cocktails of
broad host range phage would be required for this technique to be practically applicable.
The campylobacters recovered following phage treatment of the chicken skin were
diluted before placing them under conditions that will allow growth. This procedure
enabled the enumeration of the surviving bacteria. Under these circumstances any
bacterial cells with phage adsorbed would perish upon growth but the viral progeny
resulting from such an infection could not easily disseminate to other host bacteria.
However, in a situation where the phage-adsorbed bacteria are part of a larger, localized
population of host cells, the phage progeny could initiate new infection cycles due to the
propinquity of susceptible cells. If the conditions permissive for growth were a human or
animal gut, then the initial viral infective dose would be reduced with the prospect of
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further control of the host bacterium by the initiation of secondary and tertiary infection
cycles.
Bacterial resistance to bacteriophage infection can be readily demonstrated in the
laboratory and is postulated to be a major drawback for the use of phage in biocontrol.
There was no evidence of resistance arising in the Campylobacter recovered following
phage treatment in this study. The campylobacters recovered were confirmed as being
genotypically identical to the inoculation strain by PFGE of SmaI restriction fragments of
genomic DNA. However, in the absence of replication these studies do not rule out the
generation of new mutational events selected post-treatment.
In conclusion this study has demonstrated the ability of a characterized NCTC
Campylobacter and its bacteriophage predator to survive independently on the surface of
chicken skin. Phage inoculated onto the surface of skin contaminated with
Campylobacter exhibit a control effect even in the absence of host growth. Further
development of this study could lead to the use of bacteriophage in connection with other
measures to control chicken contaminated with Campylobacter.
185
CHAPTER7
THE EFFECT OF CAMPYLOBACTER MEMBRANE VESICLES ON
THE ADSORPTION AND REPLICATION OF BACTERIOPHAGE
7.0 INTRODUCTION
Many different genera of Gram negative bacteria have the potential to produce membrane
vesicles (MV) at some point during their lifecycle (Mayrand and Grenier, 1989; Zhou
et aL, 1998). During normal bacterial growth the rigid cell wall must be broken down,
extended and then re-annealed. This process primarily consists of digesting
peptidoglycan in the cell wall which liberates muramyl peptides into the periplasmic
space. These peptides are unable to diffuse out of the cell which consequently leads to
their accumulation in the periplasm, imposing a turgor pressure on the outer membrane
(Zhou et aL, 1998). If this pressure is not alleviated, the outer membrane begins to
hemeate (bleb) and finally releases a MV from the cell (Fig. 7A).
MVs retain many of the surface structures of the cells from which they emanate, though
their exact composition depends on the site at which the vesicle is most likely to form
(Beveridge, 1999). Once liberated from the cell, mature MVs, once liberated from the
cell, may interact with other Gram negative or Gram positive species in several ways.
A 8 c
Figure 7A. Origin of extracellular membrane vesicles in Gram-negative
bacteria
During growth, cell wall is excised and released from the peptidoglycan. The released
muramyl peptides create a turgor pressure on the outer membrane. If the pressure is not
alleviated by uptake of the muramyl peptides, the blebs will continue to grow and
ultimately be shed into the growth medium. A: Idealized cross-section of Gram-negative
envelope showing cytoplasmic membrane, periplasmic spaces, peptidoglycan and outer
membrane. B: Turnover of peptidoglycan and initial herniation of outer membrane. C:
Released vesicle containing components of outer membrane, periplasmic space and
peptidoglycan components. CM, cytoplasmic membrane; PG, peptidoglycan; PP,
periplasmic proteins; OM, outer membrane; LPS, lipopolysaccharide. Taken from Zhou
et al. (1999).
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The vesicles cannot fuse with Gram positive bacteria as they do not possess an outer
membrane. Consequently, the vesicles often rupture and release their contents directly
into the Gram positive cell wall. The contents of MVs usually include periplasmic
proteins which are entrapped in their lumen during formation. Some of these proteins,
e.g. peptidoglycan hydrolases, can cause direct damage to the Gram positive cell wall and
have been shown to cause death in specific circumstances (Li et al.; 1998).
Fusion ofMVs with Gram negative cells offers a greater range of possible outcomes. As
with Gram positive cells, peptidoglycan hydrolases may attack the cell wall should the
target cell not possess the appropriate homologous regulatory systems. Alternatively,
MV periplasmic enzymes which inactivate or digest antibiotics (e.g. p-lactamase) may
provide the recipient cell with a form of 'passive resistance' to antimicrobial agents
without acquisition of resistance genes (Beveridge, 1999).
As MVs are predominantly formed from the Gram negative outer membrane they should
possess many of the surface receptors necessary for bacteriophage adsorption. Bacteria
may produce MVs which could act as molecular decoys, providing receptors in an
attempt to protect the cell from antibiotics or phage. Campylobacters are known to
produce MVs with components reflecting those present in the outer membrane (Blaser et
aL,1983). This study sought to establish if bacteriophage could adsorb to MVs produced
by several Campylobacter species and whether binding impacted on the ability of phage
to replicate in the host.
,,""\.
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7.1 RESULTS
7.1.1 Analysis of Campylobacter membrane vesicle proteins
As a precursor to studying the effect of membrane vesicles on the adsorption of phage to
host cells, Campylobacter MVs were prepared and characterised with respect to their
biochemical, morphological and immunological properties. MVs were purified from
overnight Campylobacter broth cultures using two protocols (A and B). Protocol A
(2.8.1) consisted of sequential filtration, precipitation and centrifugation steps according
to the method of (Zbou et aL, 1998). Protocol B (2.8.2) involved centrifugation of a
culture filtrate through a 30 kDa molecular size cut off filter as a modification of the
method used by (Mayrand and Grenier, 1989). . The total protein content of each
vesicle preparation was determined using the BCA assay (pierce Biotech, 2.4.1.2). A
comparison of the total protein content of ten vesicle preparations from C. jejuni NCTC
12662 using protocols A and B is presented in Table 7A. The total quantity of protein in
the vesicle preparations of the present study were generally inferior to those of other
workers (Mayrand and Grenier, 1989). A possible reason for this is the use of
quantitation assays which tend to overestimate the protein content in membranes (Zhou
et ai; 1998). Vesicles prepared using protocol A contained an average of 2 mg ml"
protein which compared favourably with the 0.4 mg ml" average using protocol B.
In order to determine the profile of proteins present in the MVs, the vesicle preparations
were subjected to SOS-PAGE (2.4.2) alongside preparations of outer membrane proteins
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Preparation Method A Method B
1 1.30 0.50
2 2.10 0.50
3 2.30 0.31
4 2.00 0.30
5 1.80 0.27
6 2.10 0.29
7 2.50 0.34
8 1.60 0.61
9 1.90 0.54
10 2.30 0.32
Mean 2.0±0.4 0.4 ± 0.1
Table 7A. Protein content of vesicle preparations.
Table showing the total protein content of ten membrane vesicle suspensions prepared
from C. jejuni NCTC 12662 using a molecular filtration technique (method A) and a
precipitation technique (method B). Protein concentrations were measured using the
BCA assay kit (Pierce Biotechnology) and are presented as mg ml". Mean protein
content ± SD are presented at the bottom of the table.
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(2.9) and whole cells from the same strain used to prepare the vesicles. PAGE gels were
initially stained with Coomassie blue (2.4.3.1) followed by silver staining (2.4.3.2) to
detect differences in glycoprotein content. The protein profiles of vesicles prepared from
C. jejuni NCTC 12662 using protocol A following Coomassie blue and silver staining are
presented in Figure 7B. Protein profiles of vesicles prepared from the same strain using
protocol B are presented in Figure 7C.
Both Coomassie and silver staining revealed that several proteins were present in both the
vesicle and outer membrane preparations at a higher concentration than others. Based on
previous studies, a band present at approximately 42 kDa is likely to be the major outer
membrane protein (Blaser et aL, 1983). Likewise, bands present at 62 kDa are likely to
be flagellin. Significantly fewer protein bands were observed for vesicles prepared using
method B compared with method A. However, this is probably a reflection of the
significant differences in total protein concentrations between vesicles prepared using the
different methods. This is supported by the presence of weaker MOMP and flagellin
bands in method B vesicle preparations compared with their method A counterparts.
With the aim of confirming the origin of the vesicles, polyclonal rabbit antisera raised
against acid-glycine extractable proteins from C. jejuni was used in on-grid Immunogold
labelling (2.7.1). Examination of these grids by transmission electron microscopy
revealed that gold particles were clearly associated with MVs (Fig. 7C). Immunoblots
(performed by Dr. P. Connerton) using the same antisera against preparations of
Campy/obacler whole cells, vesicles and outer membranes (2.4.5) confirmed antibody
binding to proteins present in all three (Fig. 7C). This indicated the MVs contained
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Figure 78. Protein profiles of outer membranes, membrane vesicles and
whole cells of Campy/obacter.
A 12% SDS-PAGE gel showing the protein profiles of whole cells (1); outer membrane
(2) and membrane vesicle (3) preparations following Coomassie blue staining. Lane 4
shows the appearance of the membrane vesicle preparation following silver staining.
Molecular weight markers are shown on the left hand side of the figure.
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Figure 7C. Immunogold staining of Campylobacter membrane vesicles
The top half of the figure shows two electron micrographs of membrane vesicles from
Campylobacter jejuni NCTC 12662 stained with gold particles (A and B). The
membrane vesicles were incubated with antisera raised from a rabbit against a
Campylobacter acid-glycine extractable proteins (anti-GE). Labelling was then
performed using gold particles conjugated to goat anti-rabbit sera Bar = 200 nm. The
lower half of the figure outer membrane (1); membrane vesicle (2) and whole cell (3)
preparations of C. jejuni NCTC 12662 resolved on a 10% SDS-PAGE gel stained with
Coomassie blue (C) and immunoblotted using anti-GE antisera (D).
66-
45 - .,
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structural epitopes recognised by polyclonal anti-Campylobacter sera from rabbits,
confirming that they originated from campylobacters.
7.1.2 Adsorption of bacteriophage to membrane vesicles
In order to determine whether bacteriophage bound to membrane vesicles from
Campylobacter, phage were mixed with separate MY preparations from campylobacters
either permissive or non-permissive to infection (2.10.3). Following a 30 min adsorption
period, an aliquot (10 ul) of MV suspension was placed on a pioloform-coated copper
grid prior to staining with uranyl acetate and observation using a JOEL CXl00
transmission electron microscope. Electron micrographs showing MV preparations and
bacteriophage are presented in Figure 7D. Electron microscopy revealed that MVs from
Campylobacter appeared to be morphologically similar to those observed for other Gram
negative species (Li et al., 1998; Beveridge, 1999). The mean diameter of the MVs was
590 om ± 190 (n = 35) which is slightly larger than upper size range of 500 om reported
from previous work on other Gram negative species (Mayrand and Grenier, 1989).
Campylobacter phage were observed associating with membrane vesicles of their host
and possibly penetrating the vesicle wall to inject their genetic material into the lumen
(Fig. 7D). However, phage were not observed adsorbing to the surface of vesicles
purified from Campylobacter strains not permissive to infection.
Subsequent to these findings, a series of in vitro experiments were performed in order to
gauge the possible impact ofMVs on phage adsorption. MYs were prepared from three
C.jejuni strains (NCTC 12660, NCTC 12661, NCTC 12662); one C. coli strain (NCTC
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Figure 70. Bacteriophage associated with membrane vesicles.
Electron micrographs showing the attachment of Campylobacter bacteriophage w2 to
membrane vesicles derived from C. jejuni NCTC 12662 PT14 (A); Unadsorbed and ghost
phage ofw3 (B); Phage w5 adsorbed and penetrating (white arrow) membrane vesicle
(C) and a purified vesicle preparation (D). Bar = 250 nm.
195
C ter 7
12666) and one C. lari strain (NCTC 11352) using the methods described previously
(2.8). All of the bacteriophage used in this experiment (cjI2,w2, w3, w4, w5, w8, wl0,
CP8) were known to infect the C. jejuni strains but not the C. coli or C. lari strains.
Aliquots (0.5 ml) of different phage (titre approximately 108 pfu ml") were added to 4.5
ml volumes of either whole cells (approximately 109 cfu ml"); whole cells plus vesicles;
vesicles only or diluent only (10 mM MgS04 or Nutrient broth No.2, NB2, 2.3.1.6). The
multiplicity of infection (MOl) was maintained at 0.01 for all phage and Campylobacter
combinations. These suspensions were then incubated aerobically in a static incubator at
42°C. Aliquots (1 ml) of these suspensions were taken at regular time intervals
throughout incubation and subjected to centrifugation at 40, 000 g for 60 min at 4°C in
order to pellet the vesicles. The titre of phage in the supernatant of each treatment group
was then determined using the surface droplet technique on a lawn of susceptible bacteria
(2.3.6.4).
The titre of all phage in the controls (diluent only) remained relatively stable, showing no
significant changes over the time courses. Adsorption to the 'host cell-only' and 'host
cell with vesicles' preparations was rapid with all phage except w5. Titres of phage in
the 'vesicle only' preparation resembled that of the diluent control and did not appear to
be influenced by the either of the protocols used to prepare the vesicles. This suggested
that either phage attachment to vesicles was a relatively rare event or that attachment was
reversible. Additionally, the number of free phage in the supernatant of 'whole cell
only' and 'whole cell plus vesicle' preparations was similar, suggesting whole cells were
responsible for the majority of phage adsorption taking place. Generally, the pattern of
phage adsorption observed for the different treatment groups did not vary appreciably
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between the various phage and susceptible host combinations used. All showed a 10gIO
0.7 - I.S pfu mrl fall in supernatant phage titre within 30 seconds of mixing with host
cells. The exception was for phage wS in which no significant adsorption to host C.
jejuni NCTC 12662 was observed (Fig. 7E). This phenomenon has also been observed
for Campylobacter phage ~S (Dr. R. Mole, unpublished data). Changing the diluent
medium (either 10 mM MgS04 or NB2) did not have any appreciable effect on the phage
adsorption time. A representative graph showing the attachment dynamics of phage w2
to vesicle and whole cell combinations of host strain C. jejuni NCTC 12662 is presented
in Figure 7E.
7.1.3 Replication of bacteriophage in the presence of membrane vesicles
The effect of membrane vesicles on the in vitro replication of bacteriophage was
determined using strains C. jejuni NCTC 12660, 12661 and 12662 with phage w2, wS
and ~2 (2.10.4). Whole cells were harvested from a one litre overnight culture by
centrifugation and washing thrice in NB2 prior to resuspension in 9 ml NB2. This cell
suspension was then divided into two 4.5 ml volumes. Vesicles were collected from the
supernatant of the overnight culture using the centrifugation and filtration technique
described previously (2.8.2) and made up to a total volume of 4.S ml with NB2. Aliquots
(1 ml) of phage suspension (titre approximately 108 pfu ml") were then each mixed with
either the MV suspension or one of the whole cell preparations. Following a IS min
adsorption period, the 'phage plus whole cell' suspension was briefly mixed with 4.S ml
of NB2 prior to transfer to 200 ml of NB2. The 'phage plus MV' suspension was
incubated in an identical fashion but was mixed with 4.5 ml of the 'uninfected'
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Figure 7E. Adsorption of bacteriophage to host cells in the presence of
membrane vesicles
Bacteriophage were mixed with suspensions of host cells (.); host cells plus membrane
vesicles ( • ); diluent only(0)and membrane vesicles only (0). These graphs show
the titre of bacteriophage in the supernatant of each suspension following centrifugation.
Graphs A and B show the respective adsorption of phage w5 and w2 to whole cell and
vesicle suspensions derived from propagating strain C. jejuni NCTC 12662 over a period
of 6 h. These results are based on three replicates.
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Campylobacter cell suspension prior to immediate transfer to 200 ml of NB2. All
suspensions were then incubated under microaerobic conditions at 42°C in a gyratory
platform incubator set to 100 rpm. Nutrient broth (9mI) containing 1 ml of phage
suspension was processed in an identical manner to the other suspensions and served as a
negative control for the experiments. Volumes (1 ml) were taken periodically from each
210 ml culture and subjected to centrifugation at 13, 000 g for five minutes.
Bacteriophage in the supernatant were enumerated on lawns of susceptible bacteria using
the surface droplet technique (2.3.6.4). Where applicable, bacterial cells in the pellets
following centrifugation were thrice washed in MRD (2.0.2) prior to enumeration on
charcoal agar (2.3.1.4).
As can be seen in Figure 7F, membrane vesicles had no significant effect on the in vitro
replication of phage w2 on C. jejuni NCTC 12662. A similar pattern was observed for
phage ,2 but phage w5 failed to demonstrate any appreciable increase in progeny over
the time course (Fig. 7F). There are two possible roles of MVs during phage replication
in batch culture. Firstly, MVs containing adsorbed phage may be able to initiate infection
following rapid re-fusion to susceptible host cells. Alternatively, adsorption to MVs may
be reversible in which case specific phage attachment to host cells would be rapid
following mixing with a susceptible host population (see Chapter 4).
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Figure 7F. Replication of bacteriophage in the presence of membrane
vesicles
Bacteriophage were mixed with suspensions of host cells (.); host cells plus membrane
vesicles (. ) or diluent only (0). These graphs show the titre of bacteriophage in the
supernatant of each suspension following centrifugation. Graphs A and B show the
adsorption of phage w5 and w2 respectively to whole cell and vesicle suspensions
derived from propagating strain C. jejuni NCTC 12662 over a period of 6 h.
These results are based on three replicates.
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7.2 DISCUSSION
The production of MVs by Campylobacter was perceived as a potential threat to the
efficacy of phage intervention to control populations of this bacterium in vivo. This is a
phenomenon not previously investigated by researchers with any other phage and host
models. Several Campylobacter species were shown to produce MVs as part of their
normal growth cycle in batch liquid culture. The protein profiles of these vesicles
revealed that most of the Campylobacter OM proteins were present in MVs. Additional
bands in the MY preparations were generally of a low molecular weight « 42 kDa) and
are likely to be periplasmic in origin as they were not observed in pure outer membrane
preparations. The membrane polarity and integrity of membrane vesicles is usually
maintained and as such many of the epitopes and receptor sites present on the bacterial
cell surface are mirrored in the vesicles which they devolve (Beveridge, 1999).
Immunogold staining along with western blotting confirmed the purified MVs originated
from Campylobacter cells. Electron microscopy also revealed that phage are able to
attach to MYs produced by Campylobacter strains susceptible to infection. However, no
such attachment was observed for phage mixed with non-host Campylobacter strains
suggesting such interactions are specific.
A series of in vitro studies demonstrated that, although phage adsorption to host cells was
rapid, the permanent attachment of virions to purified MV preparations was not
appreciable. Together with the electron microscopy data, this suggested that either
attachment to membrane vesicles did not occur frequently or that attachment was a
reversible process. Myovirus adsorption to the host cell is usually a two-step process,
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with the primary association between phage and host being a reversible event
(Ackermann and DuBow, 1987). Such reversible attachment to Campylobacter MVs
may arise from a paucity of receptors on the vesicle surface or their relative
inaccessibility. Phage such as K20 require the expression of multiple surface receptors
(both LPS and OmpF) before full adsorption can take place (Silverman and Benson,
1987). Additionally, MVs do not always exactly mirror the outer membrane composition
of the cells from which they originate. For example in Pseudomonas aeruginosa, where
MVs evolve from specific sites with a higher concentration of type B LPS. This leads to
vesicles with a highly skewed outer membrane composition containing no type ALPS
which is found relatively frequently on the parent cell (Beveridge, 1999). Such a system
of vesicle blebbing in C. jejuni may preclude irreversible adsorption of phage to MVs
should some of the necessary receptors be absent. However, without knowing the
receptor(s} for phage adsorption, this remains purely speculative.
As MVs did not appear to irreversibly bind phage, it was unsurprising that they had little
impact on phage replication in Campylobacter batch cultures. In vivo, phage will likely
be exposed to a number of biotic and abiotic barriers to their host of which the
experimenter has little control. The data presented in this study suggests that host-
derived membrane vesicles would not present a significant obstacle in the therapeutic use
of phage to reduce Campylobacter populations.
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CHAPTER8
THE ABILITY OF BACTERIOPHAGE TO CONTROL
CAMPYLOBACTER POPULATIONS IN THE BROILER CHICKEN
INTESTINE
8.0 INTRODUCTION
The potential of bacteriophage to treat bacterial infections was quickly realised following
their independent discovery by Twort (1915) and D' Herelle (1917). The first known
"phage therapy" study was undertaken by Bruynogbe and Maisin (1921) working on
staphylococcal skin infections. Although the results of this trial were promising, little
more was accomplished in this field during the subsequent years (Weber-Dabrowska et
aL,2000).
Interest in phage therapy was reignited in the 1930s, although during this time reports of
its efficacy were increasingly disparate. Even the very nature of bacteriophage became a
contentious issue with some believing an enzyme to be responsible for the bactericidal
properties observed (Eaton and Bayne-Jones, 1934). This may not be surprising as
components of the virion can demonstrate lysis of their hosts without the need for
replication (Nakagawa et aL, 1985; Loeffler et aL, 2001). The failure of some of the
early therapeutic phage interventions was due to a lack of understanding of viral biology.
Present-day virologists have extensively reviewed the problems encountered in early
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phage therapy trials (Kutter, 1997; Sulakvelidze et aL, 2001; Summers, 2001), which
have been summarised below.
1. Paucity of understanding the heterogeneity and ecology of both the phage and the
bacteria involved.
2. Failure to select virulent phage prior to treatment.
3. Using single phage preparations to treat a mixed bacterial population.
4. Emergence of resistant strains either by selection or lysogeny.
5. Failure to characterise and/or titre phage prior to use.
6. Not neutralising gastric pH prior to phage oral administration.
7. Inactivation of phage by specific and non-specific host immunity.
8. Liberation of endotoxins by lysis (Herxbeimer reaction).
9. Lack of reference laboratories for bacterial infections so that suitable virulent
phage could be identified.
(Modified from Kutter, 1997)
The greater comprehension of bacteriophage today has enabled scientists to exploit the
potential benefits of phage therapy (see Chapter 1). The reassessment of bacteriophage
as therapeutic agents in the West was spearheaded by an investigation into the treatment
of systemic E. coli infections in mice (Smith and Huggins, 1982) and then calves and
piglets in the 1980s (Smith and Huggins, 1983). This work was recently repeated and
expanded by other workers with similar success (Bull et aL, 2002). In recent years there
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has been a growing archive of literature demonstrating the efficacy of phage therapy in
vivo. These include work by Berchieri et al: (1991); Soothill (1992); Barrow et al.
(1998); and more recently by Park et aL (2000); Biswas et al. (2002) and Cerveny et al;
(2002).
The current advances of phage therapy in vivo have prompted several theoretical papers
on the mathematical dynamics of phage infection (Wiggins and Alexander, 1985;
Payne and Jansen, 2001). The models derived from these studies are useful tools in
honing phage therapy towards specific objectives for controlling selected bacterial
populations. They also highlight that care must be taken to fully characterise the
replication dynamics of both phage and host as even minor changes in the timing of
phage inoculation and/or the titre administered can have a dramatic effect on the outcome
of therapy (Payne and Jansen, 2001). The relative density of the host must also be
considered in the design of phage intervention strategies. Both theoretical (payne and
Jansen, 2000; Payne and Jansen, 2001) and practical (Wiggins and Alexander, 1985)
studies report that a critical bacterial density is required to support phage replication in
vivo.
Campylobae/er readily colonises the chicken gut (Beery et aL, 1988) and is highly
prevalent in UK flocks (Humphrey et al., 1993). Fresh poultry produce is widely
regarded as the major reservoir for human campylobacteriosis (Jacobs-Reitsma, 2000).
Bacteriophage-mediated biocontrol of food-borne pathogens has already enjoyed some
success with Salmonella enterica in poultry (Barrow et aL, 1998) and fresh fruit
(Leverentz et aL, 2001), albeit in different circumstances to the present study.
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Campylobacters are not generally pathogenic in chickens and so, in the context of this
study, "phage therapy" is a misnomer as there is no evidence that the presence or absence
ofCampylobaeter in the chicken gut adversely affects the birds' health. The paradigm of
this study denotes ''phage therapy" as a process utilised to indirectly alleviate a major
human public health burden rather than treating a veterinary disease.
The ability of a strain of Campylobacter to reliably colonise the chicken gut to within a
narrow density range was a prime concern prior to commencing therapeutic phage trials
since large fluctuations in host cell density in the targeted organs could result in highly
variable efficacy (Payne and Jansen, 2001). To this end, the first aim of this study was
to determine the ability of several commercial broiler chicken Campylobacter isolates to
re-colonise broiler chickens under experimental conditions. Once this was complete and
suitable hosts were selected, the ability of bacteriophage isolated from chicken excreta
(CPS) and retail poultry (w2) to control populations of their hosts in the broiler chicken
gastrointestinal tract (Fig. SA) was investigated. The study concluded by characterising
phage-resistant campylobacters re-isolated from phage-treated birds with respect to their
colonisation potential and pulsed field gel electrophoresis (pFGE) macro-restriction
profiles.
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Figure SA. Gastrointestinal tract of the domestic chicken.
Diagram showing the major organs of the chicken gastrointestinal tract. The crop is the
major site of food storage and also moistens the food prior to digestion. The
proventriuculus produces peptic enzymes which aid the breakdown of ingesta prior to
grinding in the gizzard. The small intestine is the main site of enzymatic digestion
and nutrient adsorption in the chicken and shares many features with the mammalian
equivalent. The caeca function in the adsoption of water, the digestion of fibre and the
synthesis of water soluable vitamins. The primary role of the large intestine is water
adsorption prior to storage of waste in the cloaca. In females, the cloaca is a junction
between the gastrointestinal, urinary and reproductive systems.
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8.1 RESULTS
8.1.1 Isolation of Campylabaeter and Salmonella from broiler excreta prior
to and during trials
The chickens used in the phage therapy and Campylobaeter colonisation trails were
reared to be free of Campylobaeter ssp. and Salmonella ssp. (2.11.1) but were not
specific pathogen free (SPF). Conventionally-reared birds were chosen for the trials to
more accurately reflect the probable outcome of phage therapy should it be commercially
implemented. Prior to commencing all the trials, samples of excreta were taken
periodically from each chick and screened for the presence of Salmonella ssp (2.11.2)
and Campylobaeter ssp. using enrichment and direct plating techniques specific for each
genus. Naturally-occurring Campylobaeter and Salmonella were not recovered from any
of the excreta samples taken from the chicks on any of the trials. Campylobacter
colonies recovered from each experimental and control group (n = 10 per group where
applicable) were subjected to flo typing (2.5.8) to confirm identity with the inoculated
strain of Campylobaeter used in each trial. All recovered Campylobaeter colonies
showed identity to their respective inoculated strains and no 'rogue' flo types were
detected in any of the trials. No campylobacters or bacteriophage were recovered from
'true negative' chicken controls at any point during any of the trials. These data
suggested that the chickens used in the trials were not colonised by environmental
Campylobaeter or bacteriophage strains at detectable levels.
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8.1.2 Trial1: Colonisation potential of Campylobacter excreta Isolates.
Previous reports have recorded considerable variation in the ability of different
Campylobacter strains to colonise the chicken caecum (Cawthraw et aL, 1996; Ringoir
and Korolik, 2003). The impact of bacteriophage on bacterial populations can be
determined more accurately if the colonisation potential of their host is high and shows
minimal deviation between birds inoculated simultaneously. As a first step to selecting a
host with these traits the colonisation potential of three strains of Campylobacter (GIIC8,
HPCS and OCIICIO, previously isolated from chicken excreta by Ms. C. Loc-Carrillo)
over a five day period was determined (2.11.5). Data showing the colonisation level of
these strains in chicken caeca is presented in Figure SB. The broiler chicken caecum was
colonised to average titres (loglO cfu g-I caecal contents) of 7.2S ± 0.52 (GIICS), 6.9 ±
1.31 (HPCS) and 8.0S ± 0.39 (OCIICI0) respectively. Strain OCIICI0 was the most
stable and successful coloniser with an average titre of 10gIO8.0S ± 0.39 cfu s" caecal
contents over the five day period of the trial. Strains GIICS and HPCS colonised the
caeca to a comparable level (approximately 10glO7.0 cfu g-I) but HPCS showed greater
variation (± loglo 1.31) than GIICS (loglo ± 0.52). Figure SB also shows the comparative
colonisation of a well-characterised human faecal isolate (C. jejuni S1116) recorded in a
concurrent study by Ms. C. Loc-Carrillo. Strain 81116 colonised the chicken caecum to
an average level of 10glO7.4 ± 0.65 cfu g-I over the course of the trial which was
significantly lower (P<O.OOI) than observed by other workers (loglO 9.6 cfu got) using the
same strain passaged through the chicken gut (Cawthraw et aL, 1996). This suggested
that maximal colonisation of the chicken caecum would probably be achieved by
minimally-passaged Campylobacter isolates from the chicken intestine.
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Figure 8B. Colonisation potential of Campylobacter jejuni isolates
The level to which four strains of Campylobacter jejuni colonise the broiler chicken
caecum under experimental conditions. Data are presented for chicken isolates GIIC8
( • ); HPC5 (0 ) and aCIICI0 ( 0 ) along with human isolate 81116 (D). The
colonisation level was recorded as loglQcfu g-l caecal contents ± standard deviation.
These results are based on three replicates.
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Campylobacter strains recovered from each experimental and control group showed
identical fla types to the strains used to inoculate the chickens. The relatively high and
stable colonisation of the chicken caecum by C. jejuni strains GIIC8 and OCIICIO
compared with the other campylobacters suggested these were the most suitable hosts to
use in future phage therapy trials.
8.1.3 Trial 2: Bacteriophage therapy trial A.
The effect of bacteriophage on the colonisation of broiler chicken caeca by
Campylobacter was first investigated using phage CPS with host strain C. jejuni GIICS.
Broiler chicks (n = 40) were placed into four treatment groups (4 x 10) at 15 days of age.
At 16 days of age (Trial Day -2), birds in Group 2 ('Campy/obaeter only') and Group 4
('Campy/obaeter plus bacteriophage') were each dosed with approximately 1 ml of a
loglO 7.9 cfu mrl suspension of C. jejuni GIICS prepared in PBS. At 19 days of age
(Trial Day 0), birds in Group 3 ('bacteriophage only') and Group 4 ('Campy/obaeter plus
bacteriophage') were each dosed with approximately 1 ml of a 10giO 8.7 pfu mrl
suspension of phage CP8 prepared in 10 mM phosphate buffer (PB) supplemented with
30010 w/v CaCOJ as an antacid. Birds in Group 1 ('true negative controls') were dosed
with PB containing 30% w/v CaCOJ. On each of the five days following phage dosing,
two birds from each group were sacrificed and the titres of phage (2.11.8) and
Campylobacter (2.11.7) in the caeca were determined. The presence of phage and
Campylobacter in a selection of vital organs was determined by direct plating of tissue
samples macerated in maximum recovery diluent (MRD, 2.02) onto mCCDA selective
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agar (2.3.1.4). These organs included the heart, liver, kidneys, pancreas, crop, gizzard,
proventriculus, smaJl intestine, caeca and large intestine.
The effect of bacteriophage CP8 on the colonisation of broiler chicken caeca by
Campylobacter jejuni strain GIlC8 is presented in Figure 8C. The 'Campylobacter only'
controls (Group 2) exhibited an average caecal colonisation level oflogto 7.72 ± 0.32 cfu
g" over the period of the trial. This was marginally above the colonisation level observed
in trial I (Ioglo 7.28 ± 0.52 cfu g-I). In contrast, a fall of loglo 4.85 ± 1.77 cfu g-I was
recorded for the Group 4 ('Campylobaeter plus bacteriophage') on the first day following
phage treatment (Trial Day I) compared with the control. The second day after phage
(Trial Day 2) treatment saw the titre of the Campylobaeter host in the experimental group
fall below the limit of detection «log to 2.0 cfu g"), Thereafter, the average
Campylobacter colonisation levels in this group for days three, four, and five were 10glO
cfu g-I 2.96 ± 0.05, 3.74 ± 0.25 and 3.83 ± 0.11 respectively. The difference in average
Campylobacter colonisation between Group 2 and Group 4 over the course of the trial
was significant (P < 0.00005). All of the campylobacters recovered from the chicks were
confirmed to be of the same Jla type as the inoculated strain. None of them showed any
appreciable resistance to infection by CP8 in in vitro assays (2.3.6.5). The titre of phage
in the caeca decreased from 10glO6.14 pfu g-l on Trial Day 1 to below detectable limits
by Trial Day 3. All Campylobacter control birds harboured Campylobacter in the small
intestine, large intestine and caecum. The crops of 2110 control birds were
Campylobacter positive and one bird had a positive gizzard. No Campylobacter cells
were recovered from any sample site outside of the chicken's gastrointestinal tract. The
results from this trial indicated that bacteriophage therapy could potentially reduce the
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Figure 8C. Bacteriophage therapy trial A (CP8 and GIIC8)
The colonisation of Campylobacter jejuni strain GIIC8 in the chicken caecum when
exposed (D) and not exposed ( , ) to bacteriophage CPS at day o. The colonisation
level was recorded as IOglOcfu g- caecal contents ± standard deviation over as-day
period. These results are based on two replicates.
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caecal colonisation of a susceptible Campylobacter strain by ~ loglo 8.0 cfu g-I. The
colonisation of C. jejuni GIIC8 in the control group was relatively stable and did not
show any indications of invading organs external to the gastrointestinal system.
8.1.4 Trial3: Bacteriophage therapy trial B
This trial sought to determine the reproducibility of the significant reductions in caecal
Campylobacter colonisation recorded when using bacteriophage CP8 in trial 2. An
additional aim of this trial was to establish if antacid administration (30 % CaC03
suspension) to the chickens had any significant impact on the efficacy of phage therapy.
At 15 days of age, broiler chicks (n = 40) were placed into one of five groups. At 16 days
of age (Trial Day -2), birds in Group 2 (n = 15, 'Campylobacter plus bacteriophage, no
antacid'), Group 4 (n = 10, 'Campylobacter only' controls) and Group 5 (n = 10,
"Campylobacter plus bacteriophage, with antacid') were each dosed with approximately
1 ml of a loglo 8.6 cfu ml" suspension of C. jejuni GIIC8. At 19 days of age (Trial Day
0), the birds in Group 2 ( 'Campylobacter plus bacteriophage, no antacid'), Group 3 (n =
2, 'bacteriophage only with antacid') and Group 5 ('Campylobacter plus bacteriophage,
with antacid') were each dosed with approximately 1 ml of a 10g1O8.7 pfu ml"
suspension of CP8 prepared in PB with or without antacid. Birds in Group 1 (n = 2, 'true
negative controls') were each dosed with approximately 1 ml ofPB with antacid. During
each of the five days following phage dosing, birds were sacrificed from Group 2 (n = 3),
Group 4 (n = 2) and Group 5 (n = 2). Birds from Groups 1 and 3 were sacrificed on the
final day of the trial (Trial Day 5). The titres of phage (2.11.8) and Campylobacter
(2.11.7) in the caeca of the birds was determined as previously described.
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The effects of administering phage CP8 with and without CaCOJ supplementation on the
colonisation of the broiler chicken caeca by C. jejuni GIIe8 are presented in Figure BD.
The average Campylobacter colonisation of the caeca in the control group over the
course of the trial was 10glO 6.7 ± 0.4 cfu gol. This was lower than the average
colonisation level recorded in the preceding trial (loglo 7.72 ± 0.32 cfu g"). In contrast
with trial two, no significant difference between the experimental groups and the control
were observed until day five of the trial (P < 0.0005). There was no significant
difference (P = 0.22) in the efficacy of phage treatment with or without the concurrent
dosage of phage with 30% CaC03 throughout the course of the trial. Again, the titre of
phage CP8 in the caeca fell during the course of the experiment from 10glO4.7 ± 0.9 pfu
s" on Trial Day 1 to below the limit of detection by Trial Day 3. All Campylobacter
control birds harboured Campylobacter in the small intestine, large intestine and caecum.
All of the campylobacters recovered from the chicks were confirmed to be of the samejla
type as the inoculated strain. None of them showed any appreciable resistance to
infection by CP8 in in vitro assays. The results of this trial suggested phage therapy was
effective in reducing Campylobacter colonisation in a repeat of trial 2. However, the
reduction in host population took appreciably longer in trial 3 than trial 2. In addition,
although the fall in Campylobacter colonisation was significant in trial 3, it was much
less pronounced than in the preceding trial. The lower host cell density recorded in the
'Campylobacter only' control group in trial 3 could have influenced the ability of phage
to find a suitable host and thus delayed the onset of the Campylobacter population
decline.
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Figure 80. Bacteriophage therapy trial B (CP8 and GIIC8)
The coloni ation of ampylobacter jejuni strain GIIe8 in the chicken caecum when
expo ed to bacteriophage CP8 with ( .) and without ( ) antacid on day 0 compared
with the ampylobacter-only control (D). The colonisation level was recorded as 10glO
cfu got caecal contents ± standard deviation over a 5-day period. These results are based
on three replicate .
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8.1.5 Trial 4: Bacteriophage therapy trial C.
The final bacteriophage therapy trial sought to establish if a phage isolated from retail
poultry (w2) could reduce the population of its host (OCIICIO) when used to orally dose
chickens. Phage w2 was selected for the trial because it exhibited a different lytic
spectrum to CP8, was able to produce clear plaques on a Campylobacter strain previously
shown to be a stable coloniser of broiler chickens (OCIICIO) and had a stable titre for at
least two months when stored in PB at 4°C. At 15 days of age, broiler chickens (n = 42)
were placed into one of three groups. At 16 days of age (Trial day -2), birds in Group 2
(n = 20, 'Campylobacter only') and Group 3 (n = 20, "Campylobacter plus
bacteriophage') were each dosed with approximately I ml of Campylobacter jejuni
OCIICIO suspension (loglO8.0 cfu ml"), At 19 days of age (Trial Day 0), birds in Group
3 were each dosed with 1 ml of bacteriophage w2 suspension (loglO 9.4 pfu ml") in PB
containing 30010 w/v antacid. Birds in Group 1 (n = 2, 'true negative controls') were each
dosed with 1 ml of PB. Following Campylobacter dosing on Trial Day -2, three birds
from Group 2 were sacrificed daily until Trial Day 0 whereafter two birds were sacrificed
per day until the end of the trial. Following phage dosing on Trial Day 0, four birds were
sacrificed daily from Group 3 until the end of the trial. The birds in Group 1 'true
negative controls' were all sacrificed at the end of the trial (Trial Day 5). The titres of
Campylobacter and bacteriophage in the caeca of the sacrificed broiler chickens were
determined using the methods described in sections 2.11.7 and 2.11.8 respectively.
The impact of phage w2 on the colonisation of the broiler chick caeca by C. jejuni
OCIIC lOis presented in Figure 8E. The Campylobacter control group colonised the
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Figure BE. Bacteriophage therapy trial C (w2 and OCIIC10).
The colonisation ofC.jejuni strain OCIICtO in the chicken caecum when exposed (0)
and not exposed (.) to a single dose of l 09 pfu of bacteriophage w2 at day O. The
colonisation level was recorded as 10gIO cfu s" caecal contents ± SD over an eight day
period. These results are based on four replicates.
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caeca to an average level of 10g1O7.4 ± 0.5 cfu g", This was significantly lower (P <
0.02) than the level recorded for trial one (logm 8.08 ± 0.39 cfu g-l). In contrast to the
results presented from trials two and three, there was no significant difference in the
colonisation of OCIIC lOin the control and experimental groups at any point of the trial
for any of the three sites of the intestine sampled (P = 0.22, for caeca). As with previous
trials, the phage titre in the caecum fell from IOg105.29 pfu g-l on Trial Day I to below
detectable levels «Ioglo 3.0 pfu g-l) by Trial Day 3. No change in the susceptibility of
OCIICIO to w2 in vitro for any of the campylobacters recovered could be demonstrated.
Three to six random Campylobacter colonies recovered from each chick were confirmed
to be of the samefla type as the inoculated strain. The results of this trial suggest that the
ability of bacteriophage to infect Campylobacter in vitro is not necessarily an indication
of efficacy in vivo. There was no evidence for the replication ofw2 in vivo which may be
a prerequisite for the success of phage therapy. The colonisation of C. jejuni OCIIC lOin
the birds' caeca was significantly lower than that recorded in trial I. However, based on
host caeca colonisation in the two preceding successful phage therapy trials, the level of
Campylobacter colonisation recorded in trial four should not have been a limiting factor
in phage biocontrol.
The development of resistance to bacteriophage infection was always foreseen as a
potential problem with this intervention strategy. However, such resistance was not
detected in any of the campylobacters recovered from trials two, three or four in the
present study. A concurrent study using a phage isolate from chicken excreta (CP34)
against C.jejuni HPCS (conducted by Ms C. Loc-Carrillo and Dr. P. Connerton) resulted
in the recovery of campylobacters resistant to infection as determined by screening
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against agar lawns of bacterial hosts (2.3.6.5). Previous phage therapy trials in cattle by
other workers has shown that phage-resistant E. coli mutants exhibit a reduced
colonisation potential when used to re-inoculate calves (Smith and Huggins, 1983). In
order to determine if this was true in CP34 phage-resistance, single colonies of resistant
campylobacters recovered from phage-treated birds were propagated on blood agar
(2.3.3.1). These were then suspended in PBS and used to orally dose broiler chicks in
order to assess any changes in colonisation potential arising in the resistant strains. Four
chicks were dosed with 1 ml of a 10gIO9.1 cfu ml" suspension of resistant isolate R14
and five birds were dosed with I ml ofa 10gIO9.0 cfu ml" suspension of resistant isolate
R20. All birds were sacrificed seven days after Campylobacter dosing. Following
dissection, the titres of Campylobacter in the upper intestine, lower intestine and caeca
were determined (2.11.7). In addition, caecal contents were also tested for the presence
of bacteriophage (2.11.8). fla-typing of Campylobacter strains was unlikely to
distinguish between phage sensitive and resistant mutants. As such, the macro-restriction
profiles of campylobacters recovered from phage-treated birds were compared using
PFGE (section 8.2.7) to determine if resistance was associated with any changes in the
genome structure of these strains.
Of the 92 colonies of Campylobacter strain HPC5 originally recovered from the phage
therapy trial with CP34, 10 (11%) were resistant to phage infection in vitro. All colonies
recovered from control birds remained sensitive to CP34 infection. PFGE using
endonuclease SmaI (performed by Ms. E. Dillion) revealed that resistant strains exhibited
a different macrorestriction profile to that of the sensitive strains (Fig. SF). Specifically,
extra SmaI restriction fragments approximately 390 kb and 230 kb were present in R14
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Figure 8F. PFGE Macro-restriction profiles of phage-resistant and
sen itive campylobacters
A 1% PF E gel showing whole genome SmaI restriction profiles of Campy/obacter
strains recovered from chickens treated with phage CP34. These campylobacters were
eith r ensitive ( 1 S2) or resistant (R14, R20) to reinfection by phage CP34. The size
of the ambda concatomer markers (M) are shown inKb on the far right of the figure.
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but not in the controls. A restriction fragment approximately 147 kb was present in R20
whilst a larger DNA band present in the control (170 kb) was absent. Interestingly, both
R 14 and R20 lacked an 8S kb restriction fragment present in the phage-sensitive control
isolates (Fig. 8F). When reintroduced into chickens, average caecal colonisation of the
resistant Campylobacter strains Rt4 and R20 was 10gJO6.2 ± 1.0 cfu g" and loglo 5.9 ±
0.7 cfu g-l respectively. This was, on average, 10glO0.7 cfu g-I lower than that recorded
for the controls (log10 6.76 ± 0.3 cfu g-I). This difference was significant for R20 (P <
0.02) but not for R 14 (P = 0.13). However, of the 90 colonies recovered from the
chickens recolonised with R14 and R20 in this experiment, only three (3.3%) retained
their resistance to infection by phage CP34. Intriguingly, the changes in macrorestriction
profiles of the phage-resistant strains recorded in Figure 8F were maintained, implying
this profile change in itself does not confer phage resistance.
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8.2 DISCUSSION
Trial one demonstrated that some Campylobacter strains (e.g. OeIICI0) colonise the
broiler chick gut to a higher titre and with less variability than other strains (e.g. HPC5).
Whcn considering a model for phage therapy, host colonisation to a consistent and high
level is crucial if the results of phage intervention are not to be confused with natural
variation in host numbers. Cjejuni strains GIIC8 and OCIICI0 were stable colonisers of
the gut and were deemed suitable hosts for use in phage biocontrol trials. It was
interesting to note that the C. jejuni 8 I 116 strain passaged in vitro colonised the chicken
caeca to a significantly lower level than previous reports using the in vivo passaged strain
81116P (Cawthraw d QL, 1996). C.jejuni strains cultured in vitro tend to have a dose-
response colonisation pattern in broiler chickens compared with the "all-or-nothing"
colonisation of in vivo passaged strains (Cawtbraw et aL, 1996). Considering GIIe8,
OCIICI0 and HPCS were all fresh chicken excreta isolates with minimal in vitro passage,
they might be expected to colonise the chicken gut to a higher level than 81116 which has
been sub-cultured at least 300 times (Manning et aL, 2001). However, there was no
significant difference between the colonisation level of any of the carnpylobacters
isolated from chicken excreta and 81116 (P = 0.41, GIIe8; P = 0.24, HPC5; P = 0.15,
OCHe I0). Trial three revealed that the addition of eae03 to oral phage preparations has
little or no effect on the outcome of phage therapy. Failure to neutralise gastric pH is
purported to be a major reason for early phage therapy failures (Kutter, 1997). The data
presented here suggest that this is not a significant contributory factor to the success of
Campylobacter phage treatment in broiler chickens.
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The discrepancy in the results for trials two and three may reflect the fact that the efficacy
of phage intervcntion relics on optimising the titre and timing of the phage dose (payne
and JanKn, lOCH). The Campylobacter titre in trial three experimental birds fell on day
four and continued to fallon day five in relation to the control. The greatest decrease in
Campylobacter titre in trial three was IOg101.8 cfu golon day five compared with >log10
8.0 cfu g.' on day one recorded for trial two using the same bacteriophage (CP8).
Successful bacteriophage intervention relies not only on the titre of the phage but on the
availability and metabolic state of the host (Payne and Jansen, 2001). The generally
lower caecal colonisation of the Campylobacter host in trial three may have contributed
to the reduced efficacy of phage CPS. Unlike other predators of bacteria such as
Bdellovibrio, phage rely solely on diffusion to find their prey (Wilkinson, 2001).
Mathematical models of phage infection allude to abundance of the host as a critical
factor in the success of phage therapy (Wiggins and Alexander, 1985; Payne and
Jansen,lOOI). Since trial three concluded on day five, where the greatest reduction in
host population was recorded, it is unknown whether the same reductions observed for
trial two would have been repeated if the time course was extended.
Resistance to bacteriophage infection has always been foreseen as a drawback of phage
therapy (Kutter, 1997). The data presented in this study suggest that resistance to
Campylobacter phage does occur but may be detected in greater frequency with some
bacteriophage/host combinations than others. Classic experiments by Smith and Huggins
in 1983 showed that phage resistant E. coli mutants were less virulent than their phage-
sensitive counterparts (Smith and Huggins, 1983). Resistance to infection by one
bacteriophage often leads to susceptibility to another, hence the use of mixtures or
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"cocktails" of phage in therapeutic trials (Smith and Huggins, 1983; Bull et al., 2002).
In this study, phage resistant strains of C. jejuni HPC5 were poorer colonisers of the
broiler chicken gut with the average titre in the caeca of broiler chicks being 10g1O0.7 cfu
gO' less than the phage-sensitive control. This apparent reduction in colonisation potential
was accompanied by a clear shift in macrorestriction patterns observed using PFGE (Fig.
SE) although this was not always associated with resistance to phage infection. The loss
of a higher molecular weight band with the gain of a lower band in phage resistant strain
R20 suggested a deletion has taken place. Resistance was not maintained in the majority
(97%) of strains when used to recolonise chicken indicating a possible selection
mechanism against resistance. This would support the findings of Smith and Huggins
that phage-resistent strains were less fit (Smith and Huggins, 1983).
The declining phage titre in chicken caeca in all of the trials is confusing as active
replication on their hosts should be accompanied by an increase in virion concentration.
Concurrent trials with phage CPS and C. jejuni HPC5 recorded a stable 'out of phase'
cycling of phage and host titres throughout the time course (Dr. P. Connerton pers
comm.). However, the decrease in bacterial density in these trials (approximately 10g1O
I.S - 2.0 cfu s" caecal contents) was not as great as that recorded for trial two in the
present study. Data presented in Chapter 3 suggest the burst size of Campylobacter
phage isolated from chicken skin and belonging to the Myoviridae family may be ten or
fewer per infected cell. Consequently, the phage may infect and lyse the host when at
high titre and then be unable to maintain their population to a level where they can
readily find new hosts. In this scenario, the phage would be gradually removed from the
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system once host bacteria density had fallen below a critical value required for replication
(Wi~ins and Aluande-r. 1985; Payne and Jansen, 2001).
The failure of phage w2 to have a significant impact on C.jejuni OCIICIO colonisation in
trial 4 was unexpected. Unlike the delayed reduction in host titres recorded for trial 3, in
trial4 there was no such reduction seen at any of the sample sites at any point in the trial.
This implied that extending the time scale of the trial would not yield the desired
reductions in host colonisation. CPS is clearly different from the phage isolated from
food both in terms of genome size (130 kb) and lytic spectrum (Dr. P. Connerton pers
comm.). The therapeutic trials also demonstrate that these phage differ in terms of their
ability to control their host populations in vivo. Previous work has shown that attachment
deficiencies prevent some Campylobacter bacteriophage from completing their infection
cycle in liquid culture even when they are able to lyse lawns of their hosts on agar plates
(Dr. R. Mole pen comm.), The chicken gut contains a plethora of micro organisms of
which only a fraction have been fully characterised (Mead et al., 1996). Although non-
specific attachment of phage w2 to polypropylene test tubes or non-host campylobacters
was not observed (Chapter 3) attachment to non-host cells in the chicken's
gastrointestinal tract cannot be ruled out. The non-specific adsorption to members of
other bacterial genera could be another factor which distinguishes CP8 from w2.
In conclusion. the data presented here clearly demonstrate that phage therapy has the
potential to significantly impact on Campylobacter colonisation of the chicken caecum.
Nevertheless, more work is required to optimise the timing and level of the phage dosage
to maximise the therapeutic effect. The emergence of strains resistant to bacteriophage is
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concerning but these strains also seem less able to colonise the chicken caecum. Control
of Campylobacter contamination of broiler chickens at the farm level, if applied
uniformly, is likely to have the greatest impact on contamination on the final product
(Nnvtll aDd Wa2tDaar, 2000) and potentially the disease burden in humans (Jacobs-
Rtitsma,2000). Recent reports on Campylobacter quantitative risk assessment in the
food chain suggest a loglo 2.0 cfu reduction of this bacterium on the surface of retail
chicken would reduce the human incidence of campylobacteriosis by greater than 30-fold
(ROKaqul~t n ilL, 2(03). Slaughtering birds at the point where the bacteriophage have
reduced their host's tim: to below detectable limits would both limit the emergence of
resistant strains and maximise the efficacy of this intervention measure to assist in
reaching this goal.
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DISCUSSION
The work presented in this thesis has provided the underpinning science enabling the use
of bacteriophage to control Campylobacter in retail poultry production. Successful
application of this technique in a wider commercial setting would hopefully lead to a
significant reduction in Campylobacter contamination of retail chicken products and
subsequently lead to a decrease in the incidence of human campylobacteriosis. Recent
studies in the West have shown that "phage therapy" can be effectively applied in many
situations, from the decontamination of surfaces to the treatment of enteric and systemic
bacterial disease in humans and domestic animals. The success of phage therapy to treat
Salmonella infections in broiler chickens suggests this technique may be transferable to
Campylobacler in the same host and was the basis for the work presented in this thesis.
Before the broader issues of the in vivo efficacy of phage therapy could be addressed, the
presence and characteristics of Campylobacter bacteriophage already in the poultry food
chain needed to be determined. This was crucial if appropriate bacteriophage were to be
selected for therapeutic endeavours in the future. To this end, the first aim of this project
was to isolate and characterise Campylobacter bacteriophage from different parts of the
poultry production chain. The successful isolation of phage from retail chicken (Chapter
3) was an important milestone in the broader aims of this project for two reasons. Firstly,
Chapter9
it demonstrated that phage were able to survive abattoir processing and be a potential
source of therapeutic phage hitherto not investigated. Secondly, it also showed that
phage therapy in broilers would not introduce any new biological entity into the food
chain which was not already present The latter point is particularly important with
respect to the acceptability of food treatments to the general public being a prime concern
of government Certainly, there is broad scope for a public-relations disaster if national
media coverage of phage therapy in food production was unfavourable.
Ultimately, the phage isolated from the chicken products are likely to originate, like their
hosts, from the gastrointestinal tract of the broiler chicken. The variability in survival of
different bacteriophage isolates on chicken skin suggests that poultry processing may
select for a subset of phage able to survive under those conditions. This data may prove
useful should one wish to isolate phage suitable for direct application to decontaminate
surfaces. Indeed, the work presented in Chapter 6 indicates that the number of
recoverable Campylobocler cells from chicken skin can be significantly reduced by the
direct application of bacteriophage, even under conditions not permissive for replication
of their host. As a consequence of this, phage biocontrol may be applied as a sole or
combination treatment in both the farm and the abattoir to achieve maximum reductions
in the presence of their host However, it is unknown as to whether phage used
effectively on the farm would be transferable to biocontrol in the abattoir. The use of
similar phage at different stages of production would be unwise in any case, as any
phage-resistant mutants would bemore likely to accumulate in the food chain.
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The majority of the 170 Campylobacter phage isolated from other studies belong to the
Myoviridae family of viruses. Data from Chapter 4 confirmed that all of the phage
isolated from retail chicken also belong to this family. The majority of Myoviridae phage
follow a lytic lifecycle which bodes well for their potential as therapeutic agents.
Lysogeny has not yet been reported in Campylobacter and the lack of any phage-like
insertion clements in the complete DNA sequence of C. jejuni NCTC 11168 suggests this
lifecycle is uncommon in Campylobacter phage. Specialised transduction mediated by
temperate phage must be avoided by the exclusive use of lytic phage for therapy. The
prevention of generalised transduction would not be a practical possibility in most cases.
However, it could be minimised by careful screening to select lytic phage with a low
frequency of transduction.
The similarities in lytic spectra between phage isolates from different chicken samples
originating from different producers further supports the hypothesis that poultry
processing imposes a selective pressure on the phage. Such pressures are in addition to
those imposed in their original environment, which is likely to be the chicken
gastrointestinal tract. However, the work in Chapter 4 also highlighted the importance of
strain selection in lytic spectrum sensitivity. The large number of strains used by the
PilLS (or Campylobacter phage typing only discriminated two different lytic spectra
amongst the phage isolated (rom retail chicken products. However, far fewer
Campylobacter strains sourced from retail chicken and the NCTC were able to subdivide
these phage into eight lytic classes. Some of these differences could also be correlated
with genotypic differences using PFGE and differences in the size of the major proteins.
This difference in sensitivity may be a consequence of the relatively narrow source of the
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PHLS Campylobacter strains, all of which were isolated from human faeces. Techniques
such as multilocus sequence typing have shown human Campylobacter isolates to cluster
around relatively few sequence types whereas isolates from animals show a much broader
distribution. This raises important issues regarding the methods and strains which should
be used to determine the potential efficacy of phage against certain subgroups of
Campylobacter. The possibility exists that phage need only be selected against
campylobacters of a particular pathogenic subtype. However, in other food-borne
pathogens such as Salmonella, nearly all subtypes are capable of human disease. With
Salmonella, infection is determined by the subtype predominating in the food chain at
any particular moment.
The work presented in Chapter 5 showed that Campylobacter phage were more
frequently isolated from chicken caeca that retail poultry products. Perhaps the most
interesting conclusion from this work was that chickens harbouring phage were generally
colonised by fewer campylobacters. This strongly suggests that phage constitute a
restricting force on the level to which campylobacters are able to colonise the chicken
caecum under natural conditions. Given the knowledge of predator-prey interactions in
nature, this may not be surprising. Should the host and parasite co-exist, the likelihood of
isolating a highly virulent phage with a broad host range is minimal as such a phage
would quickly eliminate all potential ho'sts and cause their own eradication.
I
Nevertheless, virulent phage were isolated fro~ chicken caeca which were able to infect
the majority of human Campylobacter isolates with different phage types employed in the
PHLS phage-typing scheme. The highly variable titres of phage recovered and general
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insensitivity of their contemporaneous Campylobacter isolates to infection suggests a
dynamic system in which the type and number of phage isolated can change frequently.
The broiler chickens examined in Chapter 5 were each colonised by a limited number of
Campylobacter subtypes. This agreed with previous data suggesting that conventionally
reared flocks are usually colonised by one or two Campylobacter strains. The reason for
this is unclear but may be a reflection of the degree of exposure to the environment. This
could be advantageous in phage therapy as the colonisation of a flock by a uniform
genotype of Campylobacter would allow rapid dissemination of an infecting phage
throughout the flock. However, this would also present a strong selective pressure for
resistant phenotypes of the host which are likely to spread quickly. Consequently, the
phenotypic characteristics of campylobacters in phage-infected flocks may be very
dynamic and this may not be detected using the more commonly-used genetic subtyping
techniques such asJla typing unless the flagella themselves are phage receptor sites.
The in vitro replication of the Campylobacter phage isolates in Chapter 4 suggested these
phage have a low burst size and are released asynchronously from their host cells. These
properties were not advantageous when selecting appropriate phage for therapeutic trials
in chickens. Phage w2 for example, failed to reduce Campylobacter colonisation in vivo
despite showing some promise during in vitro assays. During in vitro replication on a
lawn of susceptible bacteria, the phage are presented with a high concentration of
relatively immobile genetically homogenous hosts. This scenario is far removed from the
chicken gut where the phage may encounter potentially inactivating extremes of pH,
proteolytic enzymes and a plethora of other bacteria which may act as decoys. The data
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presented in Chapters 4, 5 and 8 are important for future phage therapy endeavours as
phage activity in vitro is not necessarily mirrored in vivo. In a wider setting, the clinical
application of phage therapy needs to take this into account, especially since treatment is
often prescribed after screening an infecting bacterial strain against phage in vitro. The
potential also exists that highly lytic phage in vivo are not always detected by current in
vitro isolation methods.
Another important issue arising from the phage therapy work in Chapter 8 was the
variable efficacy of phage CP8 in vivo. This phage significantly reduced Campylobacter
colonisation in two independent trials but by appreciably different degrees and at
different times. The reasons for this are unknown but may reflect the physiological state
of the birds, the nature of the intestinal microflora, the exact time and quantity of dosing
or the titre of Campylobacter in the caecum. Further research is required to optimise
phage therapy in chickens prior to its commercial application. The emergence of phage-
resistant strains, as reported in Chapter 8, was always a predicted outcome of phage
therapy. Interestingly, phage-resistant mutants in this study appeared to be less able to
colonise the chicken caecum. This difference was statistically significant for only one of
the two resistant strains tested. However, previous studies have suggested that phage
resistance in E. coli, in certain circumstances, can be linked with either a poorer
colonisation potential or attenuated virulence.
As a Gram negative bacterium, Campylobacter has the potential to produce membrane
vesicles (MY) from blebbing of the outer membrane. In other species, such blebs have
been shown to perform a variety of functions from causing the death of competing
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bacteria to acting as molecular decoys for antibiotics. Such MVs also have the potential
to hinder phage infection by acting as decoys for phage attachment. They also have the
potential to assist phage as, once infected, they may fuse with the outer membranes of
other Campylobacter strains which do not possess the "correct" phage receptor site and
introduce the viral genome to the cell. The attachment of phage to membrane vesicles
produced by Campylobacter clearly occurs to some degree as observed by electron
microscopy. However, this process either does not affect, or does not occur at an
appreciable frequency to affect, replication on the host cell. Therefore it is unlikely that
production of membrane vesicles would be deleterious to phage therapy in chickens.
In conclusion, the work presented in this thesis has demonstrated that Campylobacter
phage are present throughout the production of retail broiler chicken meat. These phage
could be ascribed to genotypically and phenotypically distinct classes. Similarities
between phage isolates from retail chicken compared with from broiler chicken caeca
suggest some selective pressure is taking place during and after abattoir processing. The
application of a sufficient quantity of phage directly onto contaminated chicken skin can
reduce the numbers of Campylobacter recovered under experimental conditions. The
presence of bacteriophage has been correlated with a lower titre of Campylobacter in the
caeca of chickens taken from conventionally-reared flocks. This suggested that phage
predation is a controlling factor which limits the colonisation of their hosts in natural
systems. Such biocontrol was demonstrated when phage used to dose broiler chicks
experimentally infected with Campylobacter significantly reduced the presence of their
host in various sites of the gastrointestinal tract. Bacteriophage therapy is currently re-
emerging in the West. The work presented in this thesis contributes to a growing body of
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research highlighting the potential of phage to control bacterial infections in man and
animals. If used wisely, with sufficient safeguards, phage therapy could make an
invaluable contribution to both veterinary and clinical medicine and be an effective
weapon in the fight against bacterial disease.
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